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This thesis has provided evidence of increased ROIs activity following
reperfusion of liver grafts. The magnitude of changes correlated with the
severity of graft dysfunction. It also demonstrated that neutrophil activation
occurs following graft reperfusion with evidence of endothelial cell damage
as a result of such activity.
This thesis has shown that an ICG clearance <200ml/min measured within
24 hrs following liver transplantation predicted graft dysfunction due to
reperfusion injury with high specificity and sensitivity.
Finally this thesis has demonstrated that the haemodynamic changes
following reperfusion of liver graft during transplantation involve
predominantly the pulmonary vasculature. It also demonstrates that these
changes correlated significantly with a reduction in the levels of cGMP,
which suggests a causal relationship. The endothelins levels in blood were
raised before transplantation and remained so post-reperfusion, with no














The liver graft often fails to function adequately after transplant operation
for no clear reason. This thesis explores the humoral changes during the
reperfusion phase of the transplant operation that could have a profound
effect on graft outcome. The reperfusion phase of the operation is a critical
stage when haemodynamic instabilities may occur with unfavourable
consequences. Numerous studies on animal models and also in human
organ transplantation (e.g. heart, kidneys and lungs) suggested
development of ischaemia-reperfusion injury that may lead to graft failure.
This chapter serves as a background for this thesis. The history of liver
transplantation is briefly reviewed, followed by a detailed account of liver
graft dysfunction including the clinical features and the potential
pathogenic mechanisms. Aspects of preservation fluids including the
rationale behind their developments and the nature of their contents are
discussed in detail. The features of cold ischaemia are discussed followed
by detailed account on the changes during reperfusion. Finally, the
hypotheses behind the research in this thesis and a brief description of the
studies are included at the end of this chapter.
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Historical Background
The first report of a liver transplantation was by Stuart Welch in (1955). It
was a description of auxiliary canine liver transplantation that involved
insertion of an extra liver into the pelvis or right paravertebral gutter of non-
immunosuppressed recipients. Cannon (1956) speculated that because the
liver played an important role in rejection, it might be the main factor for the
rapid destruction of the grafts reported following auxiliary transplantation.
He was the first to describe orthotopic liver transplantation (OLT) (i.e.
replacement of the liver in its original site), but again as the case with the
auxiliary technique, none of his dogs survived the operation.
Further attempts with OLT were described by other workers, and despite
the absence of effective immunosuppression at that time, a solid basis for
future work with OLT was laid throughout that period. In 1960, Moore
reported on 31 canine experiments with 7 survivors of 4-12 days. Rejection
was present after 5-6 days and was the main cause of death.
From the early stages of liver transplant history, the importance of graft
preservation was appreciated and to start with, intra-portal infusion of
chilled electrolyte solutions were used in the same way as is practised
clinically today. Improved infusates in the succeeding years eventually
6
replaced the lactate Ringer's and saline solutions that were used originally.
Use of University of Wisconsin (UW) solution in 1987, dramatically
increased the length of safe preservation time from about 5 hours to 18-24
hours.
Venous bypass was used in canine liver transplantation as early as 1960
by Moore. It passively redirected blood from the occluded splanchnic and
systemic venous beds to the superior vena cava during the anhepatic
stage while recipient hepatectomy was performed and the new liver
installed. Although venous bypass has not always been essential, it
however made the operation less stressful in humans and played a role in
further expansion of the transplant service.
The clinical trials of human liver transplantation started in 1963. Seven
liver transplantations were reported by three different centres (Starzl,
1996). The results were disappointing and attempts for further
transplantation stopped for a few more years up until 1967 when
polyclonal antilymphocyte globulins were added to the standard
immunosuppression of steroids and azathioprine.
The longest survival of liver transplant recipients treated between July
1967 and March 1968 was 30 months (Starzl 1996). For the next 12 years,
the 1 year mortality rate after liver transplantation never fell below 50%.
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The losses were concentrated in the first postoperative months; after this
initial period the life survival curve flattened, leaving a residual group of
stable and remarkably healthy survivors.
Introduction of cyclosporin to clinical use in 1979 (Calne et al), had a
remarkable impact on the success of organ transplantation. Of the first 12
liver recipients treated with cyclosporine and prednisolone in the first 8
months of 1980, 11 lived for more than a year (Starzl et al ) and 7 were still
alive over 12 years later. As the news was confirmed that a 1 year patient
survival rate of at least 70% was readily achievable, new liver programs
proliferated worldwide.
Although the progress of liver transplantation was dominated by
improvements in immunosuppression, there were other significant
developments, including modifications in the details of the operation itself.
The incidence of biliary duct complications has significantly decreased.
Management of coagulopathies was facilitated by the use of the
thromboelastogram to follow the minute-to-minute clotting changes in the
operating room (Kang et al, 1985). The systematic use of veno-venous
bypasses without anticoagulation also greatly diminished the occurrence
of life thretening haemorrhages common at one time
8
GRAFT DYSFUNCTION
Even with current optimal clinical liver preservation strategies, including
short preservation time, some degree of clinical and biochemical
dysfunction almost invariably occurs, the severity of which correlates with
the degree of hepatic injury. Shaw et al (1985), were probably the first to
use the term Primary non-function (PNF) to describe early graft failure
post-transplantation. Many define PNF loosely as "initial poor hepatic
function" (Greig et al 1989) or immediate graft failure (D'Alessandro et al
1993). Almost all omit any reference to a specific time course, although
most would agree that PNF includes graft failure occurring from within
hours to the first few days after transplantation. Differences in definition
arise because organ failure exists as a continuum from potentially
reversible dysfunction, namely primary graft dysfunction (PGD) to
complete and unequivocal failure. PNF is considered to be a diagnosis of
exclusion (Kakizoe et al 1990) and it represents the failure of an allograft
soon after revascularization with no obvious cause, leading either to
retransplantation or to the patient's death.
The reported incidence of PNF varied from 2-10% according to the criteria
used for its definition (Greig et al 1989, Kamath et al 1990). It is generally,
the most common cause of early graft loss, accounting for up to 40% of
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such failures (D'Alessandro et al, 1992), and, has been the commonest
indication for retransplantation within the first weeks following OLT
(Howard et al 1990, Clavien et al 1992). There is however, a general
feeling that the PNF could be significantly underreported. Deaths occuring
early in the post-transplant period and attributed to sepsis, irreversible
neurological injury, multiple organ system failure, and other nonhepatic
causes may actually be the indirect effects of a non-functioning graft
(Kakizoe et al, 1990).
Primary graft dysfunction (PGD) is a term covers the whole spectrum of
graft failure with PNF representing its extreme and severe form. Even, in
its mild form, PGD could result in slow postoperative recovery, prolonged
intensive care stay (Ploeg et al, 1993), and subsequent allograft rejection
(Howard et al 1990).
Patients with PNF develop encephalopathy, haemodynamic instability, and
produce scanty, and pale bile. PNF is associated with increasing glucose
requirement, coagulopathy, markedly raised plasma transaminases,
metabolic acidosis and renal failure. Histologically the appearance ranges
from mild cellular infiltration to hepatocyte ballooning with focal or zonal
necrosis, along with microvesicular steatosis (Ludwig, 1988). The
ultrastructural findings are classically seen in the sinusoidal lining cells
(SLC), and include endothelial cell vaculisation, mitochondrialysis, and
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plasma membrane interruption with poor rounding of cells (Momi et al,
1989).
Considerable advances have been made in our understanding of the
pathogenesis of graft dysfunction following OLT. The following is a review
of the literature concerning the potential mechanisms in the aetiology of
graft dysfunction.
GRAFT DYSFUNCTION: PATHOGENESIS
In most of the cases, PGD is likely to be the product of a number of
different factors that arise either during and/or after transplantation. Such
factors include: donor status; organ preservation; and reperfusion. By
definition, PGD does not include the technical difficulties that can lead to
graft failure. The following section deals with the perceived relative
importance of these factors in the pathogenesis of PGD.
DONOR FACTORS:
Although PGD has been described in organs retrieved from "perfect"
donors, there has been a general acceptance that it occurs with greater
frequency in "marginal" donors. The decision regarding graft suitability at
the time of retrieval is often difficult. The time available is usually limited
for any detailed objective tests to be performed in those circumstances.
Potential donors with ongoing liver disease, abnormal liver functions,
positive viral hepatitis screen, or known with alcohol or drug abuse are
usually excluded. The macroscopic appearance of the liver at the time of
retrieval may be a helpful albeit late guide in determining graft suitability.
Donor issues which have received particular interest as are thought to be
of potential influence of graft viability, included fatty changes of the liver,
donor age, nutrition, and haemodynemic instability.
Hepatic Steatosis:
Fatty infiltration of the donor liver has been suggested as a risk factor for
graft dysfunction and is frequently related to alcohol abuse (Strasberg et al
1994, Gao et al 1995). Grafts from malnourished, obese or older donors
may also show fatty infiltration. The prevalence of fatty liver among the
potential donor liver population is high, ranging from 13-26%
(D'Alessandro et al 1991, Markin et al 1993). A key problem to the issue of
transplantation of fatty liver is to establish the degree of steatosis that
makes a donor organ unacceptable (Trevisani et al, 1996). Fatty liver is
classified as mild if up to 30% of hepatocytes are steatotic, moderate when
30-60% of cells are involved, and severe if the figure is >60%. The latter
has been identified as an absolute risk factor for graft failure and such
grafts should be excluded. Adam et al (1991) found no difference in the
one month survival of grafts with mild to moderate steatosis when
compared with non-steatotic organs. These findings however were not
supported by Ploeg et al (1993) who reported using multivariate analysis
that moderate steatosis was an independent risk factor for initial poor graft
function
The mechanism by which fatty infiltration causes graft failure is unclear. A
mechanical disruption of the hepatic sinusoids is thought by many to be
the principle cause of graft dysfunction. Todo et al (1989) postulated that
post-reperfusion, ruptured hepatocytes release fat contents into hepatic
sinusoids which then coalesce into very large fat droplets which compress
and obstruct the hepatic microcirculation. This leads to hepatocyte
damage by local ischaemic effect. Release of free lipid from the damaged
fat-laden hepatocyte into the sinusoidal circulation provides a substrate for
subsequent lipid peroxidation by reactive oxygen intermediates during
reperfusion and results in progressive endothelial cell injury that further
impairs the hepatic microcirculation and subsequent liver graft function
(Teramoto et al 1993). Enhanced Kupffer cell activity in grafts with marked
fatty infiltration was noted, and this has been suggested as another
important pathogenic mechanism (Teramoto et al 1993). Kupffer cells as
will be discussed later are major sources of reactive oxygen intermediates,




The effect of donor nutritional status on subsequent allograft function
remains unclear. Prolonged fasting has been shown to result in severe
hepatocyte deglycogenation, which compromises ATP production in the
post-reperfusion period and potentially increases the susceptibility of the
liver to ischaemia-reperfusion injury (Morgan et al 1991, Boudjema et al
1990). Sankary et al (1992) however, have demonstrated on animal
studies improved graft function in response to fasting. They speculated
that the non-parynchymal cells such as Kupffer cells which potentially
contribute to reperfusion injury are inactivated by fasting more than the
hepatocytes. So although fasting may deplete parenchymal cells of their
energy source causing biochemical abnormalities, but improved whole
organ viability suggests that this effect may be overridden by a positive
effect on non-parencymal cells.
Donor age:
Studies assessing the role of donor age on graft function have shown
variable results. Whilst Ploeg et al (1993) identified age as a risk factor
using multivariate analysis This was not found in a larger group of patients
reported by Adam et al (1991). Hoofnagle et al (1996), in a large series
concluded that receipt of an older donor liver adversely affects the
outcome of liver transplantation. Three-month graft survival was 10% less
(81% vs. 91%) for recipients of livers from donors 50 years of age or older
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than recipients of livers from younger donors. The study also showed a
higher retransplantation rate among recipients of older livers, mainly
during the first 3 months after transplantation. The differences in survival
could not be attributed to differences in recipient population, such as the
recipient's age, severity of liver disease, or diagnosis. In addition, the
differences could not be attributed to other features of the donors, such as
sex, cause of death, time in the hospital, or time in ICU before donation.
The use of older donor livers was also associated with manifestations of
poor initial graft function, although not entirley with PNF. The poor graft
function might then have predisposed the transplantation recipient to
multiple complications such as rejection and opportunistic infections.
Although the mechanisms underlying the poor initial graft function by older
donor livers remain unclear, it has been noted that elderly donors often
demonstrate steatosis which might have a role to play in the onset of poor
graft function.
Haemodynamic Status of the Donor
This is thought to influence graft function after transplantation.
Hypotensive or hypoxic episodes in a donor could adversely affect the liver
especially with the added insult provided by the preservation process.
Large doses of vasopressors such as adrenaline, or vasopressin may
significantly contribute to the iscahemic injury. None of the studies
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however looking into parameters such as hypotension, cardiac arrest or
hypoxia of the donor demonstrated an increased incidence of poor graft
function in presence of the above factors (Makowka et al 1987, Greig et al
1990). In an extreme situation, the human liver has been found to tolerate
at least 1 hour of warm ischaemia, and excellent immediate function has
been shown in organs obtained from non-heartbeating donors with warm
ischaemia times of up to 45 minutes. Moreover, the incidence of PNF in
this obviously suboptimal donor group appears to be the same as that pre-
retrieved under more controlled conditions (Ericzon et al 1987).
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PRESERVATION
Organ preservation is a key issue in the success of organ transplantation,
Organ preservation technology allows the sharing of cadaveric organs
between hospitals of relatively great distances, thus giving more patients
with end-stage organ disease an opportunity to receive an organ
transplant. Currently, methods to preserve the liver appear adequate to
meet most clinical needs, particularly that organs be preserved for a period
of about 24 hours (Southard et al 1996).
Clinical cold storage of the kidney was begun by Collins et al (1969) with
the development of Collins' solution (a phosphate-buffered solution
containing a high concentration of glucose). Belzer and Southard
developed the University of Wisconsin (UW) cold-storage solution (table
1.1), which has been effective for simple cold storage of solid organs
(Wahlberg et al 1987). The UW solution, which has found widespread
clinical use allows effective preservation of most organs for at least 24
hours and in most cases for 2 to 3 days (Belzer et al, 1990).
17
















The objective of organ preservation is to preserve the viability of the organ
for as long as possible so that, when transplanted, it will regain immediate
function. The issues upon which development of preservation fluids are
based include; the hypothermia, the physical and biochemical environment
of cold storage, and reperfusion injury.
Hypothermia
Hypothermia appears to be one of the most important issues in good
quality organ preservation. The organ is cooled to 0 to 4°C as rapidly as
possible, as soon as the blood supply has been interrupted, and the
storage temperature is maintained at 0 to 4°C. Cooling is usually initiated
by flushing out the organ through an artery with cold Ringer's solution or
cold preservative. When removed, the cooled organs are more tolerant of
the absence of a blood supply. After removal, the organs are usually
flushed again with preservation solution and packed in a sterile container,
placed on ice, and prepared for transfer.
Hypothermia is effective because it slows down metabolism and
suppresses the rate of catabolic reactions that occur spontaneously or that
are catalyzed by cellular enzymes. Many enzymatic reactions are slowed
to about one half their normal rates by a 10°C drop in temperature. A
decrease in temperature from normothermia (37°C) to hypothermia (0°C)
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would slow down metabolism to less than one tenth its normal rate (Fuller
et al 1991).
The tolerance of the liver and other organs to cold ischemia is
considerably greater than tolerance to warm ischemia. Much effort has
been made in trying to understand the mechanisms of injury to organs
during warm ischemia and on reperfusion. If the mechanisms of injury to
the liver during warm ischemia are similar to those occurring during cold
ischemia, then methods to suppress warm ischaemic injury could be
applied in liver preservation and transplantation. However, some studies
suggest that the injury caused by warm ischemia is different from that
caused by cold ischemia (Holloway et al 1990). Current work suggests that
warm ischemia is more damaging to hepatocellular functions than is cold
ischemia, and the latter, on the other hand, causes more injury to the
vascular system of the liver, including disruption of sinusoidal lining cells
(Mckeown et al 1988).
One way in which cold ischemia induces injury to the liver and other
organs is through tissue edema and cell swelling. Under conditions of cold
ischemia, ATP is lost and the activity of the membrane-bound ion pumps
that control cellular volume is decreased. Thus, cells have a tendency to
gain water because of the higher colloidal osmotic pressure inside the cell
than outside, which is created by the presence of impermeants such as
proteins, phosphorylated compounds, and other substances that cannot
permeate the cellular membrane. The prevention of cell swelling on
hypothermia appears to be important in obtaining successful organ
preservation (Southard et al 1996).
Further metabolic changes which occur as a consequence of hypothermia
include acidosis due to lactate accumulation from anaerobic glycolysis and
Na+/K+ ATPase inhibition at (Raison, 1973). Inhibition of the latter results
in intracellular sodium accumulation and water influx resulting in cell
swelling and death.
Physical Factors
Another principle of successful cold storage of organs is the establishment
of an optimal physical environment created by the components of the
flush-out solution. The physical environment is defined by the osmolality,
impermeant and electrolyte composition, hydrogen ion buffer and pH of the
preservative, and colloid components of the preservative. These factors
are important in maintaining the structural integrity of the tissue and have
less to do with maintaining the biochemical integrity of the tissue.
Organ preservation solutions originally designed for the kidney used
saccharides (mannitol, glucose, sucrose) as the primary agent to suppress
hypothermically induced cell swelling. These agents suppressed kidney
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cell swelling but were not particularly effective in suppressing cell swelling
in other organs. These solutions also contained other impermeants such
as phosphate, sulfate, or citrate that contributed to suppression of cell
swelling. Since the development of these solutions, other impermeants
have been found to be superior to the ones previously used. These include
gluconate and lactobionate, both of which suppress cell swelling in
metabolically depressed tissues. Lactobionate appears to be the most
effective agent for cold storage of organs, perhaps because of its
suppression of hypothermically induced cell swelling. Studies have shown
that lactobionate appears to be one of the essential ingredients of the UW
solution (Jamieson et al 1988, Sumimoto et al 1990). For simple cold
storage, substitution of gluconate for lactobionate was not effective for liver
preservation. It is not clear why lactobionate is such an important
component for cold storage of organs. The relationship between
lactobionate and the suppression of cell swelling as the primary benefit
has been questioned (Holloway et al 1989). Lactobionate effectively
chelates calcium and may control the calcium content during cold storage
and suppress the activation of calcium-dependent processes
(phospholipases, proteases, endonucleases) that could damage ischemic
organs. Also, lactobionate has been shown to bind iron; the release of
intracellular iron could promote oxygen free radical injury during
reperfusion of the liver. The chelation of iron by lactobionate may lower the
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iron level in the cell and reduce the injury caused on reperfusion by
oxygen free radical production (Southard et al 1996).
The physical environment of the organ is also affected by the electrolyte
content of the preservation solution. Collins' cold storage solution contains
a high content of potassium relative to sodium. It has been shown that
storage of tissues in the cold results in a leakage of potassium from the
cell in exchange for sodium in the extracellular environment. The high
potassium content was used to suppress the leakage of potassium from
the kidney during cold storage. This was thought to be beneficial because
the cell would not need to expend energy during reperfusion to re¬
establish a normal intracellular electrolyte content and to pump out the
sodium gained during cold storage. Cold storage solutions that contain a
high content of potassium and low content of sodium have been termed
intracellular-type solution. The UW solution is an intracellular type cold
storage solution and contains a high potassium content. However, organs
appear generally to be well preserved in solutions with either high sodium
or a high potassium content, as long as cell swelling is suppressed by the
presence of an approperiate anion (such as lactobionate).
The necessity of colloids in cold storage solution is controversial.
Hydroxyethyl starch is included in the UW solution to counteract the
hydrostatic pressure and to suppress tissue oedema. Some studies
however, have shown that omission of hydroxyethyl starch does not
decrease the efficacy of the UW solution (Jamieson et al 1988).
Biochemical Factors:
Metabolism continues during cold storage albeit at a much reduced rate
from that at normal temperature. The result is accumulation of end
products of metabolism in the tissue, essential metabolites necessary for
regeneration of function on reperfusion are degraded, and high energy
compounds are lost. This situation is altered only by simple diffusion and
equilibration of agents in the cold storage solution within the cells of the
organ. Diffusion does occur, as shown by the increased accumulation of
lactate reported in the cold storage solution that surrounds the liver during
preservation. Thus, it may be possible to add to cold storage solutions,
agents that can affect the biochemical environment of the tissue and can
improve the function of the organ on reperfusion.
Agents such as oxidizable substrates, precursors of essential metabolites,
enzyme inhibitors, membrane stabilizing drugs, and various cofactors
could be incorporated into preservatives to improve the quality and
longevity of preservation. This principle was, in fact, one that guided the
development of the UW solution.
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During simple cold storage, all organs rapidly lose ATP, which is
catabolized to purines (adenosine, inosine, hypo-xanthine). A loss of ATP
of nearly 90% occurs in most organs (Southard et al 1996). On
reperfusion, the purine precursors of ATP are flushed out of the cell; thus,
the organ suffers from an energy precursor deficit. The lack of substrates
for regeneration of ATP immediately after reperfusion could lead to organ
failure. In the UW solution, adenosine was added at a relatively high
concentration (5 mmol) with the idea that it would diffuse across the
plasma membrane during cold storage and provide a precursor for ATP
synthesis on reperfusion.
ATP depletion during hypoxia also results in damage of Ca++ pumps which
leads to an increase in the cytosolic free Ca++. Such an increase has been
postulated to initiate a cascade of cellular events that culminate in cell
death. Specifically, Ca++ influx into mitochondria leads to uncoupling of
oxidative phosphorylation with further ATP depletion. Ca++ also activates
proteases which in turn lead to conversion of xanthine dehydrogenase into
oxidase (McCord, 1985). Upon reperfusion, and oxygenation, xanthine
oxidase acts on hypoxanthine which accumulates during hypoxia from the
breakdown of ATP to produce reactive oxygen intermediates (ROI), such
as superoxide, and the hydroxyl group (figure-l).
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Organs stored anoxically have been shown to lose glutathione in its
reduced form, a critical cellular metabolite necessary for numerous
reactions and especially in neutralising ROI activities. Some studies
suggest that glutathione is critical for successful long-term liver cold
storage (Boudjema et al 1990). Omission of reduced glutathione has been
shown to lead to failure of rat livers transplanted after 24 hours of cold
storage and dog livers transplanted after 48 hours of cold storage.
Further attempts to improve on the current state and achievements with
UW solutions have continued. Adding of Lazaroid U74006F ( 21-
aminosteroid) a potent inhibitor of iron-dependent peroxidation with
antioxidant activity to UW solution in rats reduced releases of
transaminases from hepatic graft postoperatively (Cozenza et al 1994).
Preliminary studies suggest an advantage of adding the
immunosuppressive drug tacrolimus (FK506) to UW solution. The
mechanism of its cytoprotective effects is thought to be non-immunological
via improving tissue-ATP recovery which would minimise predominantly
the warm ischaemia damage (Okano et al 1994). Misoprostil, a
prostaglandin (PGEi) analogue demonstrated a protective effect against
hepatocellular injury in a rat model of ischaemia-reperfusion. The
mechanism of action is thought to be inhibition of endothelial cells-
neutrophil adherence and ROI generation (Ping et al 1994).
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Flushing solutions are used prior to reperfusion of the graft, principally to
clear K+ which is present in high concentrations in UW solution. Carolina
rinse solution (Table 1.2) has been shown to improve graft survival
following prolonged ischaemia in UW solution. The efficacy of this solution
seems to depend largely on the presence of GSH, allopurinol, and
adenosine, as selective elimination of these components, particularly
adenosine, resulted in reduced graft survival (Toledo-Peryera et al 1994).
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Table-1.2: Contents of Carolina rinse solution
CONTENTS CONCENTRATION
Hydroxyethyl starch 50 g/L


















Tissue damage that follows ischaemia-reperfusion has been the focus of
considerable research over the last decade. It has long been recognised
that hepatocellular damage after conventional and techniqually successful
liver transplantation appears in the early stages of revascularization of the
organ. What specifically produces this liver injury has been unclear.
Toledo-Pereyra et al (1975) recognized a well defined clinical and
pathological picture present after experimental liver transplantation
characterised by post-transplant liver congestion and insufficiency, and it
could go as far as thrombosis necrosis and bleeding. In the mid 1970's, the
term "reperfusion injury" had not been defined, and the presence of this
damage was being referred to by the descriptive physiopathological
process such as hepatic outflow block, congestion, insufficiency or
thrombosis. It was not until the mid 1980's that the term "reperfusion injury'
started to be used more in transplantation (Toledo-Pereyra, 1991).
The no-reflow phenomenon, a descriptive term for reperfusion damage
was first used by Majno et al (1967) in relation to the cerebral circulation.
Similar changes in the sinusoidal and microcirculatory changes in the liver
were later studied in relation to hepatic transplantation injury of the liver.
McKeown et al. (1988) and Cadwell-Kenkel et al (1989) were able to
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ia Reperfusion
Diagrammatic representation of classical pathway of ROI generation during ischemia/
1. (OH, hydroxyl radical; H20;, hydrogen ceroxide.)
demonstrate sinusoidal damage through more specific and direct electron
microscopy techniques. The damage to the non-parenchymal hepatic cells
of rat livers following ischaemia-reperfusion was identified by Thurman et
al (1988) using trypan blue dye. Manner et al (1990) demonstrated by
direct techniques, that the hepatic tissue perfusion measured by hydrogen
clearance, showed a significant difference before and at 30 min and 20 h
after transplantation. Livers that had a perfusion rates below 60 ml/100
gm/mm did not have a very good survival and a significant reduction of the
microcirculation was noted.
Koo et al (1992) elegantly, demonstrated the same reperfusion changes in
the liver sinusoids using in-vivo fluorescence microscopy. They showed
that reperfusion of rat livers after a period of ischaemia resulted in
adequate microcirculatory blood flow for the first 10 minutes after
reperfusion but after 30 minutes complete stasis was seen in the great
majority of sinusoids. Ultrastructural examination of the sinusoidal lining
cells after iscaemia-reperfusion revealed rounding of cells, focal
denudation, inflammatory cell adhesions and platelet aggregation.
In the last decade, considerable attention has been attracted to the role of
ROI as mediators of cell injury associated with reperfusion of ischaemic
tissue, and it is only recently that the role of other active mediators such as
leukotrienes, adhesion molecules endotholins and platelet activating
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factors has been explored. In the following section, the relative role of
these agents and their inter-relationship in the context of reperfusion injury
is discussed.
Reactive Oxygen Intermediates (ROIs)
ROIs also known as free radicals are characterised by the presence of one
or more unpaired electrons in their outer orbits which make them highly
reactive The formation of highly reactive oxygen-containing molecular
species is a normal consequence of a variety of essential biochemical
reactions. The oxygen free radicals (i.e., superoxide anion, hydroxyl
radical, singlet oxygen, and hydrogen peroxide) are capable of extensive
tissue and endothelial damage. Superoxide anion is the best studied free
radical species ( Pryor, 1976). This free radical may act as a reducing
agent donating its electrons or as an oxidizing agent, in which case it is
reduced to hydrogen peroxide.
The production of the superoxide radical is a double edged sword. It is
beneficial when produced by activated polymorphonuclear leukocytes and
other phagocytes as an essential component of their bactericidal activities
(Babior, 1978). Nevertheless, if allowed to proceed to excess, the same
action may result in tissue damage associated with inflammation (Petrone
et al, 1980). Free radicals have been implicated in the development or
exacerbation of many human diseases, including ischemia-reperfusion
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injury in myocardial infarction, organ transplantation, stroke, cancer, and in
various inflammatory-immune injuries and the disorders of aging (Halliwell,
1987).
Upon reperfusion, the enzyme xanthine dehydrogenase is converted to its
free radical producing form xanthine oxidase (XO) within endothelial and
Kupffer cells (Weizorek et al, 1994). Hypoxanthine, a metabolite of ATP
which accumulates during hypoxia reacts with oxygen in the presence of
XO generating ROIs such as superoxide and the highly reactive hydroxyl
group which are formed via the Haber-Weiss reaction, catalysed by
transitional metal ions (Halliwell et al, 1992). Figure 1.1
ROI can mediate injury by a number of mechanisms including:
indiscriminate, non-specific interactions with adjacent molecules such as
lipids, proteins, and nucleic acids (Halliwell et al, 1992); signal
transduction resulting in an increased neutrophil chemotactic activity
(Brass et al, 1994); and through interaction with nitric oxide forming the
highly toxic species peroxynitrite (Ma et al, 1995).
As a result of the potential for free radicals to damage cells and tissues, an
intricate system consisting of both enzymes and small molecular weight
molecules with antioxidant capabilities has evolved to protect against the
adverse effects of free radical reactions. There exists ultimately a critical
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balance between free radical generation and antioxidant defenses. The
first line of defence are superoxide dismutases, which catalyze the
diffusion-limited dismutation of superoxide to hydrogen peroxide and
oxygen. Hydrogen peroxide formed in peroxisomes is metabolized
completely by the high content of catalase in these organelles (Oshino et
al, 1977). Most important for the metabolism of cytosolic and mitochondrial
hydrogen peroxide is the selenium-containing enzyme glutathione-
peroxidase. This enzyme reduces hydrogen peroxide to water, requiring
reducing equivalent from glutathione (GSH). Another part of this second
line of defense is the general strategy of cells to keep any potentially
redox-active metal tightly bound to transport and storage proteins to
minimize the possibility of hydroxyl radical formation. Thus, iron is
transported bound to transferrin or stored as ferric iron bound to ferritin
(Minotti et al, 1989). Other defense mechanisms include chain-breaking
antioxidants, e.g. vitamin C and a-tocopherol (vitamin E), which interrupt
the progression of free radical chain reactions by forming stable radicals.
Studies in both humans and animal models have shown ROI generation
following reperfusion and anti oxidants such as allopurinol and superoxide
dismutase have been shown to significantly reduce reperfusion injury. In a
study by Toledo-Pereyra et al (1989) several groups of rats were included
to determine the effects of allopurinol, allopurinol and hypoxanthine, XO
and allopurinol and catalase. Following pretreatment with all these
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different compounds, donor livers were removed, subjected to 20 min of
warm ischemia, and allotransplanted into another rat. Indicators of a
favourable outcome were seen following transplantation among the rats
pretreated with allopurinol, and allopurinol and hypoxanthine, when
compared with untreated controls. The findings suggested that inhibition of
the XO system, appeared to limit the ischaemic injury in hepatic allografts
following transplantation. Merion et al (1986), studied the effect of
allopurinol on tissue XO levels, survival and post-transplant coagulopathy.
Donor pretreatment with 100 mg/K/day of allopurinol for 2 days prior to
preservation, showed excellent liver protection following transplantation,
and XO was reduced by 68% and survival was clearly improved.
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Nitric Oxide (NO)
This is another important modulator of leukocyte adhesion which has been
implicated in the pathogenesis of reperfusion injury. NO is enzymatically
synthesized from L-arginine by NO synthase. Its predominant function is
relaxation of vascular smooth muscle and inhibition of platelet aggregation
(Moncada, 1989). It also inhibits leukocyte-endothelium adhesion by down-
regulating the expression of the ligand p-selectin (Gaboury et al 1993),
and decreases ROI generation by neutrophils via inhibition of NADPH
oxidase. NO is the only known biological molecule that can be produced in
high enough concentration to outcompete superoxide dismutase (SOD) for
ROI. The interaction results in formation of peroxynitrite (ONOO), a radical
in its own right which unlike NO, induces vasoconstriction (Koppenol et al,
1992). It seems possible that NO, via its contribution to generation of
ONOO, might indirectly play a role in sinusoidal stagnation and no-reflow
phenomenon seen in reperfusion injury.
NO causes vasodilatation via its secondary mediator cyclic guanosine
monophosphate (cGMP) which is produced from the activated guanylate
cyclase in endothelial cells (Niederberger et al, 1995). ROI have a direct
inhibitory effect on guanylate cyclase and result in a reduction in
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intracellular cGMP levels (Chewy et al, 1990), and as such
microcriculatory vasoconstriction and stasis.
Pinsky et al (1994) demonstrated elegantly the changes in NO during
ischaemia-reperfusion. ECs exposed to a period of hypoxia followed by
reoxygenation demonstrate a striking reduction of NO levels and loss of
the ability to inhibit thrombin-induced platelet aggregation and 14C-
serotonin release. Addition of the antioxidant superoxide dismutase to the
reaction mixture, largely restored the ability of reoxygenated ECs to inhibit
thrombin-induced platelet aggregation. These findings further support the
hypothesis that NO reacts rapidly with superoxide, generated by
reoxygenated endothelial cells or within the vasculature during reperfusion




The endothelins are a family of vasoactive peptides with extremely potent
and characteristically sustained vasoconstrictor and vasopressor actions
in animals and man (Yanagisawa et al, 1988). Three isoforms have been
categorized (ET-1, ET-2, and ET-3), and all are of 21 amino acid but differ
in two and five residues, respectively. Endothelin-1 was the first of the
family to be isolated, and is the predominant isopeptide generated by the
vascular endothelium (Luscher et al, 1992).
Exposure of vascular endothelial cells to diverse stimuli, including other
vasoactive hormones, cytokines and physical factors, causes increased
transcription of the gene for pre-proendothelin-l, a 212 amino acid peptide
cleaved intra-cellularly to a 38 amino acid precursor, big endothelin-l. Big
endothelin-l is cleaved to endothelin-1 by several isoforms of an unique
membrane-bound neutral metalloprotease, endothelin-converting
enzyme, which is highly expressed in endothelial cells (Masaki et al,
1991).
Plasma levels of endothelins have been shown to be increased markedly
in the reperfusion phase following cardiac ischaemia in rats, as well as in
patients undergoing cardiac transplantation (Brunner et al, Lerman et al).
Administration of ET-1 to rats resulted in significant hepatic sinusoidal
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constriction and a reduction of blood velocity in a dose dependant manner
(Okumara et al 1991). ET-1 might therefore have a role to play in the no-
reflow phenomenon which has been demonstrated in reperfusion injury.
Leukotrienes:
These important inflammatory mediators are metabolites of arachidonic
acid produced by the 5-lipoxygenase pathway, primarily in Kupffer cells.
The concentration of leukotriene B4 (LTB4 ), a potent chemoattractant
increases markedly following ischaemia-reperfusion (Mangino et al 1989,
Goldman et al 1990). Oxidants have been reported to activate the plasma
membrane phospholipase A2, via an increase in the intra-cellular free
calcium (Gyllenhammar et al, 1989), which results in the production of a
number of pro-inflammatory agents including leukotriene B4(LTB4).
There have heen several in vivo studies demonstrating that LTB4 may play
an important role in mediating the granulocyte accumulation elicited by
reperfusion. Mangino et at. (1989) showed a significant increase in LTB4
production in dog ileal mucosa during reperfusion. In feline intestine, LTB4
production increased two fold following 3 h of isaemia and 1 h of
reperfusion (Zimmerman et at. 1990). Additionally, the ischaemia-
reperfusion induced increase in neutrophil infiltration (MPO determination)
into the mucosa was prevented with either a lipoxygenase inhibitor or an
LTB4 receptor antagonist. The leukotriene biosynthesis inhibitor MK-886
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has been shown to prevent post ischaemic leukotriene accumulation and
the microcirculatory changes of ischaemia-reperfusion injury (Lehr et al,
1991).
Platelet Activating factor (PAF)
This is an autacoid phospholipid with vaso-active and pro-inflammatory
activity which has been studied in relation to reperfusion injury. Evidence
that PAF may be a modulator of leukocyte adhesion in the post-ischemic
intestine is based on the observation that, in animals pretreated with PAF
receptor antagonists, the ischaemia-reperfusion induced rate of leukocyte
adherence and migration is greatly diminished (Kubes et al, 1990). Others
have demonstrated that pretreatment with PAF receptor antagonists
prevent ischaemia-reperfusion injury in intestines (Filep et al, 1989,
Chavez-Cartaya et al 1994). Further, PAF antagonists appear to be as
effective as antioxidants SOD and allopurinol in protecting rat stomach
against reperfusion induced mucosal damage (Droy-Lefaix et al. 1988).
Although the mechanism of PAF production is unclear, Lewis et al. (1988)
reported that cultured endothelial cells exposed to ROIs such as hydrogen
peroxide (H202) produce PAF, and thus promote PMN adherence.
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Neutrophils
An association between neutrophils and cell injury in ischaemic-reperfused
tissue is supported by histo-pathological studies showing neutrophil
accumulation in the injured region (Engler et al, 1986). Their accumulation
has been demonstrated to be reduced by anti-neutrophil serum or
monoclonal antibodies (Hernandez et al 1987, Korthius et al 1987).
Walden et al (1990) demonstrated an improvement in skeletal muscle
contractile function after ischaemia-reperfusion, when the neutrophil
population was reduced by vinblastin pre-treatment.
The damaging effect of neutrophils on tissues is due to release of
proteolytic enzymes (elastases, proteinases and collagenases) from their
granules and generation of ROI via the activated NADPH oxidase a
membrane associated enzyme complex. Elastase in particular can
degrade almost all components of the extra cellular matrix, attacking intact
cells and inactivating various proteins such as immunoglobulins,
complement and clotting factors (Weis, 1989).
Neutrophil elastase and ROI interact at number of levels, ai-antitrypsin, a
natural inhibitor of elastase is inactivated by ROI through post translation
oxidation of methionine at position 358 (Met-358), (Janoff, 1985).
Neutrophil elastase on the other hand enhances further generation of ROI
from endothelial cells by catalysing the conversion of xanthine
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dehydrogenase to xanthine oxidase, an action which can be inhibited by
elastase inhibitors, ai-antitrypsin and elastinal (Phan et al, 1992). Such
interactions between these mediators potentiates their damaging influence
on tissues affected.
The process of neutrophil infiltration originates with an interaction with the
endothelial lining cells of sinusoids where the maximum damaging effect is
exerted. The nature and magnitude of these adhesive interactions depend
upon the expression of various mediators such as the adhesion
receptor/ligand molecules, LTB4, PAF, and cytokines such as TNFa, ILi,
and IL2 (Bagglioni et al 1989, Strieter et al 1989, Geng et al 1990, Lorant
et al 1991, Steinhoff et al 1993).
Granule membrane protein (GMP140), and endothelial leukocyte adhesion
molecule (ELAM-1) both members of the selectin family increase
significantly in the early phases of reperfusion during liver transplantation,
to be followed a few hours later by expression of other adhesion molecules
such as the vascular cell adhesion molecule (VCAM-1), and the
intercellular adhesion molecule (ICAM-1) (Steinhoff et al 1993).
ROI have been shown to promote adherence of leukocytes to the
microvascular endothelium and this effect is thought to be mediated via
induction of adhesion molecules expression such as GMP140, and also by
activating PLA2 which in turn increases LTB4 synthesis (Lehr et al 1991,
Patel et al 1991). The interaction between ROI and adhesion molecules in
the process of leukocyte-endothelium adhesion has been demonstrated in
a feline intestinal muscle model. Upon superfusion with hypoxanthine -
xanthine oxidase a rapid and significant increase in the number of rolling
leukocytes, an early and essential event prior to adhesion, was evident.
However use of P-selectin monoclonal antibodies prior to superoxide
exposure completely inhibited the recruitment of rolling leukocytes
(Gaboury et al 1994).
Kupffer Cells:
The important role of Kupffer cells in ischaemia reperfusion injury has
been demonstrated in a number of studies (Lemaster et al 1995). In a rat
model, when hypoxia was selectively induced in pericentral regions of the
liver, electron microscopic analysis of Kupffer cells revealed numerous
lamellapodia and pseudopodia indication activation. This activation can be
prevented by pre-treatment with methyl-palmitate (Lindert et al, 1992).
Following activation, Kupffer cells release a number of inflammatory
mediators such as IL1, and IL8 which attract neutrophils, and also produce
ROI (Kobayashi et al 1992, Suzuki et al 1994, Hisama et al 1995).
Activated Kupffer cells also release TNFa which has been shown to induce
production of ET-1 by endothelial cells. Inhibition of Kupffer cell activation
using gadolinium chloride or adenosine-2 receptors agonists such as
nisoldipine and prostaglandin Et has been shown to prevent the
microcirculatory disturbances following reperfusion (Arii et al 1994,
Reinstein et al 1994)
Stellate Cells
The hepatic stellate or Ito cell is located in the space of Disse and
resembles the pericytes localised around capillaries. Its role in the
regulation of sinusoidal liver blood flow is increasingly recognised. Stellate
cells contract in response to a variety of vasoactive substances including
Endothelin-1, and substance P (Sakamoto et al 1993, Takemura et al
1995). They are also activated by free radicals (Lee et al 1995). Several
vasoactive substances are released during reperfusion injury which may
potentially stimulate stellate cells causing sinusoidal contraction with
subsequent stasis, hypoxia and further release of inflammatory mediators
to complete the vicious circle leading to graft dysfunction.
Summary:
There is an increasing evidence from studies on animal models of liver
translantation that reperfusion following a period of ischaemia could lead
to tissue injury enough to cause graft failure. It also appears that
iscahemia/reperfusion is associated with a release of a large number of
mediators, which are capable individually or collectively, perhaps in a
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cascade fashion, of activating Kupffer cells and initiating neutrophils rolling
and adhesion to sinusoidal endothelial cells. The important mediators of
chemoattraction, adhesion, transmigration and activation of neutrophils are
PAF, LTB4 and the selectin family of the adhesion molecules. The
regulation and increased expression of these mediators have been shown
both in-vitro and in-vivo studies to be enhanced by ROI. It is plausible
therefore, to suggest that ROIs are the main determinant for setting up and
triggering the chain reaction which culminates in the activation of
neutrophils and Kupffer cells.
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Rationale and introduction to the studies presented in this thesis:
It appears that ischaemia-reperfusion is a critical stage in organ
transplantation generally and liver transplantation is unlikely to be an
exception. The humoral and immunological changes during the transplant
operation as described earlier suggest that ROI and neutrophils are
probably the main determinant of ischaemia-reperfusion leading to graft
dysfunction post-transplantation. In chapters II of this thesis, the changes
in ROIs during liver transplantation are investigated, and the study
assessed their role on graft function and outcome.
Chapter III of this thesis is concentrating on the changes of neutrophil
activity using neutrophil elastase as a specific marker. The thesis also
assessed the changes in plasma levels of soluble thrombomodulin. This is
a cleavage product of a surface protein on the membrane of vascular
endothelial cells which is released into the circulation by the action of
proteases (e.g. neutrophil elastase), and is considered as a marker of
endothelial cell damage.
In chapter IV, the potential role of indocyanine green (ICG) clearance test
as an early predictor of graft function is investigated . So far, the available
tests and assessment criteria are inadequate in determing the early
outcome of transplant operation. A pilot study from our unit (Jalan et al
1994) suggested a possible place for this dynamic test in post-transplant
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management. This study is an extention to the pilot one with particular
emphasis on the relation of the changes in ICG to ROI and elastase in the
context of ischaemia-reperfusion.
Chapter V covers the haemodynamic changes during transplantation and
assessing the potential role of two major mediators of vasomotor control;
the endothelins, the most potent biological smooth muscle vasconstrictors,
and guanosine 3", 5'-cyclic mono-phosphate (cGMP) the secondary
messenger of NO as well as atrial natriutic peptides (ANP) which mediates
vasorelaxation. I became interested in doing this study when two of our
patients went into profound haemodynamic instabilities during liver
transplantation and specifically in the early part of the reperfusion phase.
Both patients unfortunately died during the operation. Their haemodynamic
changes were typical of the reperfusion syndrome which is described in
detail in chapter V of this thesis. Similar pattern and sequence of the
haemodynamic alterations post-reperfusion occured in other patients
which were transient and of mild to moderate degree. The hypothesis of a
role of vasomotor mediators NO (and its secondary mediator cGMP) and
endothelins in the pathogenesis of the haemodynamic instabilities in these
patients was supported by the studies that showed changes in the activity
of the above mediators during experimental liver transplantation.
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CHAPTER TWO
GRAFT DYSFUNCTION FOLLOWING LIVER
TRANSPLANTATION - ROLE OF FREE RADICALS
INTRODUCTION
MATERIALS & METHODS
Markers Of Free Radical Activity







In the last decade, a considerable interest has been directed to the role of
ROIs as mediators of cell injury associated with reperfusion of ischaemic
tissue. The main sources of ROI generation include; as detailed in chapter
I the classical xanthine dehydrogenase-oxidase pathway, and the
activated inflammatory cells (macrophages and neutrophils) through the
surface membrane NADPH.
Koo et al (1992), showed evidence of hepatic microcirculatory stasis which
was associated with a significant degree of hepatocellular necrosis
following ischaemia-reperfusion in rats. Such effects have been shown to
be prevented by concomitant administration of superoxide dismutase
(SOD), a free radical scavenger. The evidence of improved graft survival
by Carolina rinse and UW solution which contain antioxidants including
allopurinol and glutathione further supported the idea that ROIs are
involved in the mechanism of graft failure. However, the physical evidence
for ROIs generation following human orthotopic liver transplantation and
the causative relationship with graft dysfunction has been lacking.
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AIMS:
We aimed in this study to quantitate free radical activity during OLT and to




We studied 21 patients who underwent OLT. The characteristics of the
patients are detailed in table 3.1
Matching of donor liver to the recipient was carried out as per standard
protocols. Mean donor age was 38 + 6 (SEM) years. 11 grafts were
retrieved by the same team from our unit, while the rest (10 grafts) were
retrieved by a team according to the geographical location of the donor.
Generally, each team has followed a standard protocol of retrieval. Grafts
with significant degree of steatosis or of donors with a history of
drug/alcohol abuse were rejected.
University of Wisconsin (UW) solution was used for preservation, and
grafts were flushed with Carolina rinse solution prior to restoration of blood
flow. All patients underwent veno-venous bypass during the anhepatic
phase; mean duration 70 + 11 minutes.







Episodes of acute graft rejection of which treatments were indicated.
For objective assessment of graft function and outcome, we used criteria
described previously (Gonzalez et al, 1994), and this is detailed in table:
3-2. The scoring system of this criteria is dependent on serum ALT and
prothrombin time activity determined at 72 hours post-operatively, along
with the mean value of bile output over the first three days of transplant. In
each patient, the score was calculated from the sum of assigned values
from each parameter, ranging from 3-9. According to this criteria, Patients
with a total score up to 6 were shown to have good outcome and a score of
7-9 is associated with poor graft function. The relationship of these
parameters with the degree of free radical activity was determined.
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Markers Of Free Radical Activity:
The percentage molar ratio (PMR) of diene conjugated linoleic acid (PL-
9, 11-LA) to its substrate phospholipase-esterified linoleic acid (PL-9, 12-
LA) was used as a determinant of free radical activity. Blood samples
were taken from each patient through an indwelling catheter inserted
following induction of anaesthesia with its tip being positioned in the right
atrium. Samples were taken following induction of anaesthesia, during
anhepatic phase and following reperfusion at 30 minutes, 1, 2, 6, 9, 12
and 24 hours. Plasma was separated by centrifugation at 3000G for 15
minutes and stored at -40°C for later analysis. Plasma concentrations of
both (PL-9, 11-LA) and (PL-9, 12-LA) were measured by high
performance liquid chromatography after enzymatic hydrolysis, and solid
phase separation as described by Iverson et al (1985):
Material:
Tris and phospholipase A2 (EC 3.1.1.4) from Naja naja venom were
obtained from Sigma, Poole. Dorset. UK. Methanol, acetic acid,
acetonitrile (grade 'S'). propan-2-ol and water were obtained from
Rathburn Chemicals. Peebleshire, UK. Isolute octadecyl disposable
sample preparation columns were obtained from Jones Chromatography.
Llanbradach. Mid Glamorgan. UK. The methyl ester of 18:2(9.11) prepared
from dehydrated castor oil was obtained from the Paint Research
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Association, Teddington Middlesex, UK. HPLC was performed on a
Watters 510 pump, Perkin Elmer Dioor array ultraviolet (UV) detector set
at wavelengths 234 and 205 nm. 50 pL samples were injected into
columns (A Spherisorb ODS2 250 X 4 mm column containing 5 pm
capped spherical particles) using a Perkin Elmer IS100 autosamplers). A
mobile phase of acetonitrile/water/acetic acid 85:15:0.1 at a flow rate of
1.5 mL/min was used. Chromatograms were integrated and quantified
using a Kortran Integration Pack.
Method:
0-5 mL plasma was mixed with 0.5 ml_ of a solution comprised of 0.1 moL
Tris, pH 8.9 mol/L methanol and 5000 U/L phospholipase A2, which was
stable at 4°C for 3 weeks. The mixture was incubated at 25°C for 15 min
after which 2 mL methanol containing 0.5% acetic acid and 50 mg/L beta-
eleostearic acid [18:3(9,11,13)] was added to precipitate the protein and
add internal standard. This solution was stable at -20°C in a dark bottle
for 3 months. The preparation was then centrifuged and 2 mL supernatant
applied to a 'Bond Elut column that had been washed twice with 2-5 mL
propan-2-ol/acetonitrile 2:1 and conditioned twice with 2.5 mL of a wash
solution of methanol/water/acetic acid 67:33:0.04 immediately before use.
The 'Bond Elut' column was washed again and the sample was eluted with
1 ml propan-2- ol/acetonitrile 2:1. The eluate was injected directly into the
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HPLC filling the sample loop. The conjugated dienes were measured at
234 nm and the nonconjugated fatty acids (linoleic, linolenic and
arachidonic acids) were measured at 205 nm. The coefficient of variation
of the assays was less than 3.5% and results are expressed as diene
conjugated /linoleic acid ratio.
Spin Trapping Technique:
In a subgroup of 10 patients, we used a spin trapping method as another
determinant of free radical activity. This has been described previously
(Grech et al, 1993). In brief, from each patient, blood samples (one ml
each) were withdrawn from the same right atrial catheter after induction of
anaesthesia, during the anhepatic phase and following reperfusion at 1, 12
and 24 hours. They were immediately mixed with 50mM solution of the
spin trapping agent a- phenyl N-tert-butyl nitrone (PBN) and stored in
liquid nitrogen. The PBN-free radical adduct was extracted by adding 2 ml
of toluene to each ml of the mixture followed by centrifugation at 10,000G
for 5 minutes. The toluene extract was separated and stored at -40°C until
analysis by electron paramagnetic resonance (EPR) spectroscopy. EPR
was measured by Bruker ECS 106 spectrometer. The microwave power
was 20mW, applied field, 3355 ± 30 gauss and frequency of 9.4G Hz,
using 100KHz modulation with an amplitude of 0.5 gauss. Time constant
was 0.3s and sweep time of 84s. Sample temperature was 220°K. Free
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radical concentrations were determined by comparing the double integrals
of the EPR signals from the experimental samples with those from known
concentrations of a stable free radical, 4-hydroxy-2,2,6,6-
tetramethylpiperidine-1-oxyl, in the same solvent and recorded under
identical conditions. In those cases where very low signaknoise precluded
accurate integration, radical concentrations were estimated by comparison
of signal heights of the weaker signals with those of the stronger signals.
STATISTICAL ANALYSIS:
Results were expressed as mean + standard error (SEM). Statistical
significance was accepted for p<0.05. Difference between time points was
calculated using one way analysis of variance. Correlation between
variables was performed by linear regression analysis using the
Spearman correlation coefficient.
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TABLE 2.1: PATIENTS CHARACTERISTICS
Number 21
Mean Age 53 + 3.8 years (SEM)
Sex (M:F) 10:11
Indication for transplantation




Alcoholic liver disease 6
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Table 2.2 Parameters of scoring system for assessment of early











> 60 (spontaneous) 1
> 60 (with fresh-frozen plasma) 2
< 60 (despite fresh-frozen plasma) 3
Footnote: aHighest value in the 72 hr after transplant. Normal value is up to
40 U/L. bMean value during the first 72 hr after transplant.
cLowest value in the 72 hr after transplant.
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RESULTS
Figure 2-1, shows the intra-operative changes in free radical activity as
measured by diene conjugated method. The mean base line plasma PMR
was 10.87 + 0.78 % which although higher than those of healthy
volunteers (9.74 + 0.84 %), did not reach statistical significance. No
significant change in activity occured during anhepatic phase (10.29 +
0.71 %) but a marked rise in activity was evident following reperfusion with
an initial peak at 1 hour (24.42 + 7.81 %, p< 0.01). A second more
prominent peak appeared 12 hours post-reperfusion following a transient
decrease of radical activity (21.91 + 2.46%, p< 0.01). Figure 2-2,
represents the HPLC measurements of a patient before and after
transplantation.
Using the spin trapping technique, PBN-adduct signal were barely
detectable after induction of anaesthesia and during anhepatic phase
(figure2-3). A significant increase in intensity was evident following
reperfusion with larger signals obtained in 12 hours samples which
showed 3 lines from a nitrogen atom, with aH = 14 gauss and these are
split into doublets by a hydrogen atom, with aN = 2 gauss. Such signals are
identical to those reported by Tortolani et al (1993). Levels of PBN-radical
adducts of those samples were 2-3 times higher than the pre-transplant
ones (p< 0.05). Representative EPR spectra obtained from a patient
before and after reperfusion of the graft are shown in figure 2-4.
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The PMR ratio representing free radical activity as measures using the
diene conjugated method, correlated with alanine ALT at 24 hrs post-
transaplantation (figure 2-5), and time to prothrombin time normalization
(figure 2-6).
Six patients had poor graft function according to the criteria defined earlier
(table 2-1) with scores ranging between 7-9. Of these, three had died on
days 7, 12 and 31 days following acute post-transplant liver failure.
Another patient from the same group developed features of PNF and
required retransplantation on day 3. Figure 2-7, shows the mean delta
PMR activity which is the difference between the maximum and base-line
values plotted against total score of graft outcome for each patient. A
significant correlation was found, the higher free radical activity the worse
the graft outcome (p< 0.01).
There was no correlation between the magnitude of free radical changes
and cold iscaemia time (10.61 + 0.58 hrs) (fig 2-8) , mean blood units (7.27
+ 1.12 units) or blood products transfused (26 + 5.4 units) (fig 2-9). Acute
rejection which required treatment as judged by clinical and histological
criteria occured in 7 patients. Mean PMR of patients with rejection was
11.69 + 0.84 % compared with 11.17 + 1.54 % in the non rejection group
(NS) (fig 2-10).
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Figure 2-1: Perioperative PMR ratio as a determinant of free radical
activity. Pre: pre-transplant, A: during anhepatic phase, and then post-
reperfusion up to 24 hrs
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Figure 2-2: These diagrams represent the HPLC measurement of
plasma for one of the patients. In diagram (A), peak 4 represents the
linoleic acid concentration in the sample, peak 3 is that of arachidonic
acid, and 2 for a mixture of fatty acids. In diagram (B), the peak labeled 1
represents the internal standard, and 2 represents the concentration of











Figure 2-3: Peri-operative changes in ROI activity determined by EPR
method, and identified as PBN-radical adduct signals. Pre: pre-transplant,
Anh: anhepatic phase, and then post-reperfusion at 1,12, & 24 hrs
800
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Figure 2-4: Representative time course of EPR spectra of PBN-radical
adduct from one patient. C & D are shown in the next page: (A) prior to
induction of anaesthesia, (B) during anhepatic phase, (C) 12 h after
reperfusion and (D) spectral simulation of the PBN radical adduct, using
the parameters aH= 0.19 mT, aN= 1.36 mT. Comparison of this simulation
with the spectrum in (C), clearly shows the similarity of the radical species.
Spectra (A) and (B) show evidence of the same radical, although at the

























Figure 2-5: The correlation of free radical activity measured
by the diene conjugated method and alanine transamainase










Figure 2-6: The correlation of free radical activity determined by the



















e 2-S: This graph demonstrates the lack of correlation










Figure 2-9: Correlation of free radicals activities represented by the















Figure 2-10:This graph illustrates the relationship of rejection episodes
and free radical activity determined by the percentage moiar ratio(PMR)
using diene conjugated method.
DISCUSSION:
There is increasing evidence to suggest that oxidative stress, the result of
excessive production of oxygen-derived and other radicals, is a major
cause of reperfusion injury. These observations are based on experimental
and animal model studies (Conor et al 1992, Kobayashi et al 1991), and
This is supported by favorable effects of antioxidants such as allopurinol,
ascorbic acid and superoxide dismutase when used in such situations
(Kobayashi et al 1991, Zhong et al 1989).
In this study we have shown evidence of increased free radical activity
following reperfusion of the new liver graft. We used two methods to
quantitate free radical activity because of the limitations of the individual
methods alone as suggested previously (Halliwell et al 1992). The PMR
method is regarded as a "fingerprint" assay providing indirect evidence of
radical production by determining the end products of lipid peroxidation
which in this case is diene conjugated isomer. These methods have been
the most frequently used for detecting free radical activity in human
diseases for their safety as they are primarily in-vitro techniques. EPR
spectroscopy, on the other hand, is a direct and quantitative method which
measures the energy changes that occur as unpaired electrons align in
response to an external magnetic field (Halliwell et al 1992). As many free
radicals have a very short life (less than milliseconds), such measurement
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therefore depends first on trapping the radical by administering a
compound such as PBN (preferably intravenously) to produce a nitroxide
(a spin-trapped adduct) whose life time is considerably longer than that of
the parent free radical and therefore detectable by EPR spectroscopy
(Holley et al 1993). In human studies toxicity of PBN has limited the
technique to mixing of blood samples with the spin trap as soon as
possible after collection. Despite the inevitable reduction in the sensitivity
of the technique due to the time lag between free radical generation and
trapping, it remains by far the most specific in detecting radicals, when
compared with the other currently available techniques. Valuable data has
been obtained, for example, relating to free radical production during
angioplasty (Coghlan et al 1991, Grech et al 1993).
The results of this study have shown significant degree of correlation
between the degree of free radical activity and the markers of graft
function which is suggestive of a role for free radicals in the aetiology of
PGD. The criteria we used in this study (Gonzalez et al 1994) is a
modification to the one defined by Greig et al in which the widely accepted
parameters for assessement of early post-operative graft function are
used. This include serum levels of aminotransferases, bile production and
coagulation status, alone or in combination. In this criteria, a well defined
cut off values for each parameter is dteremined and it has also included
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the use of fresh frozen plasma which often happen in the early post-
transplant period as another determinant for scoring.
The currently available knowledge, however does not support the
suggestion that reperfusion injury is simply a matter of direct damage to
tissues by toxic radicals (Bulkley, 1994). Inflammatory mediators such as
leukotrienes, PAF, and soluble adhesion molecules (e.g. p-selectin) have
been shown to be upregulated by free radicals (Lewis et al 1988, Patel et
al 1991, Reilly et al 1991), and they have been implicated as well in
reperfusion injury (Kubes et al 1990, Lehr et al 1991, Steinhoff et al 1993).
These molecules react with the complementary ligands on the circulating
neutrophils, leading to their arrest and consecutively activation with
release of proteases and free radicals (Gyllenhammer et al 1989, Lorant et
al 1991). The biphasic appearance of free radical generation seen in this
study (figure-l) may support the view of their importance in the initiation of
the inflammatory cascade and consecutively reperfusion injury, as the
earlier rise of free radicals is likely to result from xanthine oxidase on the
endothelial cell surface, via the classic free-radical- mediated chain
reaction with the late surge of radicals being a direct product of activated
neutrophils.
We did not see a correlation between cold iscaemia time and the degree
of free radical activity. Prolonged ischaemia can lead to increased
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accumulation of XO and hypoxanthine which subsequently could
determine the extent of free radical activity. It is possible that the limited
ischaemia time in this study has been a factor and this could be supported
by findings of a previous study that showed extended preservation beyond
16 hours in UW solutions is unfavourable and likely to influence
subsequent graft function.
Acute graft rejection which required treatment occured in 30% of the
patients studied. We did not see a difference in free radical activity in the
patients with rejection as compared with non-rejection group. Poor graft
function has been shown to increase the incidence of graft rejection
(Howard et al 1992). The mechanism for such relationship is however
unclear, and from the results of this study it would seem unlikely to be free
radical related.
In conclusion, this study provides evidence of increasing free radical
activity following reperfusion of liver grafts and the magnitude of changes
correlated with the severity of graft dysfunction.
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CHAPTER THREE
NEUTROPHIL ELASTASE: A DETERMINANT
OF ENDOTHELIAL DAMAGE AND REPERFUSION




















The polymorphonuclear neutrophils (PMNs) provide a host defense
against bacterial, fungal and other injurious agents that is vital to the
survival of the organism. However, if PMN functions become excessive, it
can lead to tissue injury. This is illustrated by the increasing body of evi¬
dence that implicates these cells as mediators of tissue injury in a variety
of inflammatory diseases, including rheumatoid arthritis,
ischaemia/reperfusion injury, ulcerative colitis and various skin diseases
(Malech et al 1987).
Although early restitution of blood flow to an ischemic tissue is essential to
prevent further hypoxic cellular injury, a paradox exists in that it is at the
time of reperfusion that much of the injury occurs. Parks et al (1986)
demonstrated that the mucosal injury produced by 3 h of ischaemia and 1
hour of reperfusion is significantly greater than that caused by 4 hours of
ischaemia alone. Crissinger et al (1989) showed greater mucosal
dysfunction in the piglet intestine during the reperfusion period than the
ischaemic period. It is now believed that a potential explanation for this
observation is that neutrophil infiltration and migration out of the
vasculature occurs primarily at the time of reperfusion.
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Activated neutrophils cause tissue damage by release of free radicals and
proteolytic enzymes such as metalloproteinases and elastase, from the
granules. They are capable of direct tissue damage and enzymatic
inactivation unless neutralized by their natural inhibitors (Weiss, 1989).
Neutrophil elastase (NE) is the most potent and because of its specificity,
has been established as a means of assessing in-vivo neutrophil activation
(Plow, 1982).
Endothelial Cell Damage and Thrombomodulin
release:
Several in-vitro and in-vivo studies have suggested that the endothelial
cell damage by NE results in cleavage and inactivation of surface
thrombomodulin (TM) via a specific hydrogen peroxide (H202) facilitating
mechanism involving oxidation of Met 388 in the TM molecule (Hiroki et al
1994). This results in the loss of transmembrane and cytoplasmic domains
and release of the soluble form into the circulation(sTM).
TM is a surface protein of vascular endothelial cells. When thrombin is
bound to TM, its procoagulant properties are reduced and its anticoagulant
ability to activate the zymogen protein C increases. Protein C catalyzes in
conjunction with its cofactor protein S the proteolysis of the activated
coagulation factors Va and Villa and inhibits the activity of the
plasminogen activator inhibitor thereby augmenting indirectly fibrinolytic
activity (Dittmann et al 1990, Himmelreich et al 1994). Thus, TM plays an
important role as an anticoagulant protein on the blood vessel wall.
Immunohistochemically, TM has been found to be mainly present on
endothelial cell surfaces of blood and lymphatic vessels in all organs
except the brain (Maruyama et al 1985, Ishii et al 1986).
A smaller form of TM, the soluble thrombomodulin (sTM), has been
isolated from human blood and urine (Ishii et al 1985). The structure of
sTM is not known but is thought to be similar to the soluble protein
obtained after proteolytic modification of TM with elastase (Kurosawa et al,
1987), a cleaved form of tissue TM with loss of part of the transmembrane
domain, and the cytoplasmatic tail (Dittmann et al 1987). Therefore, sTM in
plasma appears to be derived from injured endothelial cells or to be
proteolytically cleaved from TM by proteases (Himmelreich et al 1994).
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AIMS:
In this study we assessed the degree of proteolytic activity of neutrophils
by determining the changes in NE before and after reperfusion in liver
transplantation. We looked at the relationship of the changes with the
parameters of subsequent graft function. Perioperative changes in sTM
was used as a marker of endothelial cell damage.
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MATERIALS & METHODS
We studied 19 patients who underwent OLT. The details, including the
indications are summarized in table 3-1.
Transplant details
Donor age was 42 + 6 years. ABO blood group compatibility and matching
of donor-recipient sizes were observed. As per protocol grafts with
macroscopic steatosis or from donors with known history of drug/alcohol
abuse were rejected. University of Wisconsin solution was used for
preservation.
All patients underwent veno-venous bypass (WB) during the anhepatic
phase. It was started after dissecting the porta hepatis and clamping of the
portal vein. The mean duration of WB was 72 ± 25 min, which was
discontinued just before unclamping of the portal vein and reperfusion of
the donor liver.
Details of blood and blood products transfusion perioperatively were
recorded. Following OLT, data collected included
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bile flow, serum transaminases (ALT), and prothrombin time (PT). These
were recorded daily up to the time of discharge, retransplantation, or death
Postoperative graft function was assessed using the above parameters
and were graded according to the criteria that was described earlier in the
method section of chapter III, and summarized in table 3-2. patients with a
total score of up to 6 (group l:up to 3, and group II: 4-6) were shown to
have good outcome and a score of 7-9 (group III) is associated with poor
outcome.
Blood samples were collected into EDTA containg tube, and were taken
from an indwelling catheter in the right atrium before transplantation,
during the anhepatic phase, and then post reperfusion at 0.5, 1, 2, 6, 9,
12, and 24hrs. Plasma was immediately separated by centrifugation (3000
rpm for 20 minutes) and stored at -40°C for later analysis.
Neutrophil Elastase Measurement:
Principle:
Plasma NE was measured by a specific radioimmunoassay using rabbit
polyclonal antiserum (Plow, 1982). The antigen was purified from human
neutrophils following leukophoresis. The antibody was absolutely specific
for neutrophil elastase with no cross-reaction with pancreatic or platelet
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elastase. Neutrophil elastase was measured either as the free enzyme or
as a complex with its natural inhibitors, ai-antitrypsin and a2-
macroglobulin.
Materials:
1. Assay buffer:- This contains; 0.05M phosphate [pH 7.4], 0.6M NaCL, 2
mM EDTA, 20 U/ml (130 pg/ml) heparin, 20p/ml aprotinin and 2% heat
inactivated horse serum.
2. Standard:- Calbiochem purified elastase in normal human plasma,
prepared in a solution to give aconcentration of 200 ng/ml.
3. 1st Antibody made to a dilution 1/1500 using the assay buffer.
4. Tracer: The same standard elastase is iodinated in-house using
Chloramine T method to give 125l-elastase at a concentration of 10ng/ml.
5. 2nd Antibody: Donkey anti-rabbit antibodycoupled to a solid phase
support (DAR-SP) diluted by the assay buffer to 1/6 concentration.
Assay Procedures:
50pl of the standards or samples were added to the tubes (labelled
previously) containing 50pl 125l-elastase (10ng/ml), and 50pl anti-elastase
(1/1500). The mixture in each tube was made up to a final volume of 200
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pi by adding 50pl of the buffer solution. Samples were incubated at room
temperature overnight.
In the second day, 50pl of DAR-SP (1/6 dilution) was added to the tubes
followed by agitation for 45 min (setting 8).
Each tube, was then washed once with 1ml of the assay buffer, and
followed by addition of 1ml sucrose (10%) and left to stand for 20 minutes
to allow for sedimentation of the bound complex in the solid phase. The
supernatant was aspirated and discarded. The bound complex was then
counted using a NE1600 gamma counter. Plasma PMN elastase was
expressed in ng/ml and the sensitivity of the assay was 5 ng/ml with a 4%
interassay coefficient of variation.
Results from the transplant patients were compared with those from
healthy volunteers matched for age, as established in our laboratory
reference ranges.
Soluble Thrombomodulin measurement (sTM)
Plasma antigen levels of sTM were determined using an enzyme
immunoassay which was described previously (Amiral 1994).
Principle:
A solid support (micro-Elisa plate) is coated with a specific mouse
monoclonal antibody which binds thrombomodulin in the assay standard or
in the patient's sample. The bound Thrombomodulin is next revealed by the
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use of a second mouse anti-thrombomodulin monoolonal antibody labelled
with horseradirh peroxidase which binds to another antigenic determinant
of the thrombomodulin molecule that is at a distance away from the first
one
The bound enzymatic activity is then demonstrated by its oxidative action
on the substrate ortho-phenylenediamine (OPD) in the presence of
hydrogen peroxide. After the reaction has been stopped by the addition of
sulphuric acid, the colouration that is obtained is measured at 492 nm. The
observed optical density is directly proportional to the concentration of
thrombomodulin.
Materials:
1. Six of of 16-well strips precoated with the F(ab')2 fragments of an
anti-thrombomodulin monoclonal antibody (Mab).
2. Dilution buffer: 1 vial of 20 ml dilution buffer, tenfold concentrated.
This buffer contained phosphate, bovine albumin, and tween 20.
Distilled water (dH20) was used to make a 1:10 dilution of this
concentrated buffer before use.
3. Anti-thrombomodulin peroxidase: 3 vials of immunoconjugate were
mixed with 8ml of dilution buffer to reconstitute a vial of anti-
thrombomodulin peroxidase conjugate.
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4. Reference thrombomodulin; reconstituted with 2ml of dilution buffer
to obtain a solution containing 100ng/ml.
5. Washing Solution: 1 vial of 50ml washing solution, 20 fold
concentrated. Distilled water was used to prepare a 1:20 dilution to
obtain a ready for use washing solution.
6. Hydrogen peroxide.
7. Ortho-Phenylenediamine (OPD) substrate
8. M sulphuric acid:This was obtained by adding 1 volume of
9. concentrated sulphuric acid (18M) to 5 volumes of distilled water.
Assay Protocol:
The reconstituted Reference Thrombomodulin containing 100ng/ml was
used to prepare assay calibrators by performing serial dilution (1:2) with
dilution buffer.
All plasma to be tested were diluted with 1/5 with dilution buffer. When
necessary, a 1/10 dilution were used when samples were suspected to
contain an elevated level of thrombomodulin.
Assay Procedure:
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Antigen fixation: 200 jj.1 of the test sample (calibrator or test plasma)
were added to each microwell. After an incubation for 2 hours at room
temperature (18 - 25°C), 5 successive washes with washing solution was
performed.
Addition of immunoconjugate: Immediately after the last washing cycle,
200 pi of immunoconjugate was added to each microwell. Again after an
incubation for 2 hours at room temperature, the microwells were
successively washed 5 times with the washing solution.
Colour development: Immediately after the last wash, 200 pi of OPD
and hydrogen peroxide were added to each microwell. After an incubation
at room temperature for exactly 8 minutes, the enzymatic reaction was then
stopped by adding 50 pi of 3M sulphuric acid to each microwell.
Plate reading : The plates were kept at room temperature for 10
minutes for colour stabilization. After that, the optical density of each
microwell was read at 492 nm.
Obtaining results: A log-log paper was used. The concentration of
thrombomodulin calibrators (ng/ml) was plotted on the x-axis, and the
corresponding optical density values on the y-axis. The concentrations of
thrombomodulin of test dilutions were interpolated on the calibration curve
to determine their values. The value obtained was multiplied by the
dilution factor (5 or 10) to get the concentration of the tested sample.
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STATISTICAL ANALYSIS
Results were expressed as mean + standard error (SEM), Statistical
significance was accepted for p<0.05. Difference between the time points
was calculated using one way analysis of variance. Tukey-HSD test
(ANOVA) was used to determine the significance of change in NE in
relation to outcome. Spearman rank correlation coefficient test was used to
determine correlation.
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TABLE 3.1: PATIENTS CHARACTERISTICS
Number 19
Mean Age 56 + 4.5 years (SEM)
Sex (M:F) 7:12
Indication for transplantation
Primary biliary cirrhosis 7
Primary sclerosing cholangitis 2
Autoimmune hepatitis 4
Subacute liver failure 1
Alcoholic liver disease 5
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RESULTS
NE prior to OLT was 40.13 ± 4.84 ng/ml which was significantly higher
than those of normal controls (18.7 + 5.6 ng/ml, p< 0.05). During the early
anhepatic phase, NE levels increased moderately to (71.28 + 9.11 ng/ml,
p< 0.05). Following unclamping of portal vein (i.e. reperfusion), there was
a marked increase in NE antigen which peaked two hours post-reperfusion
(370 + 50.5 ng/ml, p< 0.001). Although there was a gradual decline in the
levels of NE, they remained elevated 24 hours after reperfusion (186 +
60.94 ng/ml) though not statistically significant (fig 3-I).
Two patients died of graft failure on days 7, and 12. A further patient died
on day 31 after a stormy postoperative course, which started with initial
poor graft function and was later complicated by acute rejection,
septicaemia and massive G.I bleeding due to multiple CMV induced ulcers
involving different parts of the G.I. tract. The outcome score of these
patients ranged between 6-8.
Mean delta NE (the difference between maximum and base-line values for
each patient) correlated with time to prothrombin time (PT) normalization
(p = 0.002, r2 = 0.52, fig 3-2), but not to alanine transaminase (ALT) levels
at 24 hrs post-reperfusion (fig 3-3). Using the criteria of graft outcome
which is detailed in chapter two, the mean delta NE was 224.8 + 36.3 in
group I, 442.6 + 48.5 in group II, and 720 + 195.8 ng/ml in group III. Only
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Figure 3 - 1: Changes in NE levels before and after reperfusion up to 24
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Figure 3-3: This graph demonstrates the lack of correlation between
mean changes in neutrophil elastase (NE) and alanine transaminase




















Figure 3 - 4: Changes in delta NE in relation to graft outcome (patients
classified into three groups according to their total outcome score, using
the criteria in table 2-2): group I, mild graft dysfunction with a total score up
to 3; group II, moderate dysfunction, with a score of 4-6; and group III,
severe dysfunction, with a score of 7-9. A total score of up to 6 is usually




Figure 3-5: Changes in sTM and NE levels before transplantation (pre),
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Figure 3-6: This graph shows the relationship between cold ischaemia
time and the mean changes in neutrophil elastase (NE) perioperatively
REJECTION
Figure 3-7: This graph demonstrates that the mean increase in
neutrophil elastase (NE) perioperatively is not significantly different
in patients with or without rejection.
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Figure 3-8:Correlation of the changes in neutrophil elastase (NE)
activity and the total amount of blood and blood products administered
peroperatively (NS).
DISCUSSION
Histological studies demonstrating infiltration of neutrophils in tissues
which were exposed to transient ischaemia followed by reperfusion
support the notion that neutrophils contribute to reperfusion injury (Engler
et al 1986). Once released from neutrophils, NE causes direct damage to
intact cells and inactivates various proteins such as immunoglobulins,
complements, and clotting factors (Weiss, 1989). Further, NE facilitates
increased generation of free radicals by converting xanthine
dehydrogenase into oxidase in the vascular endothelial cells (Phan et al,
1992). Such effect would set the scene for a vicious cycle by which free
radicals in addition to their direct tissue damage would contribute to further
neutrophil chemmoattraction, rolling, and adhesion via enhancing
expression of pro-inflammatory mediators such as adhesion molecules (e.g
GMP-140) platelet activating factor (PAF) and the leukotriene LTB4 (Lewis
et al 1988, Lehr et al 1991, Patel et al 1991). Free radicals also inhibits
neutralizing NE by its specific inhibitor ai.antitrypsin via oxidation of
methionine at position Met-358 (Janoff, 1985).
We have shown that the baseline values of NE in the patients studied
were higher than those of a healthy volunteer population. This is in
keeping with the observations of previous studies from our group, and
others which demonstrated evidence of neutrophil activation in patients
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with chronic liver diseases, particularly those with an alcoholic etiology
(Hayes et al 1989, Antonsen et al 1988).
The level of NE increased markedly following reperfusion which was
sustained for several hours thereafter. The relatively short duration
between the samples taken during anhepatic phase and early post-
reperfusion further suggests that neutrophil activation rather than for
instance delayed renal or hepatic clearance is the likely mechanism of
such changes.
Changes in NE activity post-reperfusion were significantly higher in
patients with poor graft function using the criteria described shown in
table-l. Patients in group II showed higher mean NE compared with those
of group I, however the changes did not reach statistical significance. The
highest values were seen in two of the three patients who died post¬
operatively as a consequence of poor graft function. Such findings would
further suggest a significant role played by neutrophils in reperfusion injury
The degree of rise in NE levels following reperfusion seen in this study
was markedly higher than that detected in conditions such as acute
myocardial infarction, multiple trauma, or inflammatory bowel diseases
(Bell et al 1990, Donnelly et al 1992, Gionchetti et al 1994). This might
indicate a more significant neutrophilic damage following liver graft
reperfusion when compared with the above mentioned conditions. The fact
101
that we collected our samples much more central and closer to the likely
site of increased activity in order to minimize the effects of dilution could
have played a significant role in such differences.
Although WB could potentially cause neutrophil activation, we do not feel
that this has played a significant role in the changes seen in this study, as
the most marked increase in NE levels occurred well after WB was
discontinued, and remained so for several hours thereafter. In some
patients, significantly high levels of NE were seen 24 hours following the
discontinuation of WB. In addition the continuous infusion of aprotinin
which inhibits platelet aggregation and formation of NE-a1 antitrypsin
complex during the WB reduces neutrophil activation further (Wachtfogel
et al, 1993).
In this study sTM increased significantly following reperfusion, which is
comparable to those of a recent study in patients who had OLT (Sido et al
1995). There was a trend of earlier rise in NE to be followed shortly with
rapid rise of sTM. Further a strong correlation was found between the
mean perioperative changes of sTM with those of NE, which suggests an
endothelial cell damage as a result of increased proteolytic activity of
neutrophils following graft reperfusion in this group of patients.
The nonthrombogenic property of endothelial cells is important in
maintaining proper blood circulation. Components of the nonthrombogenic
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mechanism include two major well-characterised anticoagulant systems
that operate on the endothelial cell surface: the TM-thrombin-protein C
system (Esmon et al, 1982), and the glycosaminoglycan-antithrombin III
system (Rosenberg et al, 1984). The physiologic relevance of the TM-
thrombin-protein C system is emphasised by the occurrence of thrombosis
in patients with a congenital deficiency of protein C (Comp, 1986)
Numerous reports have demonstrated that inflammatory mediators from
activated neutrophils damage the barrier function and the integrity of
endothelial cells. Loss of the anticoagulant property of the endothelial
surface in such a way in liver transplantation potentially leads to
microcirculatory stagnation and tissue ischaemia and this might be an
important mechanism behind the onset of no-reflow phenomenon, a
recognized feature of preservation-reperfusion injury.
Conclusion
This study demonstrated a significant degree of neutrophil activation
following graft reperfusion during OLT, with evidence of endothelial cell
damage as a result of such activity. As early neutrophil recruitment and
graft thrombosis appear to play a major role in graft failure following
prolonged preservation, additional strategies to interfere with neutrophil




INDOCYANINE GREEN CLEARANCE REFLECTS
REPERFUSION INJURY FOLLOWING LIVER










Graft dysfunction could result in prolonged ITU care, increased risk of
sepsis, and in severe cases (PNF) a need for early retransplantation. Early
diagnosis is vital for appropriate action. Reliable tests, however, which
permit early diagnosis of this condition are not currently available. Liver
function tests are difficult to interpret in the early post-operative period and
the diagnosis at present relies on a combination of biochemical,
haemodynamic and clinical markers (Forester et al 1989, Chazouilleres et
al 1993)
Greig et al (1989) have proposed a four stage classification of primary
graft dysfunction based on transaminase activity, bile production and
coagulopathy but serial observations up to 72 hours are required for their
scoring system. In addition, bile flow is no longer easily measured as most
transplant centres do not routinely insert a biliary T-tube. We have
previously shown in a preliminary report that indocyanine clearance
measured on the day after liver transplantation accurately reflected graft
function and may be used to predict graft survival and final outcome (Jalan
et al 1994).
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Indocyanine green is a water soluble tricarbocyanine dye which is
extracted by hepatic parenchymal cells and excreted almost entirely into
bile. It does not undergo any enterohepatic circulation (Wheeler et al,
1958) . The concentration in the plasma can be easily measured by
spectrophotometry and its rate of elimination has been widely used as a
measure of liver blood flow and liver function (Caesar et al, 1961) . In
patients with chronic liver disease, ICG clearance is probably the preferred
method of expressing the rate of elimination as the volume of distribution is
highly variable (Gilmore et al, 1982) .
AIMS
The aim of this study was to further evaluate ICG clearance as a predictor
of outcome and to test the hypothesis that ICG clearance following
orthotopic liver transplantation reflects the degree of reperfusion injury.
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METHODS
The ICG clearance is an already existing and established clinical test. As
such, there was no need for ethical approval and this was discussed with
the ethical subcommittee.
Patients & Transplant Details:
Peripheral ICG clearance was measured in 41 consecutive patients (46
transplants), between 18 and 24 hours after liver transplantation. Details of
the patients included are summarized in table 4-1.
The first 24 transplants were used to determine the cut-off value of ICG
clearance which best predicts graft outcome . This has been found to be
200 ml/min, and was reported in a preliminary study (Jalan et al 1994).
The subsequent 22 transplants were used to further evaluate this cut-off
value for the prediction of graft function.
The postoperative data recorded were:
Haemodynamic stability.
Time to correction of acidosis.






ICG clearance was measured using standard methodology (Gilmore et al,
1982). Sterile freeze dried indocyanine green (Paeselain Lorei,
Biochemika, Frankfurt) was dissolved immediately prior to injection in the
aqueous solvent provided to the concentration of 2.5 mg/ml. A dose of 0.5
mg/kg of body weight was injected rapidly into a central vein after a
baseline plasma sample was taken. Samples were repeated at 5 minute
intervals from the time of injection for 30 minutes.
Plasma was separated by centrifugation (3,000 rpm for 15 minutes). ICG
concentration was measured by spectrophotometry. This was calculated
by reading the absorbency of plasma samples at 805 nm; background
turbidity was corrected by measuring the absorbency at 900 nm. The
absorbency was converted to a concentration expressed as mg/l from a
standard curve. The concentration was subsequently plotted on semi-
logarithm paper against time. The line of best fit was drawn using the least
squares method. Clearance was calculated as the product of the
elimination rate constant K multiplied by the volume of distribution. The
volume of distribution was calculated as the ratio of the dose to the
extrapolated concentration at time 0 while the elimination rate constant K
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was the ratio of the logarithm to the graphically read half life. The
coefficient of variation was 4% .
(b) Reactive Oxygen Intermediates (ROIs)
ROIs were measured in 24 patients using the diene conjugated linoleic
acid method. The percentage ratio of diene conjugated linoleic acid (PL-9,
ll-LA) to its substrate phospholipase esterified linoleic acid (PL-9, 12-LA)
was used as a determinant of free radical activity. Details of the method
used are included in chapter two.
A blood sample was taken just before the operation (baseline sample) and
subsequent samples were taken during the anhepatic, reperfusion phase
and at 6-hourly intervals for 24hrs. The maximum rise of ROI (maximum
Diene/Linoleic acid ratio minus the pre-operative (baseline) value) was
recorded for each patient.
(c) Neutrophil Elastase (NE)
NE was measured by radioimmunoassay using rabbit polyclonal antiserum
(14). Details of the assay are included in chapter four. Results were
expressed in ng/ml. The sensitivity of the assay was 0.5 ng/ml. The normal
range was between 20-51 ng/ml. Blood samples were taken before the
operation (baseline) and during the anhepatic, reperfusion phase and at 6,
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12 and 24 hrs. The maximum rise in NE (maximum NE concentration
minus pre-operative "baseline" value) was recorded for each patient.
STATISTICAL ANALYSIS
A receiver operator curve (ROC) was used to determine the best cut-off
value to predict outcome, using the sensitivity and specificity of several cut
off values of ICG clearance. The Pearson correlation coefficient was used
to correlate ICG clearance with a number of biochemical parameters
postoperatively and with reactive oxygen intermediates and neutrophil
elastase levels; a p value at a level of 5% was taken as statistically
significant (two-tail test of significance). All values were expressed as
Mean ± SEM.
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TABLE 4.1: PATIENTS CHARACTERISTICS
Number 41 (46 transplants)
Mean Age 49 + 2 (SEM) years
Sex (M:F) 15:26
Indication for transplantation








T1 sclerosing cholangitis 1
Hepatocellular carcinoma 1
Alcoholic liver disease 4
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RESULTS
In all patients, ICG clearance was performed between 18 to 24 hours
following transplantation. None of the patients was actively bleeding or
clinically septic at the time of the test. All but seven patients were still
ventilated and 8 patients required inotropic support. Duplex colour flow
Doppler and ultrasonography was performed at day 1 and confirmed
normal hepatic arterial and portal venous flow in all patients.
At 24 hrs post-transplantation, the mean ICG clearance was 347.3 ± 17.8
ml/min, ALT I389 ± 188 u/1, bilirubin I29 ± 12 pmol/l and prothrombin time
26 + 2 sec. The mean time to correction of acidosis and prothrombin time
were 1.2 ± 0.1 and 3.2 ± 0.4 days respectively.
In figure 4-1, the data for all 46 transplants is presented. 37 out of 38
patients with ICG clearance above 200 ml/ min. were discharged home
within 30 days of the transplant and well with no problems due to graft
function. One patient with paracetamol induced fulminant failure required
prolonged ITU support and was discharged home well after 2 1/2 months.
Eight patients had a clearance below 200 ml/min. of whom six had either
died or required re-transplantation (four retransplanted for primary graft
non-function from whom two died 4 and 7 days later, two died at 12 and 31
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days post-transplantation). Two survived after prolonged stay in ITU and
intensive ventilatory and renal support. The highest sensitivity and
specificity of ICG clearance as a test to predict outcome was at cut-off
values of 200 & 250 ml/ min (100% sensitivity, 95% specificity) (figure 4-2).
When ICG clearance was plotted against ROIs, there was a significant
negative correlation between maximum rise of ROI activity and ICG
clearance indicating that the higher the oxygen radical activity which is a
mediator of reperfusion injury, the lower the ICG clearance (r = -0.64, p <
0.0008) (figure 4-3).
When ICG clearance was plotted against maximum rise of NE, a
significant negative correlation between those two parameters was found,
the higher the neutrophil elastase, the lower the ICG clearance (r - -0.65, p
< 0.0005) (figure 4-4).
ICG clearance significantly correlated with the ALT activity (r = -0.35,
p<0.02), and prothrombin time (r= -0.40, p<0.0077) at 24 hrs post¬
transplantation (figures 4-5, and 4-6 respectively). However neither ALT
nor prothrombin time at day 1 were found to be sensitive and specific
enough to predict outcome. No correlation was found between ICG
clearance and serum bilirubin (r = -0,26, p=0.08, figure 4-7) , hydrogen ion
concentration at 24 hrs post-transplantation (r = - 0.05, p= 0.7), time to
113
correction of prothrombin time (r = -0.20, p=0.2) or time to correction of
acidosis (r = -0.19, p= 0.24).























Figure 4-2: ROC curve of 4 cut-off values of ICG clearance test as a
predictor of outcome.
R= -0.64, p=0.0008, N=24
100 200 300 400 500
ICG Clearance (ml/min)
600
Figure 4-3: Relationship between ICG clearance within 24 hrs post¬
transplantation and maximum rise of reactive oxygen intermediates (ROI)
perioperativeiy; a statistically significant inverse correlation was found
ICG Clearance (ml/min)
Figure 4-5: This graph illustrates the correlation between ICG clearance
and alanine aminotransferase at 24 hrs.
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Figure 4-6: This graph illustrates the correlation between ICG clearance
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Figure 4-7: This graph illustrates the of correlation between ICG clearance
and bilirubin level at 24 hrs.
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DISCUSSION
Primary graft dysfunction when serious is a life-threatening condition and
early diagnosis is critical. Recently several groups have attempted to
devise a classification of primary graft dysfunction either based on the
combination of clinical and biochemical parameters (Greig et al 1989,
Gonzalez et al 1994) from both donor and recipient data or by using
dynamic liver function tests including galactose or caffeine (Nagel et al
1990, Svensson et al 1989) but none has been adopted into routine
clinical practice. Measurement of ICG clearance appears to be a simple
and safe test to assess early liver graft function. It can be easily measured
by spectrophotometry and the development of non-invasive techniques
such as Near-lnfra Red Magnetic Spectroscopy (NIMRS) (1B-20) has
enabled bedside assessment of the elimination of ICG with immediate
results thereby increasing its clinical usefulness.
Although ICG clearance has been traditionally thought to reflect liver blood
flow, recent studies using NIMRS technology by Shinohara et al (1996)
have demonstrated that the elimination of ICG by the rabbit liver follows
two exponential rate constants; the first reflects the dye uptake from
plasma to hepatocytes and the second represents the dye removal from
the liver by cytoplasmic transport and biliary excretion. The latter process
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can be inhibited by the presence of excess bilirubin. In primary graft
dysfunction it is probable that both the mechanisms of uptake as well as
removal of the dye are affected.
In the present study we have shown that ICG clearance is the most
specific and sensitive single test to predict graft function and outcome in
the immediate post-operative period thus enabling an earlier consideration
of retransplantation for graft failure. In our study group, a clearance of both
200 and 250 ml/min had the same sensitivity and specificity in predicting
outcome, but we opted to use the lowest threshold (200 ml/ min) as a cut
off value for significant graft dysfunction since we had two patients who
survived despite a clearance below 200 ml/ min.
All patients had normal hepatic artery and portal vein blood flow post-
transplant, therefore the most likely cause of deranged uptake from plasma
to hepatocytes appears to be a change in the liver microcirculation.
Changes in the microcirculation as a result of sinusoidal endothelial
damage and Kupffer cell activation secondary to reperfusion injury are
common (Koo et al 1992), this being a result of accumulation and
enhanced endothelial adhesion of neutrophils (Engler et al 1986),
increased platelet aggregation and adherence (Kubes et al 1990) and the
release of a number of mediators such as reactive oxygen intermediates
(Parks et al 1983, Arthus 1988, Bzeizi et al 1993), neutrophil elastase
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(Janoff, 1985, Phan 1992, Bzeizi et al 1996), leukotrienes (Lehr et al 1991)
and endothelin-ll (Goto et al 1994). These phenomena are likely to exert a
direct effect on delivering oxygen to the hepatocytes thereby decreasing
their function which may be reflected by reducing their ability to excrete
indocyanine green. In our study high serum bilirubin did not appear to
have any significant inhibitory effect on excretion of indocyanine green
because no correlation of day-ll post-operative bilirubin level and ICG
clearance was found. This favors the hypothesis that a reduced ICG
clearance is mainly due to impaired microcirculation and compromised
hepatocyte function.
In this study we have chosen to measure two markers of reperfusion injury
namely reactive oxygen intermediates (ROIs) and neutrophil elastase (NE)
and found that those markers correlate well with ICG clearance reinforcing
the hypothesis that ICG clearance reflects the degree of reperfusion injury.
We therefore propose that ICG clearance reflects graft function and can be
used routinely in the evaluation of primary graft dysfunction in the
immediate post-operative period. Although the routinely used
haemodynamic and biochemical parameters, are clearly useful in the
evaluation of the clinical condition of the patient, they are misleading in the
early post-operative period because several factors, such as sepsis,
derangement of fluid and electrolyte balance, transfusion of blood products
and degree of renal dysfunction, can make their interpretation difficult.
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In conclusion, this study has shown that an ICG clearance <200 ml/min
measured within 24 hrs following liver transplantation predicted graft
dysfunction due to reperfusion injury with high specificity and sensitivity.
ICG clearance is a relatively cheap and easy to perform test with
immediate results. The use of NIMRS technology can simplify the
measurement of ICG clearance and may increase further its usefulness
further by permitting frequent bedside monitoring of the clearance (Hopton
et al 1995, Shinohara et al 1996).
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CHAPTER FIVE
INFLUENCE OF cGMP CHANGES ON THE













The reperfusion phase during orthotopic liver transplantation (OLT) is a
critical event with well recognized haemodynamic and cardiac changes
which sometimes could be profound and may result in intra-operative
death (Lichtor, 1991). The haemodynamic changes, defined as post-
reperfusion syndrome are predominantly an increase in pulmonary
capillary wedge pressure (PCWP) and central venous pressure (CVP),
along with a reduction in mean arterial pressure (MAP) and systemic
vascular resistance (SVR). Such haemodynamic derangements tend to
improve in the majority of patients within 30-60 minutes, requiring only
cardio-vascular pharmacological support. However, the changes may be
severe enough in a small proportion of patients to be life threatening
(Aggarwal, 1989).
Several potential mechanisms for these changes have been considered
including sudden influx of cold, acidic and hyperkalaemic blood,
embolization, or release of vasoactive substances from the grafted liver
(Marino et al 1985). Ischaemia and reperfusion which accompany organ
transplantation is associated with release of pro-inflammatory mediators,
generation of free radicals along with neutrophil sequestration and
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activation (Bulkely, 1994). Such mediators could influence endothelial cell
function leading to disturbance of vasomotor control.
Free radicals have been shown to counter-act the relaxation effects of
nitric oxide (NO), on vascular smooth muscle cells via inhibition of guanylyl
cyclase and reduction in the release of guanosine 3', 5'-cyclic mono¬
phosphate (cGMP) from endothelial cells (Cherry et al, 1990). We have
demonstrated earlier evidence of an enhanced free radical activity post-
reperfusion in liver transplantation which leads to the suggestion that
cGMP generation could be reduced as a result of that, and hence impaired
vascular smooth muscle relaxation.
Endothelins play an improtant role in vasular tone control (Masaki et al
1991), with their potent vasoconstrictor actions and they might influence
the haemodynamic changes during transplantation. Studies have shown
an increase in the levels of endothelins following ischaemia-reperfusion.
Lerman et al (1991) showed an increase in circulating endothelins
immediately after liver transplantation and Textor et al (1992)
demonstrated that the increased endothelins after liver transplantation had
a profound effect on the renal haemodynamics.
They are released from the vascular endothelial cells to act on specific
endothelin (ET) receptors which are abundant predominantly in the renal
and pulmonary vascular beds (Shibuta et al 1990). Endothelins caused
Profound increase in PVR in rat lung transplantation following ischaemia-
reperfusion.
AIMS:
This study was designed to investigate the potential role of cGMP and




Fourteen patients (6 males and 8 females) with a mean age of 52.4 + 5.4
(SEM) years were studied. The indication for transplantation was:
Patients
Primary biliary cirrhosis. 6
Alcoholic liver disease. 5
Cryptogenic cirrhosis. 3
All patients underwent veno-venous bypass during the anhepatic phase of
the transplant procedure, with a mean duration of 71.5 + 9.3 minutes.
Detailed haemodynamic measurements were recorded after induction of
anaesthesia, during the anhepatic phase and following reperfusion at 30,
60 and 120 minutes.
The haemodynamic measurements were:
Pulmonary arterial pressure (PAP)
Pulmonary capillary wedge pressure (PCWP)
Both, were determined using a Swan Ganz catheter.
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Mean arterial pressure (MAP): continuously measured using an intra¬
arterial line.
Cardiac output (C.O): obtained in triplicate using the thermodilution
technique.
Systemic vascular resistance (SVR): calculated, using the standard
equations, SVR(dynes/sec/cm5) = (MAP - CVP) x 79.9/C.O.
pulmonary vascular resistance: PVR(dynes/sec/cm5) = (PAP - PCWP) x
79.9/C.O.
We also recorded the amount of fluid administered to maintain
haemodynamic stability, and the blood products used to maintain
haemoglobin concentration > 10 gm/dl, platelet count > 50 x 109/L, and
prothrombin time < 16 seconds.
Blood samples collection:
Blood samples were collected into EDTA containing tubes from a catheter
placed at the right atrium, at the same time points as the haemo-dynamic
recordings. Plasma was separated immediately (centrifuged for 15
minutes, at 3000 g) and stored at -70°C until analysis. The plasma
samples were later used for measurement of cGMP and endothelins. The
cGMP was measured by an in-house radioimmunoassay using rabbit
antibody RIBG and ED2-3 respectively. Endothelins (ET-1, &ET-2) were
131
measured by radioimmunoassay using 125I-ET-A (Amersham, London, UK).
Both assays are described in detail in the following part of this section.
cGMP MEASUREMENTS
The cyclic nucleotide (cAMP and cGMP) concentration in each sample
was measured using an in-house radioimmunoassay (Millat et al., 1993).
This method is based upon that described by Brooker et al. (1979), and
uses rabbit antisera produced in response to an acetylated form of the
appropriate cyclic nucleotide. Consequently, the sensitivity of the assay is
increased by acetylating the nucleotides in both test samples and
standards. In our laboratories this assay gives inter (on 10 samples)and




40 mis 0.5M Acetic Acid (BDH Chemicals Ltd. Poole,England)
60 mis 0.5M Sodium Acetate (BDH Chemicals Ltd.Poole,England)
0.1% BSA (Sigma Chemical Company, St. Louis, USA) added to 900 mis
distilled water.
Acetylating mix:
Trichioroethylamine (TEA) and Acetic Anhydride in a ratio of 2:1 (Sigma
Chemical Company, St. Louis, USA).
Dextran coated charcoal solution:
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22.6g Na HPO (BDH Chemicals LTD Poole, England), 5.44g KH PO (BDH
Chemicals LTD Poole, England), 2g NaN (Sigma Chemical Company, St.
Louis, USA), 12g charcoal (Sigina Chemical Company, St. Louis, USA)
l.2g dextran (Pharmacia Uppsala, Sweden), and 0.8g gelatin (Sigma
Chemical Company, St. Louis,USA)
Summary of the Method:
Cyclic nucleotides were extracted by mixing 500pl of plasma using 2
volumes (1ml) of 100% ethanol, followed by cooling at 4°C (15min). The
samples were then spun at 3, OOOrpm at 4°C (15min) and the supernatant
containing the extracted cyclic nucleotides, was decanted into fresh tubes.
The samples were subsequently dried under air (50°C) and resuspended
in 500ml assay buffer (0.05M acetic acid; 0.05M sodium acetate; 0.1%
gelatin; pH 4.8).
For the radioimmunoassay, a standard curve was prepared covering the
range 320-0.03nM. Each standard (500pl) and each sample (500pl ) was
acetylated using 15ml of a mixture containing triethylamine (2 vols) and
acetic anhydride (1 vol). Duplicate samples (100pl ) of each standard and
each sample were taken and both an 125l-cyclic nucleotide trace (150pl / 4,
OOOcpm) and the relevant, appropriately diluted, antiserum (10Opil ) were
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added. The samples were mixed thoroughly and allowed to equilibrate at
4°C (16-20 hours). Following equilibration, 600pl dextran coated charcoal
were added to each tube, and these were centrifuged at 3, OOOrpm (15
min). The supernatant was separated from the charcoal and discarded,
and the contents of each tube was counted in a gamma counter. The cyclic
nucleotide content of each sample was calculated by interpolation from the
standard curve.
ENDOTHELINS MEASUREMENTS:
Principles of the assay:
Amersham's endothelin-1,2 (high sensitivity) [125l] assay system was used
for quantitative determination of endothelin-1 (ET-1), ET-2 and big ET-1.
The system utilizes a high specific activity [125l] endothelin-1 (synthetic)
tracer, together with a highly specific and sensitive antiserum. The assay
is based on the competition between unlabelled ET-1 and a fixed quantity
of [125l] labelled ET-1 (synthetic) for a limited number of binding sites on an
ET-1 specific antibody. With fixed amounts of antibody and radioactive
ligand, the amount of radioactive ligand bound by the antibody will be




• Assay buffer concentrate (10 ml). On dilution to 100 ml, this will give
0.02M borate buffer PH7.4 containing 0.1% sodium azide.
• Endothelin-1 (synthetic), lyophilized, Upon reconstitution, the vial
contained 320fmol/ml ET-1.
• Rabbit anti-endothelin serum.
• Tracer as 125I-ET-A (synthetic)-41 kBq, 1.1 pCi, lyophilized.
• Amerlex-M second antibody reagent. Donkey anti-rabbit serum coated
on to magnetizable polymer particles. This solution contained 0.06% w/v
sodium azide
Specimen Collection And Sample Preparation:
Blood samples were taken from an indwelling catheter placed in the right
atrium and collected in tubes containing EDTA. The time points of the
samples taken were identical to those for cGMP sampling and
corresponding to the haemodynamic recordings used in this study. Plasma
was separated immediately (centrifuged at 3000g for 15 minute, at 4 °C)
and was stored at -40°C until analysis.
Extraction Procedures:
1. The columns were equilibrated by washing with 2ml methanol followed
by 2ml of water.
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2. Plasma (1ml) was acidified with 0.25ml 2M HCI, centrifuged at 10000g
for 5 min at room temperature and loaded onto the column. This was
followed by washing with 5 ml water and 0.1% trifluoroacetic acid(TFA).
3. Further washing with 2 ml 80% methanol in water + 0.1% TFA. The
eluent was collected in a glass tube, and later dried down in a
centrifugal evaporator.
Radioimmunoassay Procedure:
1. 2.0 ml of the assay buffer was added to the standard to make a solution
contains of ET-1 (synthetic) at a concentration of 320 fmol/ml in 0.02M
borate buffer.
2. 11 ml of the assay buffer was added to the antiserum and another 11ml
to the tracer to make solutions containing antiendothelin serum in 0.02M
borate buffer, and [125I]ET-1 (synthetic) in 0.02M borate buffer
respectively.
3. 500 pi of assay buffer was added onto each of the polypropylene tubes
labelled 0.25, 0.5, 1, 2, 4, 8, and 16. Into the 16 tube, 500 pi of the
assay standard was added (320 fmol/ml), and vortexed thoroughly.
4. 500 pi were transferred from tube 16 to the 8 tube to make a double
dilution. The doubling dilution procedure was then repeated
successively with the remaining tubes.
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5. 100 |il aliquots from each serial dilution along with 100 pi aliquots of
320 fmol/ml standard solution gave rise to 8 standard levels of ET-1
ranging from 0.25-32 fmol (0.623-79.74pg).
Assay Protocol:
1. Reagents and assay standards were prepared as described above, and
were equilibrated to room temperature.
2. Polypropylene tubes were labelled in dublicate for total counts (TC),
non-specific binding (NSB), zero standard (B0), standards and samples.
3. 200 pi of assay buffer were pipetted into the NSB tubes, and 100 pi into
B0 tubes.
4. 100 pi of each standard and 100 pi of the unknown sample were
pipetted into the appropriately labeled tubes. 100 pi of 320 fm/l standard
were added into tube labeled 32.
5. 100 pi of the antiserum were added into all the tubes except NSB and
TC. All the tubes were mixed thoroughly, covered with a plastic film and
incubated for 4 hours at 2-8 °C.
6. 100 pi of [125I]ET-1 were added into all tubes, followed by thorough
vortex mixing and incubation for 16-24 hours at 2-8 °C.
7. 250 pi of Amerlex-M second antibody reagent were added into each
tube except the TC and incubated for 10 minutes.
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8. The antibody bound fraction of each tube was separated by
centrifugation at 4°C for 10 minutes at 3000g. After centrifugation, the
supernatant was discarded, and the tubes were inverted and allowed to
drain for 5 min.
9. The radioactivity present in each tube was determined by counting for
60 seconds in a gamma scintillation counter.
10. Calculation of results: The average count per minute (cpm) was
calculated for each set of replicate tubes. The percent Bo/TC, and the
percent bound/ B0 (for each standard and sample) were calculated using
standard formulae.
11.The standard curve was generated by plotting the percent B/B0 (a
function of the log ET-1 concentration) on the y-axis against fmol
standard/tube in the x-axis. The fmol/tube was read directly from the
graph.
Statistical Analysis:
All results were expressed as mean ± standard error (SE). Difference
between mean before and after reperfusion was determined by one way
analysis of variance. Correlation between variables was determined using
Spearmann rank correlation coefficient. Values were considered as
statistically significant when the p value was less than 0.05.
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RESULTS
Changes in the haemodynamic parameters are summarized in table 5-1.
The main changes were of PVR and PAP. The PVR increased slightly
during the anhepatic phase from a base line value of 62.8 ± 12.9 to 72.5 ±
9.6 dyn/s/cm5 (NS). More marked changes were seen following reperfusion
with PVR increased to 135 + 42.7 dyn/s/cm5 (p< 0.01), and PAP from 17 +
1.2 to 22.8 +2.6 mmHg, (p< 0.05), 30 minutes after reperfusion. The latter
increased to a maximum of 23.5 + 1.9 mmHg, 2 hours after reperfusion.
C.O decreased slightly but not significantly during the anhepatic phase to
8.8 ± 0.78 L/min from mean pre-transplant value of 10.3 ± 2.4 L/min. MAP
decreased significantly at 30 minutes post-reperfusion (p<0.05) with
spontaneous improvement and return to base-line values subsequently.
The mean pre-transplant level of cGMP was 5.33 + 0.7 ng/ml (fig 5-1)
which was significantly higher than those of healthy volunteers (1.35 ±
0.43 ng/ml, n = 10, p<0.01). cGMP increased marginally during the
anhepatic phase to 6.31 ± 0.76 ng/ml (NS) but following reperfusion there
was rapid and significant decrease in cGMP to 1.63 ± 0.50 ng/ml (p<0.01).
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The mean pre-transplant level of endothelins was 28.75 ± 1.45 pg/ml (fig
5-2), significantly higher than those of healthy volunteers matched for age
(15.4 ± 0.8 pg/ml, p <0.01). During anhepatic phase , ET activity
decreased to 26.09 ± 1.81 pg/ml, however the changes were not
statistically significant. Post-reperfusion, ET values remained comparable
to those obtained during the anhepatic phase (26.92 ± 1.38, and 25.08 ±
1.45 pg/ml at one and two hours respectively).
The base-line cGMP correlated inversely with SVR, and MAP (p<0.05, and
p = 0.023 respectively) and directly with PVR recorded at the same time
point (p< 0.05). The correlation however was more obvious between the
mean changes in post-reperfusion cGMP and those of PVR (r = 0.7, p =
0.01, n = 12) and PAP (r = 0.74, p = 0.005, n = 12), (figures 5 - 3 & 5 - 4).
No correlation was detected between the intraoperative cGMP changes
and those of CVP, and CO at any time point.
Mean blood transfusion requirements were 7.3 + 4.2 units (range: 2-18),
cryoprecipitates 3.6 ± 1.5 units (0-16), platelets 5.2 ± 1.3 units (0-10), and
fresh frozen plasma 7.5 ± 2.1 units (2-12). No correlation was found
between these parameters and the changes in cGMP or the endothelins.
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All patients received dopamine at a fixed infusion rate of 2 pg/kg/min.
Seven patients required noradrenaline (8 mg%) at a rate of 4.5 ±1.2 ml/hr,
and 4 of these patients also required adrenaline (1:100,000) at a rate of 3
± 0.5 ml/hr. Mean post reperfusion changes in cGMP was 2.9 ± 0.7 ng/ml,
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Figure 5-I: The perioperative profile of cGMP. Pre - pre-anhepatic, Anh -
anhepatic, and then post-reperfusion at oO, 60, 1z0 minutes.
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INTRAOPERATIVE CHANGES IN ENDOTHEUNS
Figure 5-2: The perioperative profile of endothelins. Pre = pre-anhepatic,
Post-rep: 1= post-reperfusion at 60 minutes, and post-rep:2 = post-
reperfusion at 120 minutes.
Figure 5-3: Correlation of the changes in cGMP (difference between
pretransplant value and minimum post-reperfusion one for each patient)
with those of pulmonary vascular resistance (PVR).
Figure 5-4: Correlation of the changes in cGMP with the those of
pulmonary arterial pressure (PAP).
DISCUSSION
This study confirms the previous observations of major haemodynamic
disturbances during OLT (Kang et al 1987). The most striking changes
were in PVR and PAP; both of which rose shortly after reperfusion. The
changes in PVR and PAP correlated with the changes in cGMP levels.
cGMP, the vascular smooth muscle cell relaxant (Cherrry et al 1990), was
elevated in this group of patients with end stage chronic liver disease prior
to transplantation. Reduction in its concentration after reperfusion could be
a result of decreased activity of its main stimulants, or perhaps it could
represent mere normalization. Whichever the mechanism behind such
changes, the reduction in cGMP levels after reperfusion of the graft and
the correlation with the changes in the pulmonary haemodynamic
parameters suggest a causal relationship.
Although, levels of cGMP continued to fall after reperfusion, PVR showed
signs of recovery. There is no direct explanation to these changes . One
possibility could be the release of other vasomotor mediators that could
interfere with the actions of cGMP. Prolongation of the haemodynamic
readings and measurements of cGMP for several hours afterwards may
help in delineating this relationship further.
Our findings of elevated pre-transplant cGMP are comparable to the
previous reports of elevated levels of NO, the main stimulant of cGMP
generation in patients with cirrhosis Cahill et al 1995, Claria et al 1994).
Niederberger et al (1995), have shown in a cirrhotic animal model an
increase in aortic cGMP which was reduced significantly following
inhibition of NO production by the NO synthase inhibitor NG-monomethyl-L-
arginine (L-NMMA). This reduction in NO followed by reversal of the
hyperdynamic abnormalities of the systemic circulation. Recently, Sogni et
al (Sogni et al 1995), showed a significant correlation between
endogenous NO and pulmonary vasodilatation seen in cirrhosis. Addition
of the cGMP analog 8-(4-chlorophenylthio)-guanosine-3',5'-cGMP to the
preservation fluid in an experimental rat model of lung transplantation lead
to significant reduction of PVR and an increase in pulmonary artery blood
flow after reperfusion (Pinsky et al 1994). These findings further support
our conclusion about the role of cGMP in the haemodynamic alterations
observed during transplantation.
Although cGMP may be generated by pathways that do not involve NO,
such as stimulation of membrane associated guanylyl cyclase by atrial
natriuretic peptide (ANP), or by enterotoxins, NO is the major stimulant for
cGMP release from the soluble guanylyl cyclase (Kelly et al 1992). cGMP
is released by virtually all cell types through activation of guanylyl cyclase.
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cGMP levels are regulated by its rate of synthesis by guanylyl cyclase and
its rate of hydrolysis by cyclic nucleotide phosphodiestrase (Murad, 1986),
and its half life ranges between 10-20 minutes (Voderwinker 1991).
The release and effects of cGMP and NO, could be influenced by free
radicals which are generated following ischaemia-reperfusion. NO is the
only known biological molecule that can be produced in high enough
concentration to outcompete superoxide dismutase (SOD) for radicals.
This interaction results in formation of peroxynitrite anion (ONOO ), a
radical with vasomotor properties unlike those of its parent compound NO
(Darley-Usmar et al, 1994). Superoxide anion has been shown to induce
vasoconstriction, and is known to have a direct inhibitory effect on guanylyl
cycalse leading to a decrease in cGMP production (Cherry et al, 1990).
Pinsky et al (1994), studied in-vitro the interaction of NO-cGMP with free
radical activity during ischaemia-reperfusion, as detailed earlier in chapter
one. They showed a reduction of NO production by vascular endothelial
cells exposed to hypoxia followed by reoxygenation with a consequent loss
of the ability to inhibit thrombin-induced platelet aggregation, addition of
superoxide dismutase to the reaction mixture largely restored the ability of
reoxygenated endothelial cells to inhibit thrombin-induced platelet
aggregation. These findings support the hypothesis that NO reacts rapidly
with superoxide, generated by reoxygenated endothelial cells or within the
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vasculature during reperfusion of an organ (forming peroxynitrite in the
process). As a result, not enough NO is available to activate guanylate
cyclase. The findings in our study of decreased cGMP levels post-
reperfusion are supported by those of Pinsky et al, and it makes it plausible
to consider that free radicals could have played a role in the changes of
cGMP observed in our study.
Base-line endothelins were higher than those of age matched healthy
volunteers. These findings are comparable to the previously reported
results in patients with cirrhosis (Uchihara et al 1992). Mean values of ETs
during anhepatic phase and post-reperfusion were not significantly
different from the base-line ones. We could not identify any correlation
between ETs measurements and any of the haemodynamic parameters of
the similar time points.
Despite the the lack of any significant correlation between the endothelins
and the haemodynamic alterations observed in this study, it is however still
possible that endothelins could have played a role. One possibility
perhaps is the imbalance in vasomotor control caused by the rapid
reduction in the vasorelaxing effects of cGMP.
In human liver transplantation as compared to experimental animal
studies, several factors could influence the overall levels of humoral
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mediators measured from plasma or serum. These include the
haemodilutions effects of perioperative blood and fluid administration, as
well as the role of veno-venous bypass(WB). In this study we have
collected our samples through a catheter placed in the right atrium, a point
in proximity to the effluent blood from the liver in order to minimize the
effects of dilution. We have also determined in detail the fluid and blood
requirements throughout the operation, and none of these correlated with
endothelins measurements.
In summary, this study demonstrates haemodynamic changes affecting
predominantly the pulmonary vasculature following reperfusion of liver
graft during OLT. These changes correlated significantly with a reduction
in the levels of cGMP, the mediator of vascular smooth muscle relaxation,
which indicates a causal relationship. It also suggests that endothelins do
not change significantly post-reperfusion and are unlikely to contribute to
post-reperfusion syndrome. Further studies looking at the relationship of
cGMP and NO with the other mediators which rise following graft
reperfusion will be of major interest. These will provide the
pathophysiological basis behind therapeutic options of maintaining
cardiovascular stability during the critical phase of reperfusion in organ
transplantation.
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CHAPTER SIX - DISCUSSION
153
DISCUSSION
Prediction and Recognition of Primary Non-Function:
The technical advances in the field of liver transplantation including the
developments of preservation fluids, operation techniques and the intra-,
and post-operative anaesthetic and ITU care have all contributed
significantly to the progress and widespread application of transplantation
in the management of acute and chronic liver disease. Despite these
advances however, the reported incidence of primary graft dysfunction has
not changed significantly. Predicting and avoiding PNF, the severe form of
graft dysfunction remains a challenge. Unfortunately, PNF can also
become a challenge to diagnose when it does occur. Distinguishing
between the initial poor function of a graft that will eventually recover
(PGD), and one that is displaying PNF is not an easy task. Thus, there
have been many efforts both to predict and to recognize PNF as early as
possible in the transplantation process. Perhaps the most obvious means
by which to assess and predict graft function is to perform a biopsy of the
organ. Several studies have examined the use of frozen section biopsies
to predict graft outcome without success except in the presence of the
most severe pathological changes (D'Alessandro 1991, Adam 1990, and
Markin et al 1990). To illustrate the frustrating nature of PNF further, one
has only to appreciate the impressive number of parameters that have
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been investigated in efforts to identify its risk factors. Makowka et al (1987)
retrospectively analyzed a variety of commonly used donor criteria in an
attempt to predict outcome after transplantation. They found these criteria
to be completely unreliable and, most interestingly, found that more than
one half of donors judged to be "poor" provided organs with good early
function. Subsequent reports have made similar observations (Greig 1990,
and Kakizoe et al 1990). It would also be satisfying to identify some
particular laboratory value or test that might be predictive in allograft
outcome. Again, a multitude of parameters have been investigated.
Preoperative serum creatinine (Cuervas-Mons et al 1986), enzyme levels
in the perfusate of stored organs (lu et al 1987), hydrogen clearance rates
as an assessment of microcirculation (Manner et al 1990), liver tissue
oxygenation at the time of reperfusion (Goto et al 1992), platelet
adherence within the graft (Cywes et al 1993), post-transplantation
thrombocytopenia (McCaughan et al 1992), and intraoperative measures
of multiple variables (Paulsen et al 1989) have all been advocated as the
best predictors of early graft function. Unfortunately none are accurate or
practically suited as clinical tests (Kamath et al 1991), and it appears that
no one test, combination of tests, examinations, or observations can
accurately predict PNF. Methylglycinoxylidide (MEGX) a dynamic test of
liver function that determines lignocaine clearance, has been used to
assess the quality of the donor graft with encouraging results (Adam et al
1991, Buckel et al 1993). This test has been championed as a measure of
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both liver perfusion and function and thus a predictor of early graft viability
(Schroeder et al 1991). This examination can be performed to assess
function before retrieval of the graft (D'Alessandro et al 1991). Its place in
assessing outcome of graft function is however still uncertain. Rending et
al (1993) have failed to show a correlation between donor
monoethylglycinexylidide levels and the occurrence of PNF. Adams et al
(1993) however, have found that grafts with high MEGX values (>90ng/ml)
were associated with good function. The authors however highlighted the
limited predictive power of the test and suggested that grafts with a score
less than 90ng/ml could still be used.
This thesis has shown that an ICG clearance <200 ml/min measured within
24 hrs following liver transplantation predicted graft dysfunction due to
reperfusion injury with high specificity and sensitivity. ICG clearance is a
safe, relatively cheap and easy to perform test with immediate results.
NIMRS technology can simplify the measurement of ICG clearance and
may increase further its usefulness further by permitting frequent bedside
monitoring of the clearance. Future studies should be directed towards
exploring the potential use of ICG clearance in determining suitability of
liver graft before retrieval at the donor bedside. Should the test prove to be
successful for such a purpose, then the potential for improving the
outcome of transplantation is likely to be significant. With the shortage in
organ required for transplantation, the test may also help in minimising the
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number of grafts turned down because of potential poor quality as judged
by our current inadequate measures.
Reperfusion Injury: Prevention & Thoughts For Future Studies:
The recent studies and the findings reported in this thesis suggest an
importance of the humural changes during the reperfusion phase that
could influence the immediate post-operative outcome and development of
primary graft dysfunction. The findings of our studies have shown an
important role for both neutrophils and ROIs in PGD as a consequence of
ischaemia-reperfusion. It is likely that the interaction of neutrophils and
ROIs at different stages occur for augmented damaging effects to tissues
but remains unclear which one has the more important role. The answer to
this question is essential in order to develop a specific preventative and/or
therapeutic measures to minimize this injury. The pattern of early increase
in ROIs followed by a more sustained increase in NE points favourably
towards an earlier activation of the hypoxanthine-xanthine oxidase
pathway, which in turn contribute to recruitment and activation of
neutrophils. As detailed in the first chapter of this thesis, ROIs enhance the
release of mediators such as, PAF and LTB4, and upregulate the
expression of specific ligand/adhesion molecules on the luminal surfaces
of the sinusoidal endothelial cells. These molecules interact with
complimentary ligands on the surfaces of circulating neutrophils resulting
in endothelial cell/neutrophil adhesion leading to neutrophil activation and
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At present, no effective preventative treatment exists for reperfusion injury
following organ transplantation. Prostaglandins have been studied in
relation to reperfusion injury with variable results of success. Greig et al
(1989) demonstrated an improvement in graft and patient survival following
infusion of PGEi in patients with evidence of PNF. In a double blind
placebo controlled study by Henley et al (1995), PGEi was administrated
intravenously to OLT recipients for 21 days starting intra-operatively. No
difference was found between the two groups in relation to the incidence of
acute cellular rejection or PNF. They however, found a reduction in the
duration of hospitalization, and the need of renal support in the PGEi
group. Antioxidants such as allopurinol, superoxide dismutase, N-
acetylcysteine, and s-Adenosylmethionine have shown promising results in
preventing reperfusion injury in animal models (Koo et al 1992, Kobyashi
et al 1991, Vivot et al 1993, Dunne et al 1994), and warrant further study of
their role in human liver transplantation. The selection of an antioxident
must take into account both efficacy and safety. Allopurinol for instance
acts via the hypoxanthine-xanthine oxidase pathway, without affecting the
degree of ROI production by the activated neutrophil which is an equally
important mechanism. N-acetylcysteine on the other hand acts by
replenishing glutathione stores and is likely to be more effective, but has
the disadvantage of reducing tissue extraction of oxygen in cirrhotic
patients (Jones et al 1994). A recent study has shown a possible role of s-
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Adenosylmethionine (SAMe) if given perioperatively in attenuating
reperfusion injury (Dunne et al 1994). SAMe is an endogenous methyl
group donor, a precursor of adenosine and GSH. We have discussed
earlier in this review the evidence for the protective role of adenosine
against graft loss in the studies that followed selective elimination of
individual components of either UW or Carolina rinse solution. The effects
of adenosine are probably more significant at the end of the ischaemic
phase during rewarming of the graft when ATP stores fall rapidly, and
following reperfusion through inhibition of ROI release from the activated
neutrophils (Bruce, 1985). Such effects would augment the antioxidant
capacity of GSH. A further advantage of SAMe is its safety profile in
patients with chronic liver diseases as determined by the well documented
pharmacokinitec studies (Kaye et al 1990, Manzillo et al 1992).
Endothelins, with their vasoconstrictor effects might have a role to play in
reperfusion injury and graft dysfunction, Okumara et al (1991) and more
recently Nakamura et al (1995) evidence for no-reflow and sinusoidal
circulatory stasis with an increase of endothelin levels. Inhibition of of
endothelin-1 release by mono-clonal antibodies in animal models in the
latter study lead to improved graft viability. In our study, in human OLT
endothelins remained similarly elevated post-reperfusion when compared
to the pre-transplant levels which in a sense limit the significance of their
role in reperfusion injury. As the purpose of our study was originally to
assess the changes in vasomotor mediators (cGMP and endothelins) in
the context of peri-transplant haemodynamic alterations, it would be
difficult to extrapolate our findings on reperfusion injury. It however, opens
the debate again about the role of endothelins in ischaemia-reperfusion,
and it suggests a need for a more detailed study with a larger number of
transplant patients to address this question.
Reperfusion Syndrome:
This thesis confirmed the findings of previous studies of reperfusion
syndrome with the hallmark of haemodynamic instabilites that could have
fatal consequences. The thesis has shown that depletion of cGMP during
reperfusion was associated with adverse haemodynamic instabilities
particularly in the pulmonary circulation. The current knoweldge suggests
that the reduction in cGMP activity is probably not a primary phenomenon
but rather secondary to the effects of humural changes particularly the
ROIs released following ischaemia-reperfusion. Studies assessing the
impact of antioxidant therapy on the haemodynamic changes and cGMP
activity during transplantation would be of value in elucidating the extent of
this relationship.
Attempts to replenish cGMP directly by adding the cGMP analog 8-(4-
chlorophenylthio)-guanosine-3',5'-cGMP to the preservation fluid in an
experimental rat model of lung transplantation lead to significant reduction
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of PVR and an increase in pulmonary artery blood flow after reperfusion
(Pinsky et al 1994). Also, NO inhalation was used successfully during OLT
to control further rise in PAP in patients with hepatopulmonary syndrome.
Such reports supports the findings in this thesis and raises the interest for
further studies to explore the full potential of preventing cGMP depletion
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Primary Graft Dysfunction After Liver
Transplantation: From Pathogenesis
to Prevention
Khalid I. Bzeizi, Rajiv Jalan, John N. Plevris, and Peter C. Hayes
After orthotopic liver transplantation (OLT), somedegree of clinical and biochemical dysfunction
almost invariably occurs, the sevency of which corre¬
lates with the degree ofhepatic injury. This early injury,
known as primary graft dysfunction (PGD), varies
from minor insignificant abnormality to primary non¬
function (PNF). The incidence of PNF varies widely
depending on the criteria used for its definition.1 The
reported incidence in recent studies has been up to
7%.2"4 If the refined definition of PNF as death or
retranspiantation within 2 weeks of OLT5 is adopted, it
would then become apparent that this complication is
underreported.
Patients with PNF develop encephalopathy,
hemodynamic instability, and produce scant}', pale
bile. PNF is associated with increasing glucose
requirement, coagulopathy, markedly raised piasma
transaminases, metabolic acidosis, and renal fail¬
ure.6-7 Patients with PGD have increased morbidity,
prolonged intensive care,1 and an increased inci¬
dence of subsequent graft rejection.3
Histologically, the appearance of PGD ranges
from mild cellular infiltration to nepatocyte balloon¬
ing with focal or zonal necrosis, along with micro-
vesicular steatosis.9-10 The ultrastructural findings
are classically seen in the sinusoidal lining cells
(SLC) and include vacuolisation of endothelial
cells, mitochondrialysis, and interruption of piasma
membrane resulting in poor rounding of cells (Fig.
1). Inflammatory ceils often cluster in areas of
microarchitectural distortion and denudation.11-12
Considerable advances have been made in our
understanding of the pathogenesis of graft dysfunc¬
tion following OLT. In this article we will review
the current literature concerning causes of graft
dysfunction and discuss the preventative and thera¬
peutic strategies under consideration.
Pathogenesis
PGD is likelv to be the product of a number of
different elements that arise before, during, and
after transplantation. These include
• Donor factors
• Factors associated with organ preservation
• Reperfusion
The following section deals with the relative impor¬
tance of these factors in the pathogenesis of PGD.
Donor Factors
Potential donors with a known history of alcohol
or drug abuse, previous liver disease, abnormal
liver functions, or a positive viral hepatitis screen
are usually excluded. The macroscopic appearance
of the liver at the time of retrieval may be a helpful,
albeit late, guide in determining graft suitability. It
is, however, not uncommon for suboptimal grafts
to be transplanted because of the urgency of the
recipients clinical condition and limitations of the
donor screening methods.
Fatty infiltration of the donor liver has been
suggested as a risk factor for graft dysfunction, and
this is frequently related to alcohol abuse.5-13 Grafts
from malnourished, obese, or older donors may
also show fatty infiltration. The severity of fatty
infiltration is classified according to the percentage
of steatotic hepatocytes as mild (30%), moderate
(30%-o0%), or severe (>60%). Adam et al14 found
no difference in the 1-month survival of grafts with
mild to moderate steatosis when compared with
nonsteatotic organs. These findings were not sup¬
ported by Ploeg et al,15 who reported that moderate
steatosis was an independent risk factor for initial
poor graft function. Although debate regarding the
use of grafts with moderate steatosis continues,
severe fatty infiltration should be considered an
absolute risk factor for graft failure, and such grafts
should be excluded.
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Figure 1. Schematic representation of the uitrastructural changes of the hepatocytes and sinusoids in
liver transplants with poor graft function. Endothelial cells (EC) showing poor rounding with interruption
of plasma membranes. Hepatocytes (H), demonstrating vacuolization (V) and steatosis. Mitochondria
(M) appear vaculated and enlarged. Rolling and transmigration of activated neutrophils (N). Kupffer cell
(K). Aggregated platelets (P) within the sinusoid. Stellate cell (S) shown in a contracted state.
The mechanism by which fatty infiltration causes
graft failure is unclear, although sinusoidal irregu¬
larity and narrowing as a result of compression
with fat-laden hepatocytes has been suggested as a
possible cause.16 Other studies have implicated
enhanced Kupffer ceil activity in grafts demonstrat¬
ing fat infiltration.17-18
The effect of donor nutritional status on subse¬
quent allograft function remains unclear. Pro¬
longed fasting has been shown to result in severe
hepatocyte deglycogenation, which has been sug¬
gested to have a deleterious effect on graft viabil¬
ity.19-20 Sankarv et al.a on the other hand, reported
that grafts from fasting donors have improved
function and suggested that the beneficial effect of
fasting was due to reduced Kupffer cell activity.
Donor age has been reported to influence graft
viability; however, studies assessing the role of
donor age on graft function have shown variable
results. While Ploeg et ai" identified age as a risk
factor for graft failure, this was not confirmed in a
larger study by Adam et ai.— Hoofnagle et ai13
assessed the impact of donor age in a cohort of 772
liver transplants. Twentv-five percent of the donors
were aged 50 years or above. Intraoperativelv, there
was poor bile production by grafts of the oider
donors as compared to younger ones. Graft sur¬
vival was significantly less for recipients of older
donor livers at 3 months (82% v. 91%). Of impor¬
tance is that the grafts of older donors, which are
judged to be good by the harvesting surgeon, were
not associated with a decrease in patient or graft
survival after OLT. Grafts from elderly donors often
demonstrate steatosis, which may be the major
factor in determining quality, rather than age alone.
Organ Preservation
Reduction in metabolic rate and energy require¬
ments by induction of hypothermia is the primary
principle behind prolonged organ preservation;
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however, some degree of metabolic activity occurs
even in tissues preserved at 1°C. causing depletion
of high energy phosphates in the donor organs.
Tissues preserved in the University of Wisconsin
(UW) solution at 4°C for 48 hours demonstrate a
reduction in the concentration of adenosine triphos¬
phate (ATP) by 70%.24 This degree of reduction in
the concentration of ATP would occur over 2 hours
if the tissue is stored at room temperature. Further,
metabolic changes that occur as a consequence of
hypothermia include acidosis due to the accumula¬
tion of lactate from anaerobic glycolysis. Cellular
injury is further exacerbated by inhibition of
Na~/K~ ATPase,23 which results in the accumula¬
tion of intracellular sodium. This results in water
influx, which causes cell swelling and cell death.
Depletion of ATP during hypoxia damages the
Ca~^ pump, which leads to an increase in the
cytosolic free Ca~~. This increase has been postu¬
lated to initiate a cascade of cellular events that
culminate in cell death. Specifically, Ca" influx
into mitochondria leads to uncoupling of oxidative
phosphorylation with further depletion of ATP.
Ca"r~ also activates proteases, and this in turn leads
to conversion of xanthine dehydrogenase into
XO.26 Upon reperfusion and oxygenation, XO acts
on hypoxanthine (which accumulates during hy¬
poxia from the breakdown of ATP) to produce
reactive oxygen intermediates (ROD, such as super¬
oxide, and the hydroxvl group (Fig. 1).
Prolonged cold ischemia (beyond 16 hr) has
been shown in a rat model to be associated with
sinusoidal endothelial cell damage and activation
of Kupffer cells. These events result in microcircu-
latory changes, which are characterized by reduced
and uneven blood flow and increased leukocyte
and platelet adhesion. Reduction in Kupffer cell
activity with nisodipine or pentoxip'nylline im¬
proves graft survival.27
Reperfusion Injury
Tissue damage that follows ischemia-reperfusion
has been the focus of considerable research over
the last decade. Maino et al2S described the no-
reflow phenomenon in the cerebral circulation in
which reduction or complete cessation of blood
flow was observed upon reperfusion of ischemic
tissue. Koo et al2° studied changes in blood flow in
the liver sinusoids with in-vivo fluorescence micros¬
copy in an ischemia-rcperfusion model and showed
complete stasis in the majority of sinusoids 30
minutes after rcperfusion.
Ultrastructural examination of the SLC after
ischemia-reperfusion has demonstrated rounding
of cells, focal denudation, adhesion of inflamma¬
tory cells, and platelet aggregation. In this same
study the extent of reperfusion injury was reduced
with the ROI scavenger, allopurinol.
Various inflammatory mediators such as adhe¬
sion molecules and leukotrienes have been impli¬
cated in the pathogenesis of reperfusion injury.
Vasomotor mediators such as nitric oxide (NO)
and endothelin have also been shown to contribute
to reperfusion injury. In the following section, the
relative role of these agents and their interrelation¬
ship in the context of reperfusion injury is dis¬
cussed.
Reactive Oxygen Intermediates
ROI are characterized by the presence of one or
more unpaired electrons in their outer orbits,
which make them highly reactive and potentially
toxic. On reperfusion, the enzyme xanthine dehy¬
drogenase is converted to XO within endothelial
and Kupffer ceils.30 Hypoxanthine, a metabolite of
ATP that accumulates during hypoxia, reacts with
oxygen in the presence of XO to produce ROI such
as superoxide and the highly reactive hydroxyl
group. This is formed by the Haber-Weiss reaction
and requires transitional metal ions as a catalvst31
(Fig. 1).
ROI mediates cellular injury by a number of
mechanisms. First, it interacts nonspecificallv and
indiscriminately with adjacent molecules such as
lipids, proteins, and nucleic acids.31 Second, it
increases signal transduction, which results in
neutrophil chemotaxis and activation.32 Third, it
reacts with NO to produce the highly toxic peroxy-
nitrite radical.33
Studies in both humans and in animal models
have shown increased ROI production after reperfu¬
sion.34"36 Antioxidants such as allopurinol and
superoxide dismutase29-37 have been shown to
significantly reduce reperfusion injury. Infusion of
allopurinol perioperatively in rats undergoing liver
transplantation with the grafts preserved in UW
solution was associated with a reduced production
of ROI and improved graft function.38We have also
shown that ROI production continues for 24 hours
after OLT and that the degree of free radical
production correlates with indices of graft func¬
tion.39-40 This suggests that ROI is an important
mediator of reperfusion injury and its production
occurs not oniv during the reperfusion event but
continues for some time after reperfusion. The
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prime candidates for this later production of ROl
are inflammatory cells, particularly neutrophils,
which are known to have a significant capability to
generate ROI upon activation.
Inflammatory Cells
The role of neutrophils in the cellular injury of
ischemia-reperfusion is supported by histological
studies, which show an accumulation of neutro¬
phils in the injured tissue.41 This accumulation is
reduced by antineutrophil serum or monoclonal
antibodies.''2-43 Walden et al44 demonstrated an
improvement in the contractile function of skeletal
muscles subjected to ischemia-reperfusion by pre-
treatmenc wich vinblastin to reduce the neutrophil
population.
The process of cellular infiltration starts with
adhesion of the neutrophil to the sinusoidal ceil.
The nature and magnitude of these adhesive inter¬
actions depend on the expression of various media¬
tors such as the adhesion receptor/ligana mol¬
ecules, leukotnene B* (LTB*), platelet activating
factor (PAF), and cytokines such as tumor necrosis
factor (TNF)a, interieukin (IL)-l. and lL-2.45~9
Granule membrane protein (GMP140) ana endo¬
thelial leukocyte adhesion molecule (ELAM-1),
members of the seiectin family, increase signifi-
candv in the early phase of reperfusion during liver
transplantation. This is followed a few hours later
by expression of other adhesion molecules such as
the vascular cell adhesion molecule (VCAM-1) and
the intercellular adhesion molecule (ICAM-L).45
The cellular injury produced by neutrophils is
due to release of proteolytic enzymes (elastases,
proteinases, and collagenases) from their granules
and production of ROl through activation of nico¬
tinamide adenine dionucieotide phosphate
(NADPH) oxidase. Neutrophil elastase can degrade
almost all the components of the extracellular
matrix, attack intact cells, and inactivate various
proteins such as immunoglobulins, complement,
and clotting factors.50
Neutrophil elastase and ROI interact at number
of levels. Aipnai-antitrypsin, a natural inhibitor of
elastase, is inactivated by ROI through posttransla-
tional oxidation of methionine.31 Neutrophil eias-
tase. on the other hand, enhances further produc¬
tion of ROI from endothelial cells by catalyzing the
conversion of xanthine dehydrogenase to XO, an
action that can be inhibited by elastase inhibitors,
alphai-antitrypsin. and elastinal.32 Such interac¬
tions among these mediators potentiates their dam¬
aging influence on the tissues affected.
ROl promotes adherence of leukocytes to the
microvascular endothelium, and this effect is
thought to be mediated by induction of adhesion
molecules such as GMP140 and by activation of
phospholipase .4. (PLA;). which in turn increases
LTB4 synthesis.3134 The interaction between ROl
and adhesion molecules in the process of leukocyte-
endothelium adhesion has been demonstrated in a
feline intestinal muscle model. Upon superfusion
with hvpoxanihine-XO there was a rapid increase
in the number of rolling leukocytes, which is an
early and essential event prior to adhesion. The use
of monoclonal antibodies to P-selectin before super¬
oxide exposure inhibited the recruitment of rolling
leukocytes.'3
Kupffer Cells
The role of Kupffer cells in ischemia-reperfusion
has been demonstrated in a number of studies. In a
rat model, when hypoxia was selectively induced
in pericentral regions of the liver, electron micro¬
scopic analysis of Kupffer ceils revealed numerous
lamellapodia and pseudopoaia. These changes indi¬
cate activation of Kupffer ceils. This activation can
be prevented by pretreatment wich methvl-palmi-
tate.56 Following activation. Kupffer ceils release a
number of inflammatory mediators such as IL-L
and IL-8, which attract neutrophils and also pro¬
duce ROl.37'39 Activated Kupffer cells also release
TNFa, which has been shown to induce produc¬
tion of enaocheiin (ET)-l by endothelial cells.
Inhibition of Kupffer ceil activation with gadolin¬
ium chloride or adenosine-2 receptor agonists such
as nisoldipine and prostaglandin E( has been shown
to prevent microcirculatory disturbances after reper¬
fusion.60-61
Stellate Cells
The hepatic stellate or Ito ceil is located in the
space of Disse and resembles the pericytes localized
around capillaries. Its role in the regulation of
sinusoidal liver blood flow is being increasingly
recognized. Stellate ceils contract in response to a
variety of vasoactive substances, including ET-1
and substance p.02-63 They are also activated by free
radicals.04 Several vasoactive substances are re¬
leased during reperfusion injury that can poten¬
tially stimulate steilate ceils causing sinusoidal
contraction with subsequent stasis, hypoxia, and
further release of inflammatory mediators to com¬
plete the vicious circle leading to graft dysfunction.
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Nitric Oxide
NO is another important modulator of leukocyte
adhesion that has been implicated in the pathogen¬
esis of reperfusion injury. NO is enzymaticallv
synthesized from L-arginine by NO synthase, its
predominant function is relaxation of vascular
smooth muscle and inhibition of platelet aggrega¬
tion.65 It also inhibits neutrophil-endothelium ad¬
hesion by down-regulating the expression of the
ligand P-selectin60 and decreases ROI production
by inhibiting neutrophilic NADPH oxidase.
NO is the only known biological molecule that
can be produced in high enough concentration to
compete with ROI for superoxide dismutase. The
interaction results in formation of peroxynitnte, a
radical in its own right that, unlike NO, induces
vasoconstriction.67 This may contribute to sinusoi¬
dal stagnation and the no-reflow phenomenon seen
in reperfusion injury
NO causes vasodilatation through its secondary
mediator cyclic guanosine monophosphate (cGMP),
which is produced from the activated guanvlate
cyclase in endothelial ceils.68 ROI has a direct
inhibitory effect on guanviate cyclase, which re¬
sults in a reduction in intracellular cGMP levels,69
which is probably a further contributing factor
involved in microcirculatory stagnation ana reper¬
fusion injury.
Endothelins
Endothelins are a family of vasoactive peptides, of
which three forms have been identified (ET-L,
ET-2. and ET-3). All isoforms contain 21 amino
acids but differ in the two and five amino-acid
residues. Endothelial cells appear to produce ET-1
exclusively, which is considered the most impor¬
tant biological vasoconstrictor, acting on both
venous and arterial smooth muscle cells.70
Plasma levels of endotheiins are increased mark¬
edly in the reperfusion phase after cardiac ischemia
in rats, as well as in patients undergoing cardiac
transplantation.71-72 Administration of ET-1 to rats
results in significant hepatic sinusoidal constric¬
tion and a reduction of blood flow in a dose-
dependent manner.73 ET-1 could therefore mediate
the no-reflow phenomenon, which is the hallmark
of reperfusion injury.
Leukotrienes
Leukotrienes are important inflammatory media¬
tors that are metabolites of aracnidonic acid pro¬
duced by the 5-Iipoxygenase pathway, primarily in
Kupffer cells. The concentration of LT3», a potent
chemoattractant, increases markedly following is-
chemia-reperfusion.79-75 The leukotriene biosynthe¬
sis inhibitor MK-886 has been shown to prevent
poshscnemic leukotriene accumulation and the
ischemia Reperfusion
=:gure 2. Diagrammatic representation of classical pathway of ROI generation during ischemia/
eperfusion. (OH, hydroxyl radical; H20;, hydrogen peroxide.)






















Figure 3. Schematic representation of the ceiiuiar and intravascular events in relation to ischemia/
reperfusion following liver transplantation.
tnicrocirculacory changes of ischemia-reperfusion
injury.54
The relationship between leukotrienes and ROI
has been studied, and it seems that ROI, by
increasing the intracellular free calcium, activates
plasma membrane PLAi, which in turn enhances
leukotriene production by converting cell mem¬
brane phospholipids into arachidonic acid.76
Platelet Activating Factor
PAF is an autacoid phospholipid with vasoactive
and proinflammatory activity that has been studied
in relation to reperfusion injury. Its main functions
are to induce platelet aggregation and prime inflam¬
matory cells to release various mediators such as
proteases and cytokines.77
ROi enhances the release of PAF from endothe¬
lial cells, leukocytes, and platelets by increasing the
permeability of endothelial cells and platelets to
calcium [lux. which would activate the PLAj.78
Studies of PAF have shown increased levels after
reperfusion, but the use of the specific inhibitor
WE3-2170 in the hepatic ischemia-reperfusion rat
model did not protect against injury.7' Its role in




Selection criteria for liver grafts are somewhat
arbitrary, and more specific and objective measures
are required. The limited time available before
retrieval undoubtedly imposes a significant con¬
straint on the ability to determine suitability of the
graft. Liver function tests such as serum transami¬
nases and measurement of prothrombin time are
heipful but have limited sensitivity and specificity.
Frozen section liver biopsy, for instance, should be
considered whenever doubt about graft quality
exists.
Methylglvcinoxylidide (MEGX), a dynamic test
of liver function that determines lignocaine clear¬
ance. has been used to assess the quality of the
donor graft with encouraging results.:--30 It is easv
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to perform, relatively cheap, and provides rapid
results. In this test, lignocaine clearance is deter¬
mined by the activity of the cytochrome P-450
system, and, therefore, concomitant drug use can
affect the sensitivity of this test. Adams et al81 have
found that grafts with high MEGX values (>90
ng/mL) were associated with good function. The
authors, however, highlighted the limited predic¬
tive power of the test and suggested that grafts with
a score less than 90 ng/mL could still be used.
Indocvanine green (ICG) clearance is another
dynamic test of liver function with potential value
in determining suitabilicy of grafts for retrieval. We
have shown that ICG predicted subsequent graft
function within 24 hours after transplantation.32
ICG values below 200 mg/mL indicate poor graft
function in our experience.
Organ Preservation
Advances in methods of organ preservadon have
contributed significandy to the progress and wide¬
spread application of liver transplantation in the
management of acute and chronic liver disease.
The UW solution has an established place in organ
preservation and has made it possible to preserve
grafts for a period of up to 24 hours before
transplantation. This allows retrieval and transport
of grafts over considerable distances, thereby greatly
increasing the number of grafts available for trans¬
plantation. Surgeons can now choose convenient
times for the operation, and it is becoming possible
for the same surgeon to undertake both the re¬
trieval and the transplant operation.
Despite these advances, however, the reported
incidence of primary graft dysfunction has not
changed significantly. This emphasizes the need for
further improvements in preservation techniques.
The composition of the UW solution is complex
(Table I), and the value of some of its components
has not been clearly defined. Adenosine, a precur¬
sor for ATP synthesis, is probably important during
warm ischemia when ATP breakdown is acceler¬
ated.83 Adenosine is also known to inhibit produc¬
tion of ROl from activated neutrophils by interact¬
ing with the adenosine A-2 receptors on their
membranes.84 Allopurinol and glutathione arc in¬
cluded as scavengers of ROl. whereas lactobionate
and raffinose. which are large organic molecules
(molecular weight of 35S and 594, respectively),
provide osmotic support and prevent cell swelling
bv interfering with membrane permeation.35 Re¬















cently, it has been found that elimination of allopu¬
rinol, phosphate buffer, and MgSO.. does not affect
graft survival after 9 hours of preservation. Graft
survival, on the other hand, improved upon elimi¬
nation of insulin, which raises questions about its
inclusion in UW solution.86
Addition of agents such as calcium channel
blockers, tryptophan, cnlorpromarine, and glycine
have shown variable results, with the last being
most promising.86439 It probably acts by inhibiting
phospnoiipase, blocking caicium channels, and
stabilizing cell membranes. Lazaroid U74006F (21-
aminosteroid) is a potent inhibitor of iron-
dependent peroxidation, which has been shown to
reduce superoxide anion activity. When added to
UW solution, there was a significant reduction in
transaminases after OLT.90
Preliminary studies suggest an advantage in
adding the immunosuppressive drug tacrolimus
(FK506) to UW solution. The mechanism of its
cvtoprotective effects is probably nonimmunologi-
cal. Its effect is thought to be through recovery of
tissue ATP, which minimizes cellular injury during
warm ischemia.91
Misoprostil. a prostaglandin E( analogue, dem¬
onstrated a protective effect against hepatocellular
injur)' in a rat model of ischemia-repenusion. The
mechanism of.action is thought to be mediated
through inhibition of endothelial ceil-neutrophil
adherence and production of ROl.92
Limiting the duration of ischemia remains an
important priority because the incidence of graft
dysfunction increases rapidly with cold storage
beyond 12 hours.93
Bzetz' <i al
Flushing solutions are used before reperfusion
of the graft to clear K~. which is present in high
concentrations in UW solution. Carolina rinse
solution (Table 2) improves graft survival after
prolonged ischemia in UW solution. The efficacy of
this solution seems to depend largely upon the
presence of glucathione. allopunnol. and adeno¬
sine. Selective elimination of these components,
particularly adenosine, resulted in reduced graft
survival.36
Reperfusion
Despite the large number of studies demonstrating
evidence of reperfusion injury after organ transplan¬
tation. there is at present no effective preventive
treatment.
Prostaglandins have been studied in relation to
reperfusion injury with variable degrees of success.
Greig et ai9"4 demonstrated an improvement in graft
and patient survival following infusion of prosta¬
glandin E[ in patients with evidence of PNF. In a
double-blind, placebo-controlled study, Henley et
al.95 administered prostaglandin Et intravenously
to OLT recipients for 21 days, starting intraopera-
tivelv. No difference was found between the two
groups in relation to the incidence of PNF or acute
ceiluiar rejection. The investigators did find, how¬
ever, a significant reduction in the duration of
Table 2. Contents of Carolina Rinse Solution
Contents Concentration

















hospitalization and the need for renal support in
the prostaglandin E, group.
Antioxidants such as allopurinoi. superoxide
dismutase, N-acetvlcysteine. and S-adenosvlmethio-
nine (SAMe) have shown promising results in
preventing reperfusion injury in animal mod¬
els2996"98 and warrant further study of their role in
human liver transplantation. The selection of an
antioxidant must take into account both efficacv
and safety. Allopurinol, for instance, acts through
the hypoxanthine-XO pathway without affecting
the degree of ROl production by the activated
neutrophil, which is an equally important mecha¬
nism. N-acetvlcvsteine. on the other hand, acts by
replenishing glutathione stores and is likely to be
more effective, but it has the disadvantage of
reducing tissue extraction of oxygen in cirrhotic
patients.09 A recent study has shown a possible roie
for SAMe. if given penoperativelv, in attenuating
reperfusion injury.98 SAMe is an endogenous methvi
group donor, a precursor of adenosine and glutathi¬
one. We have discussed in this review the evidence
for the protective role of adenosine against graft
loss in the studies that followed selective elimina¬
tion of individual components of either UW or
Carolina rinse solution. The effects of adenosine
are probably more significant at the end of the
ischemic phase, during rewarming of the graft,
when ATP stores fail rapidly, and after reperfusion
through inhibiuon of ROl release from the acti¬
vated neutrophils.3"4 Such effects would augment
the antioxidant capacity of glutathione. A further
advantage of SAMe is its safety profile in patients
with chronic liver diseases as determined bv the
well-documented pharmacokinetic studies.91-92
Conclusions
PGD is an important complication after liver trans¬
plantation, and in the last few years, considerable
advances in our understanding of its etiological
mechanisms have been made. Undoubtedly, more
questions are yet to be answered about the degree
of interactions among the various contributing
factors in its development. Donor selection criteria,
although significantly improved, need to be refined
further. More emphasis should be given to assess¬
ing the currently available and promising dynamic
liver tests in addition to developing other discrimi¬
natory measures that can deliver rapid and reliable
answers regarding graft suitability.
Preservation and rinse solutions that have been
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important in establishing the success of liver trans¬
plantation need to be further modified to maximize
benefit. Components such as insulin, phosphate,
and MgS04 could probably be eliminated from UW
solution without adversely influencing graft viabil¬
ity. On the other hand, addition of substances such
as tacrolimus and NAC may improve graft function.
It is evident from this discussion that a large
number ofmediators are released following reperfu-
ston that are capable, individually or collectively or
perhaps in a cascade fashion, of activating Kupffer
cells and initiating neutrophil-endothelial cell inter¬
actions. The detrimental effects of ROI are medi¬
ated by directly damaging tissues and by their
capacity to stimulate the release of mediators such
as PAF, LTB4, and the selectin family of the adhe¬
sion molecules. These are important in the process
of chemoattraction, adhesion, and activation of
neutrophils (Fig. 3). Strategies to prevent ROI
production with pharmacological modalities such
as SAMe are likely to be of potential clinical value.
Experimental studies have shown evidence of at¬
tenuation of reperfusion injury by using monoclo¬
nal antibodies to block P-selechn—dependent neu¬
trophil-endothelial interactions. Further work is
also required to explore the benefits of measures
aiming to inhibit activation of Kupffer cells with
agents such as adenosine-2 receptor agonists.
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resolution ofmenopiuxal rymptomi «he itopped the HRT(and
tamoxifen) after only 3 months. 12 months later jbe developed a
pleural effusion and probable lung metastases.
Tamoxifen did not seem to compromise the effectiveness of
HRT. There is no evidence of rapid disease progression in
these patients receiving HRT and tamoxifen. Thus, it may be
possible to design hormone replacement that retains the ability
to control menopausal symptoms while protecting against
breast cancer.' Nevertheless, there is an urgent need for
randomised trials of HRT, with or without tamoxifen, before
such untested treatments become common.
Trevor J Povrles, Tamas Hiokish. Sharon Casey, Mary O'Brien
Royal Marafen Ho>so*a(. Sutton. Somey SM2 SPT. UK
1 Early Breast Cancer Triaiists' Collaborative Group. Systemic
treatment of early breast cancer by hormonal, cytotoxic, or immune
therapy: 133 randomised trials involving 31000 recurrences and 24000
deaths among 75 000 women. Lancet 1992; 334: 71-85.
2 Stoli BA. Hormone replacement therapy for women with a past hissory
of breast cancer. Clin Oncol 1990; 2: 309-12.
Mysterious respiratory disease In USA
Sir—Details of the mysterious respiratory illness mentioned
by Nelson (June 12, p 1526) among Navajo Indians arc at
present sparse, but the symptoms are reminiscent of those
described early in the course of an "acute nephritis" which
occurred with trench warfare in the First World War.1
Although proteinuria and fluid retention was the norm, many
soldiers presented with acute dyspnoea and probably low
pressure pulmonary oedema, although death from the acute
respiratory phase was rare. The cause was never known but
affected soldiers all had close contact with soil—which may
explain why the cavalry and officers were rarely affected.
A similar illness was seen during trench warfare in the
American Civil War. In data quoted by Langdon Brown,1 the
condition appears to have been more common in summer
months, and in June-July, 1862, there were 148 deaths. It has
been proposed by several workers' that trench nephritis was
caused by hantavirus, although the classic descriptions from
the First World War do not tally closely with the variants of
hantavirus infection that have been described in the past 40
years.
Guy Neild
Division of Nepnroiocy. Instrtute of Urology & N«©r»roiogy. Middlesex Hospital.
London WIN 8AA. UK
1 Brown W"L- Trench ncpfmns. Lancet 1916; i: 391—95.
2 Fisher-Hocfa SP, McGocxruck JB. Hacmonhagic fever with renal
syndrome: a review. Abszr Hyg Comntun Dis 1985; 60: Rl—R20.
QT Interval, autonomic neuropathy, and
alcoholic liver disease
Sir—The finding by Day and colleagues (June 5, p 1423) that
prolonged QT interval in alcoholic liver disease is an indepen¬
dent prognostic indicator and associated with sudden death is
of considerable interest. Patients in their study initially had no
clinical or echocardiographic evidence ofheart disease and they
suggest that the QT interval abnormalities may have been early
indicators of alcohol-induced myocardial toxicity.
Another possibility is that these changes are related to an
autonomic neuropathy, which may alter the length of the QT
interval in the electrocardiogram.1 A prolonged interval is seen
in diabetic autonomic neuropathy where it is associated with
rudden death,' and in chronic alcoholics.' 50% of patients with
alcohol-re la ted hver disease will have evidence of vagal
neuropathy on standard cardiovascular reflex tests.4 Kempler
et a],' noted a close correlation between prolonged QT interval
and vagal neuropathy in both alcohol-related and noo-alcohol-
rclated liver disease. Autonomic neuropathy could have
contributed to the QT interval abnormalities and increased
mortality noted by Day and colleagues.
M T Hertdrickse
Department of Med torse. Soutfvnead no«xtal. Bristol 8S10 5N6. UK
1 Eilcx M. The xutooomic acrvou* system and cardiac arrhythmia*. Clin
Auicm Res 1992; 2z 133-35.
2 Kahn JK, Sisson JC, Vinik AI. QT interval proioogaboo and sudden
cardiac death in diabetic autonomic neuropathy. J Clin Endocrinol
Metab 1987; 64: 751-54.
3 Duncan G, Johnaoo RH, Lambie DG, Whiteside EA. Evidence of
vagal neuropathy in chrome alcoholics. Lancet 1980; ii: 1053-57.
4 Hendrickse MT, Triger DR. Peripheral and cardiovascular autonomic
impairment in chrome liver disease: prevalence and relation to hcpanc
function. J Hepasoi 1992; 16: 177-83.
5 Kcmpler P, Varadi A, Szaiay F. Autonomic neuropathy and
prolongation of the QT interval in liver disease. Lancet 1992; 340: 318.
Free radical production following vascular
reperfusion
Sir—Grech and colleagues (April 17, p 990) show evidence of
free radical production in a spin-crapping method after
coronary recanalisation. With an indirect method (the ratio
between linoleic add and its phospholipid esterfied conjugated
diene isomer by high-performance liquid chromatography1),
we measured free radicals in a patient who had a liver
transplant. We were struck by the similarities between free
radical signals that appeared after reperfusion and those
noticed by Grech and colleagues (figure). An increase 30 min
after reperfusion of the graft was followed by a fall, then a
second increase at 12 h.
We believe that the initial rise is related to increased levels of
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after organ rrtrievij. However, this explanation doer not
account for the second peak. He agree with Grech and
colleaguci that ncutrophii activation may be responsible. A
liver biopsy specimen taken from our patient shortly after
reperfuxion of the graft showed neutrophil infiltration. Since
neutrophils are known to have a membrane-associated nicoti¬
namide adenine dinucleocide phosphatcoxidase system that
generates large numbers of free radicals, this seems a likely
source for late free radical generation.
K / Bzeizi, A Soutar, P C Hayes
ScoCUifi L/v«r Transotar* Unrt arxi Departmmc at Uodone. Royal Infirmary.
EOlntXjrcn £H3 9YW. UK
Iverxcn SA, Grwood P, Dormaruty TL_ A method for the
measurement of diene-conjugated dcrrrravc of linoleic acid 18:2(9,11)
in serum phospholipid and possible origins. Ann Clin Biochem 1985;
22: 137-40.
Anomalous acetylcholinesterase In CSF
without clinical diagnosis of Alzheimer's
disease
SIR—Navaratnam et al1 and Smith et al3 reported that an
anomalous molecular form of acetylcholinesterase (AChE)
(also called AOiF-AD) could be found in postmortem and
antimortem cerebrospinal fluid (CSF) of patients with histo-
pathologically proven Alzheimer's disease (AD) but not in
patients without AD. We have found, however, that whenmore
samples were investigated with the same methods, die
abnormal AChF is not oniy associated with AD but also related
to other neurological diseases that may cause dementia,
although these patients are currently non-demented (Mini-
Mental State examination):
Diagnosis "to o< cases No witfi ACHE40 band
Brain cysbcercosis 8 3
Myelopathy 4 0
Multiple sclerosis 4 1
Other- 13 IT
Total 29 5
■Virulent meningitis. GuIUirvearrE syndrome, heacacne. 3 eacrz intracranial tiypertenson. 2:
tuberculoses meningibs. varicocele. 1 each. T TuOercjwsiS mervngrtis.
The positive cases were aged 35-50 (M/F 2/3); the negative
cases were aged 15-58(13/11).
The biochemical and pathological process in AD takes years
to develop senile plaques and neurofibrillary tangles (before
dementia) and the plaques and tangles are not specific for AD.3
The AChF is involved early in plaque and tangle formation.'
Kokmen et al,5 in an investigation of clinical risk factors for
AD, stated: "We are unable to rule out a similar increase in risk
with a history of previous meningitis or encephalitis", which
indicates a possible relation between AD and our 5 positive
cases. Sotelo et al* studied 753 patients with brain cysticercosis
and found 16°0 with intellectual deterioration and 3°'0 with
disturbances of behaviour. The fact that 3 of our patients had
had brain cysticercosis might indicate that an abnormal
AChF could be related to the intellectual deterioration in this
disease, when a certain number of cysts are located in the
regions responsible for memory and cognition. Davis et al7
reviewed 157 necropsy-proven cases of multiple sclerosis and
found 47° 0 of patients with a mentai disturbance. In tubercul¬
osis meningitis, Alvarez and McGbri reported 7 cases with
abnormal behaviour or altered mental status in a total of 13
patients.
These findings, with the clinical risk study, might form a
reasonable explanation for our 5 positive samples, and raise
new insights that the CSF AChE-AD may not be specific for
AD and may participate in the long biochemical and patho¬
logical abnormality of not only AD but also organic dementia.
An AChF-AD in the CSF of noo-demented patients might
mark a "brain at nik", and treatment to clear the abnormal
molecular form of AChE should be given with anti-cyst,
and-ruberculoais, and anti-multiple-sclerosis drugs.
Zheog-Xuan Sben
Department at Heuro4o©r. Un*«n/ty of Minnesota, Mmneapofcv U*wesota 55455.
USA
Zhou Zhang
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A walking aid for Parkinsonian patients
IMS Pearce
304 Severity Rood. Arrtaoy. Hud HU10 7BG. UK
1 Pexrce JMS, Parkinson's disease and ics management. Oxford: Oxford
Univcrsxry Press. 1992: 30—32.
Sir—Frequent falls are a common source of embarrassment
and injury in patients with parkinsonism. When postural
dizziness, fainting, and tripping are excluded, many falls are
caused by akinetic freezing—an inability to move the leading
foot forward when the trunk starts in motion. Physiologically,
there is a failure to select the right
agonist muscles in advance of
rapid and precise movement; a
delay in switching from one
movement to another; and a
defect in simultaneously activat¬
ing different parts of the body.1
Patients find visual propriocep¬
tive cues very useful—eg, aiming
at marks or patterns on the floor,
trying to kick forward the leading
leg, or turning up the toes inside
the shoe.
A patient of mine has partly
overcome his trips and freezing
of gait by inventing a small hori¬
zontal metal bar, attached by a
hinge to the bottom of his
walking stick, 4 cm above the
Figure: Seynour stick ground (figure). If he glances at
this, he is able to step quickly over it with a good length stride,
without tripping or interrupting the rhythmical pattern of
normal walking. A friend fashioned this for him at negligible
cost.
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Graft dysfunction following liver transplantation:
role of free radicals
K. I. Bzeizi1, R. Dawkes1, N. J. F. Dodd2, J. N. Plevris1 and P. C. Hayes1
'Scottish Liver Transplant Unit. Royal Infirmary ofEdinburgh and :Paterson Institute for Cancer Research. Christie Hospital. Manchester. UK
Background/Aims: Following orthotopic liver
transplantation primary graft non-function
occurs in about 10% of patients, and survival
depends on early retransplantation. The aetiology
has yet to be defined, but reperfusion injury as a
result of free radical production has been consid¬
ered as a possible mechanism. In this study we
looked for evidence of free radical generation
intraoperatively and assessed the relationship
between free radical production and graft func¬
tion.
Methods/Results: Twenty-one patients (M:F 10:11,
mean age; 53±3.8 years) who underwent liver
transplantation for end-stage liver disease were
studied. Free radical activity increased significant¬
ly following reperfusion, as shown by: (i) the diene
conjugated method, where the percentage molar
ratio increased from a baseline of 10.87±0.78% to
24.42±7.8% (p<0.01), and (ii) by electron para¬
magnetic resonance, where a more than a twofold
rise in radical concentration was detected (/?<0.05).
The increase in free radical activity detected by the
diene conjugated method was significantly higher
in patients with poor outcome as compared with
those who had uneventful recovery (p<0.01).
Conclusion: Free radical activity is increased fol¬
lowing reperfusion of liver graft during transplan¬
tation, and the magnitude of the rise is related to
the severity of graft dysfunction.
Key words: Free radicals; Liver transplantation;
Primary non-function; Reperfusion injury.
Failure of the graft to function following ortho¬topic liver transplantation (OLT) is common
and is recognized in its extreme form as primary non¬
function (PNF), which occurs in ~10% of patients
(1). It is the principal cause of retransplantation in the
first 2 weeks post-operatively (2). A less severe form
is defined as primary graft dysfunction (PGD), which
is associated with increased morbidity, prolonged
I.T.U stay and later graft rejection (3).
Features of PNF include marked encephalopathy,
haemodynamic instability and poor bile production.
Patients demonstrate increasing glucose requirement,
coagulopathy, markedly raised plasma transaminases,
metabolic acidosis and renal failure.
It is likely that PGD is due to a number of coexist¬
ing factors resulting in complications that arise dur¬
ing transplantation, starting with the donor stage
Received 20 November 1995: revised 11 April: accepted 13 May 1996
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through preservation to reperfusion. Koo et al. (4)
showed evidence of hepatic microcirculatory stasis
which was associated with a significant degree of
hepatocellular necrosis following ischaemia-reper-
fusion in a rat model. Such effects have been shown
to be prevented by concomitant administration of
superoxide dismutase (SOD), a free radical scaven¬
ger.
Reperfusion injury has been the focus of consider¬
able research over the last decade. This has largely
concentrated on the release of various inflammatory
mediators, such as leukotrienes, adhesion molecules
and free radicals, with the latter attracting most atten¬
tion (4—7). Free radicals are characterized by the
presence of one or more unpaired electrons in their
atomic orbital. They are highly reactive and poten¬
tially toxic. During ischaemia, the enzyme xanthine
oxidase (XO) accumulates as a result of calcium
influx and activation of proteases. Upon reperfusion,
XO acts on hvpoxanthine in the presence of 0-, and
generates radicals such as superoxide and hydroxy!.
Antioxidants such as SOD, N-acetvlcysteine and
69
irvodcis were shown to amelio-
y (8—10).
study to quantitate free radical
and to identify the relationship
between their magnitude of change and subsequent
graft function.
Materials and Methods
We studied 21 patients (10 males and 11 females with
a mean age of 53±3.S years) who underwent OLT.
The indications were primary biliary cirrhosis (9
patients), alcoholic liver disease (6), primary scleros¬
ing cholangitis (3), and cryptogenic cirrhosis (3). The
mean donor age was 38±6 years.
Matching of donor liver to the recipient was car¬
ried out as per standard protocols. Eleven grafts were
retrieved by the same team from our unit, while the
rest (10 grafts) were retrieved by a team according to
the geographical location of the donor. Generally,
each team has followed a standard protocol of
retrieval. Grafts with a significant degree of steatosis
or of donors with history of drug/alcohol abuse were
rejected.
University of Wisconsin (UW) solution was used
for preservation, and grafts were flushed with Caro¬
lina rinse solution prior to restoration of blood flow.
All patients underwent veno-venous bypass during
the anhepatic phase; mean duration 70±11 min.
Following OLT, data collected included daily rate
of bile production, time to correction of acidosis,
serum transaminase, and prothrombin time. For
objective assessment of graft function and outcome,
TABLE 1
Parameters of scoring system for assessment of early postoperative












>60 (with fresh-frozen plasma) 2
<60 (despite fresh-frozen plasma) 3
1 Highest value in the 72 h after transplant. Normal value is up to 40
u/T
b Mean value during the first 72 h after transplant.
c Lowest value in the 72 h after transplant.
wc used criteria described previously (11) and these
are detailed in Table 1. The scoring system of this cri¬
teria is dependent on serum ALT and prothrombin
time activity determined at 72 h post-operativety,
along with the mean value of bile output over the first
3 days of transplant. In each patient, the score was
calculated from the sum of assigned values from each
parameter, ranging from 3 to 9. According to these
criteria, patients with a total score up to 6 were shown
to have good outcome, and a score of 7-9 was associ¬
ated with poor graft function.
Further data collected included cold ischaemia
time, blood transfusion requirements, and acute
rejection episodes. The relationship of these parame¬
ters with the degree of free radical activity was deter¬
mined.
Markers offree radical activity
The percentage molar ratio (PMR) of diene conju¬
gated linoleic acid (PL-9, 11-LA) to its substrate
phospholipase-esterified linoleic acid (PL-9, 12-LA)
was used as a determinant of free radical activity.
Blood samples were taken from each patient through
an indwelling catheter inserted following induction
of anaesthesia, with its tip being positioned in the
right atrium. Samples were taken following induction
of anaesthesia, during the anhepatic phase and fol¬
lowing reperfusion at 30 min, 1, 2, 6, 9, 12 and 24 h.
Plasma was separated by centrifugation at 3000 G for
15 min and stored at -40°C for later analysis. Plasma
concentrations of both (PL-9, 11-LA) and (PL-9, 12-
LA) were measured by high performance liquid chro¬
matography after enzymatic hydrolysis, and solid
phase separation as described by Iverson et al. (12).
The coefficient of variation of the assays was less
than 3.5%, and results are expressed as diene conju-
gated/linoleic acid ratio, to reduce error due to sub¬
strate variation.
In a subgroup of 10 patients, we used a spin trap¬
ping method as another determinant of free radical
activity. This has been described previously (13). In
brief, from each patient, blood samples (1 ml each)
were withdrawn from the same - right atrial catheter
after induction of anaesthesia, during the anhepatic
phase and following reperfusion at 1, 12 and 24 h.
They were immediately mixed with 50 mM solution
of the spin trapping agent cc-phenyl N-tert-butyl
nitrone (PBN) and stored in liquid nitrogen. The
PBN-free radical adduct was extracted by adding 2
ml of toluene to each ml of the mixture followed by
centrifugation at 10000 G for 5 min. The toluene
extract was separated and stored at -40°C until anal¬
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"microwave power was 20 mW,
3355±30 gauss and frequency of 9.4 G
'mf*"usina 10° modulation with an amplitude of
Qs'oauss. The tme constant was 0.3 s and the sweep
[imeC84 s. The sample temperature was 220°K.
free radical concentrations were determined by
comparing the double integrals of the EPR signals
from the experimental samples with those from
known concentrations of a stable free radical, 4-
hydroxy-2,2,6,6-tetramethylpiperidine-l-oxyI, in the
same solvent and recorded under identical conditions.
In those cases where very low signalmoise precluded
accurate integration, radical concentrations were esti¬
mated by comparison of signal heights of the weaker
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Fig 1. Peri-operative changes in PMR ratio as a determi¬
nant offree radical activity. Pre: pre-transplant. A.- During
anhepatic phase, and then post reperfusion up to 24 h.
Statistical analysis
Results were expressed as mean±standard error
(SEM). Statistical significance was accepted for
p<0.05. The difference between time points was cal¬
culated using one-way analysis of variance. Correla¬
tion between variables was performed by linear
regression analysis using the Spearman correlation
coefficient.
Results
Figure 1 shows the intra-operative changes in free
radical activity as measured by the diene conjugated
method. The mean base line plasma PMR was
10.87±0.78%, which although higher than those of
healthy volunteers (9.74±0.84%), did not reach statis¬
tical significance. No significant change in activity
occurred during the anhepatic phase (10.29±0.71%),
but a marked rise in activity was evident following
reperfusion with an initial peak at 1 h (24.42±7.81%,
p< 0.01). A second more prominent peak appeared 12
h post-reperfusion following a transient decrease of
radical activity (21.91±2.46%, p><0.01). Six patients
had poor graft function according to the criteria
defined earlier (Table 1) with scores ranging between
7 and 9. Of these, three had died on days 7, 12 and 31
days following acute post-transplant liver failure.
Another patient from the same group developed fea¬
tures of PNF and required retransplantation on day 3.
Fig. 2 shows the mean delta PMR activity, which is
the difference between the maximum and base-line
values plotted against the total score of graft outcome
for each patient. A significant correlation was found:





Fig. 2. Relationship ofPMR as a determinant free radical
activity to the markers of postoperative graft function as
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Fig. 3. Peri-operative changes in free radical activity de¬
termined by EPR method, and identified as PBN-radical
adduct signals. Pre: pre-transplant. Ann: during anhepatic
phase, andjhen post-reperfusion at 1, 12. and 24 h.
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Fig. 4. Representative time course ofEPR spectra ofPBN-radical adducts obtainedfrom one patient; (A) prior to induction
of anaesthesia. (B) during anhepatic phase, (C) 12 h after reperfusion and (D) spectral simulation of the PBN radical ad-
duct, using the parameters aH=0.19 mT, as= 1.36 mT. Comparison of this simulation with the spectrum in < C), clearly shows
the similarity of the radical species. Spectra (A) and (B) show evidence ofthe same radical, although at the lower concentra¬
tion, the hydrogen hyperfine splitting is not resolved.
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Using the spin trapping technique, PBN-adduct
signals were barely detectable after induction of
anaesthesia and during the anhepatic phase (Fig. 3).
A significant increase in intensity was evident fol¬
lowing reperfusion with larger signals obtained in 12-
h samples which showed 3 lines from a nitrogen
atom, with aH=14 gauss, and these are split into dou¬
blets by a hydrogen atom, with aN=2 gauss. Such sig¬
nals are identical to those reported by Tortolani et al.
(13). Levels of PBN-radical adducts of those samples
were 2-3 times higher than the pre-transplant levels
(p<0.05). Representadve EPR obtained from a
patient before and after repeifusion of the graft are
shown in Fig. 4.
There was no correlauon between the magnitude
of free radical changes and cold ischaemia ume
(10.61±0.58 h) or mean blood units transfused
(7.27±1.12, range 2-19 units).
Acute rejection which required treatment, as
judged by clinical and histological criteria, occurred
in seven patients (30%). The mean PMR of patients
with rejection was 11.69±0.84% compared with
11.17±1.54% in the non-rejecuon group (NS).
Discussion
There is increasing evidence to suggest that oxidative
stress, the result of excessive production of oxygen-
derived and other radicals, is a major cause of reper¬
fusion injury. These observations are based on exper¬
imental and animal model studies (7,14) and further
supported by favourable effects of antioxidants such
as allopurinol, ascorbic acid and superoxide dis-
mutase when used in such situation (14,15).
In this study we have shown evidence of increased
free radical activity following reperfusion of the new
liver graft. We used two methods to quantitate free
radical activity because of the limitations of the indi¬
vidual methods alone, as suggested previously (8).
The PMR method is regarded as a "fingerprint" assay
providing indirect evidence of radical production bv
72
s Qf lipid peroxidation.
[■ffiSpp)|P^^W-P^.Uconjugated isomer. These■ajPliySalT^**; is irequently used methods for
Bafg^ bArn &<* nct'v'ty 'n human diseases for
C,CC'aferyr" ^ie-v axe primarily in vitro techniques.
spectroscopy, on the other hand, is a direct and
janthative method which measures the energy
lances that occur as unpaired electrons align in
v-ponse to an external magnetic field (8). As many
;e radicals have a very short life (less than millisec-
lds), such measurement therefore depends first on
roping the radical by administering a compound
ccn as PBN (preferably intravenously) to produce a
troxide (a spin-trapped adduct) whose lifetime is
msiderably longer than that of parent free radical,
id therefore detectable by EPR spectroscopy (16).
. human studies toxicity of PBN has limited the
cnnique to mixing of blood samples with the spin
=ap as soon as possible after collection. Despite the
evitable reduction in the sensitivity of the technique
re to the time lag between free radical generation
id trapping, it remains by far the most specific in
erecting radicals, when compared with the other cur-
mtlv available techniques. Valuable data have been
stained, for example, relating to free radical produc-
on during angioplasty (17,18).
The results of this study have shown a significant
egree of correlation between the degree of free radi-
ai activity and markers of graft function, which is
iggestive of a role for free radicals in the aetiology
f PGD. The criteria we used in this study (11) are a
lodincation of those defined by Greig et al, in
hich the widely accepted parameters for assessment
: early post-operative graft function are used. They
.elude serum levels of aminotransferases, bile pro-
iction and coagulation status, alone or in combina-
on. In these criteria, a well-defined cut-off value for
ich parameter is determined.
The currently available knowledge, however, does
x support the suggestion that reperfusion injury is
mplv a matter of damage to dssues by toxic radicals
9). Inflammatory mediators such as leukotrienes,
AF, and soluble adhesion molecules (e.g. p-selectin)
ive been shown to be upregulated by free radicals
0—22), and they have been implicated as well in
perfusion injury (5,6,23). These molecules react
ith the complementary ligands on the circulating
rutrophils. leading to their arrest and consecutive
tivation with release proteases and radicals (24,25).
le bipnasic appearance of free radical generation
en in this study (Fig. 1) may support the view that
ev are important in the initiation of the inflamma-
rv cascade and consecutive reperfusion (26), as the
earlier rise of free radicals is likely to result from xan¬
thine oxidase on the endothelial cell surface, via the
classic free-radical-mediated chain reaction with the
late surge radicals being a direct product of activated
neutrophils. It will be interesting to look into these
aspects in more detail to determine the likely mecha¬
nisms of free radical generation at different time
intervals. This would be of help in determining an
appropriate therapeutic strategy to reduce reperfusion
injury.
We did not see a correlation between cold ischae-
mia time and degree of free radical activity. Pro¬
longed ischaemia can lead to increased accumulation
of XO and hypoxanthine, which subsequently could
determine the extent of free radical activity. It is pos¬
sible that the limited ischaemia time in this study has
been a factor, and this could be supported by findings
of a previous study that showed extended preserva¬
tion beyond 16 h in UW solutions is unfavourable
and likely to influence subsequent graft function.
Acute graft rejection which required treatment
occurred in 30% of the patients studied. We did not
see a difference in free radical activity in the patients
with rejection as compared with the non-rejection
group. Poor graft function has been shown to increase
the incidence of graft injection (3). The mechanism
for such a relationship is, however, unclear, and from
the results of this study it would seem unlikely to be
free radical related.
In conclusion, this study provides evidence of
increasing free activity following reperfusion of liver
grafts and the magnitude of changes correlated with
the severity of graft dysfunction.
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NEUTROPHIL
DAMAGE
Reperfusion injury has been implicated in the devel¬
opment of primary graft dysfunction (PGD) after liver
transplantation. Neutrophil migration and activation
may be involved in the pathogenesis of this injury.
We studied neutrophil activation and its role in the
etiology of PGD by measuring neutrophil elastase by
radioimmunoassay, in serial blood samples of 19 pa¬
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tients before, during, and for 24 hr after transplanta¬
tion. In a subgroup of patients, we also measured sol¬
uble thrombomodulin at the same time points as a
marker of endothelial damage.
The pretransplant elastase level was significantly
raised (40.13tz4.84 ng/ml. mean ct SEM) compared with
levels of healthy controls (18.7z:5.6 ng/ml. P<0.05). A
marked increase in elastase activity followed reperfu¬
sion. with a peak at 2 hr (370m50.5 ng/ml, P<0.01).
Thereafter, there was a decline, but elastase remained
elevated at 24 hr (186z:60.94 ng/ml). The mean increase
in neutrophil elastase after reperfusion correlated sig¬
nificantly with markers of graft function (P<0.05) and
with the mean rise in soluble thrombomodulin
ELASTASE: A DETERMINANT OF ENDOTHELIAL
AND REPERFUSION INJURY AFTER LIVER
TRANSPLANTATION?
K.I. Bzeizi,1-- R. Jalan.1 I. MacGregor,3 O. Drummond,3 A. Lee,1 and P.C. Hayes1
Scottish Liver Transpianc Unit, The Royai Infirmary ofEdinburgh, and National Science Laboratory,
Blood Transfusion Service. Edinburgh, Scotland
is. I"6
o42), which increased from a pretransplant level
V^,°V>=ii.32 to 186=50.4 ng/ml, 6 hr after reperfusion
tf &
p<0.05).
The results of this study indicate that marked neu-
-ophil activation and endothelial cell damage occurs
fter graft reperfusion during orthotopic liver trans-
lantation, and the degree of activation correlates
•ith markers of graft function, which may suggest a
3le in the etiology of PGD.
After orthotopic liver transplantation (OLT*), many grafts
low some degree of hepatitis, which when severe is associ-
;ed with poor graft function, known as primary graft dvs-
nction (PGD). Patients with this complication have a
■eater risk of developing graft rejection (1).
Primary graft nonfunction (PNF) is an extreme form of
ID, occurring in about 10% of liver transplant cases. It is
e most common indication for retransplantation within the
■st 2 weeks (2). Patients with PNF develop encephalopathy
id hemodynamic instability, and have poor or no bile flow,
lagulation is markedly deranged in association with in-
eased glucose requirements, raised transaminases, meta¬
llic acidosis, and renal failure.
The pathogenesis of PNF remains unclear. Preservation
id later reperfusion of the graft have been suggested to play
significant role in its etiology (3). We ana others have
oduced evidence of increased free radical generation follow-
g reperfusion of a liver graft (4—6), probably by way of the
issical hypoxanthine-xanthine oxidase pathway and from
utrophils. The latter have been shown in histopathological
idies to accumulate in tissues with reperfusion injury (7);
len their infiltration is prevented, using antineutrophil
rum, monoclonal antibodies, or vinblastine pretreatment,
hemia-reperfusion damage is reduced (8, 9).
Activated neutrophils cause tissue damage by release of
e radicals and proteolytic enzymes, such as metallopro-
nases and elastase, from the granules. They are capable of
ect tissue damage and enzymatic inactivation unless neu-
lized by their natural inhibitors (10). Neutrophil elastase
3) is the most potent and, because of its specificity, has
•n established as a means of assessing in vivo neutrophil
ivation (11).
'he endothelial cell damage by NE has recently been
wn to result in cleavage and inactivation of thrombo-
iulin (TM), with the loss of transmembrane and cvtopias-
domains and release of the soluble form into the circu-
on. TM is a glycoprotein that acts as a receptor for
imbin on the endothelial cell surface. It piavs an impor-
t role in maintaining the antithrombogenic property of
endothelial cell via the TM-thrombin-protein C complex
26).
l this study, we assessed the degree of proteolytic activity
eutrophils by determining the changes in NE before and
r reperfusion in liver transplantation. We looked at the
tionship of the changes with the parameters of subse-
nt graft function. Perioperative changes in soluble TM
vl) were used as a marker of endothelial cell damage.
Abbreviations: NE. neutrophil elastase: OLT. orthotopic liver
splantation; PGD, primary graft dysfunction: PNF, primary
nonfunction: sTM. soluble thrombomodulin: TM, thrombo-
llin: WB, venovenous bypass.
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MATERLALS AND METHODS
We studied 19 patients (7 men and 12 women; mean age. 56 = 4.5
years) who had undergone OLT for primary biliary cirrhosis m = 7).
alcoholic liver disease (n = 5), autoimmune hepatitis (n = 4). pnmarv
sclerosing cholangitis (n = 2), and subacute liver failure in= 1).
Blood was taken from an indwelling catheter in the right atrium
before transplantation, during the anhepatic phase, anc then after
reperfusion at 0.5, 1. 2, 6, 9. 12. and 24 hr. Plasma was immediately
separated by centrifugation (3000 rpm for 20 min) and stored at
-40°C for later analysis.
NE measurement. Plasma NE was measured by radioimmunoas¬
say as described previously (13). In brief. 50 pi of standard or sample
was added to 50 p.1 of 125I-elascase (10 ng/ml) and 50 pd of antielas-
tase antibody raised in rabbits and made up to a final voiume of 200
IJ with buffer (0.05 mol of phosphate [pH 7.4], 0.6 moi of NaCL. 2
mmol of EDTA, 20 U/ml heparin, 20 U/ml aprotinin, ana 2% heat
inactivated horse serum).
Samples were incubated at room temperature overnight and sep¬
arated with donkey anti-rabbit immunoglobulin immobilized on
Sepharose. After agitation at room temperature, the bound complex
was separated from the free complex by sedimentation under gravity
through a 10% sucrose solution, aspirated, and counted in a gamma-
counter (NE 1600).
Plasma neutrophil elastase was expressed in ng/ml. and the sen¬
sitivity of the assay was 5 ng/ml with a 4% interassav coefficient of
variation.
Results from the transplant patients were compared with those
from healthy volunteers matched for age. as established in our lab¬
oratory reference ranges.
Soluble TM measurement. Plasma antigen levels of sTM were
determined using an enzyme immunoassay, provided by Diagnostics
stago, Asnieres, France, as described previously (14). In brief, a solid
support (micro-ELISA plate) is coated with a mouse monoclonal
antibody that binds sTM in the assay standard or in the patient's
sampie.
The bound sTM is next revealed by the use of a second mouse
anti-sTM monoclonal antibody labeled with horseradish perioxiaase,
which binds to another antigenic determinant of the sTM molecule
that is remote from the first one. The bound enzymatic activity is
then demonstrated by its oxidative action on the substrate ortho-
phenvlene-diamine in the presence of hydrogen peroxide.
After the reaction has been stopped by the addition of sulfuric
acid, the coloration that is obtained is measured at 492 nm. The
observed optical density is directly proportional to the concentration
of sTM. Results are expressed in ng/ml.
Transplant details. Donor age was 42x6 years. ABO blood group
compatibility and matching of donor-recipient sizes were observed.
As per protocol, grafts with macroscopic steatosis and grafts from
donors with a known history of drug/alcohol abuse were rejected.
University of Wisconsin solution was used for preservation.
All patients underwent venovenous bypass (VVB) during the an¬
hepatic phase. It was started after the porta hepatis was dissected
and the portal vein was clamped. The mean duration of VVB was
72 = 25 min. VVB was discontinued just before the portal vein was
undamped and the donor liver was reperfused.
Details of transfusion of blood and blood products perioperativeiy
were recorded. After OLT, data collected included bile flow, serum
transaminase levels (alanine aminotransferase), and prothrombin
time. These were recorded daily up to the time of discharge, retrans¬
plantation, or death.
Early postoperative graft function was graded according to crite¬
ria described previously (15). Table 1 shows a scoring system depen¬
dent on serum alanine aminotransferase level and prothrombin ac¬
tivity determined 72 hr after surgery, and includes the mean value of
bile output over the first 72 hr after transplantation. For each pa¬
tient. the score was calculated from the sum of the assigned value for
each parameter, ranging from 3 to 9. According to this criterion.
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Table 1. Parameters of scoring system for assessment of early












>60 (with fresh-frozen plasma) 2
<60 (despite fresh-frozen plasma) 0u
" Highest value in 72 hr after transplant. Normal value is up to 40
U/L. .ALT, alanine aminotransferase.
4 Mean value during the first 72 hr after transplant.
c Lowest value in the 72 hr after transplant.
patients with a total score of up to 6 'group I: up to 3: group II: 4-61
were shown to have good outcome. Scores of 7-9 (group III) were
associated with poor outcome.
Analysis. Results are expressed as mean ~ SEM. Statistical sig¬
nificance was accepted for P<0.05. The difference between the time
points was calculated using one-way analysis of variance. The
Tukey-HSD test (analysis of variance) was used to determine the
significance of change in NE in relation to outcome. Spearman's rank
correlation coefficient test was used to determine correlation.
RESULTS
Before OLT, the mean NE level was 40.13=4.84 ng/'ml.
which was significantly higher than levels of normal controls
(18.7=5.6 ng/ml, P<0.05). During the early anhepatic phase.
NE levels increased moderately to 71.28=9.11 ng/mi
(P<0.05). After unciamping of the portal vein (i.e., reperfu-
sion), there was a marked increase in NE antigen, which
peaked 2 hr after reperfusion (370=50.5 ng/ml, PcO.OOl).
Although there was a gradual decline in the levels of NE.
they remained elevated 24 hr after reperfusion (186=60.94
ng/ml), although this was not statistically significant (Fig. 1).
Two patients died ofgraft failure on days 7 and 12. Another
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Figure 2. Changes in ANE in relation to graft outcome 'patients
classified into three groups according to their total outcome score,
using the criteria in Table 1): group I. miid graft dysfunction, with a
total score up to 3: group II. moderate dysfunction, with a score of
4-6: and group III. severe dysfunction, with a score of 7-9. A total
score of up to 6 is usually associated with good outcome.
which started with initial poor graft function and was later
complicated by acute rejection, septicemia, and massive gas¬
trointestinal bleeding due to multiple cytomegalcmrus-in-
duced ulcers involving different parts of the gastrointestinal
tract. The outcome scores of these patients ranged between 6
and 8.
Mean delta NE (the difference between maximum and
baseline values for each patient) was 224.8 = 36.3 ngunl in
group I. 442.6=48.5 ng/ml in group II. and 720=195.8 ng'ml
in group III. Using analysis ofvariance (Tukey-HSD test), we
found that only patients of group III showed a significant
increase in NE, as compared with group I patients (P<0.05),
Fig. 2.
The mean baseline level of sTM was 81.2= 11.32 ng'inl
(Fig. 3). It increased during the anhepatic phase to 38.5 = 29.8
ng''ml; however, this did not reach statistical significance.
After reperfusion. there was a marked increase in sTM,














Pre 1 2 24
N.EIastase S-thromoomodulin
Pre Ann 1/2 I 6 j IE <1 ^ oFigure 3. Changes in sTM and NE Ieveis before transDiancation
Figure 1. Changes in NE levels before and after reperfusion up to (Pre), dur.ng the anhepatic phase (A), and after reperfusion up to 24
24 hr. Pre, before induction of anesthesia: Anh. anhepatic phase. hr.
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; hr after reperfusion (P<0.05). The mean postreperfusion
'crease of sTM correlated with that of NE (P = 0.042).
Mean requirements were: blood transfusions. 8.07 r 7.47 U
ange. 2-24 U); platelets, 5.47r 1.36 U (range. 0-20 (J);
yoprecipitates, 4.2rl.88 U (range. 0-20 U), and tresh-
ozen plasma. 8.27rl.01 U (range. 2-15 U). There was no
-gruficant difference in any of the above parameters in the
itients of the different groups. No significant correlation
as found between these parameters and the changes in NE
• sTM.
DISCUSSION
Histological studies demonstrating infiltration of neutro-
hils in tissues that had been exposed to transient ischemia
illowed by reperfusion support the notion that neutrophils
jntribute to reperfusion injury (7). Once released from neu-
-ophils, NE causes direct damage to intact ceils and inacti-
ates various proteins, such as immunoglobulins, comple-
lents, and clotting factors (10). Furthermore. NE facilitates
lcreased generation of free radicals by converting xanthine
ehyarogenase into oxidase in the vascular endothelial cells
'6). Such an effect would set the scene for a vicious cycle by
nich free radicals, in addition to their direct tissue damage,
oula contribute to further neutrophil chemoattraction, roll-
ig, and adhesion via enhancing expression of pro-inflamma-
iry mediators such as adhesion molecules (e.g., GMP-140),
iatelet-activating factor, and the leukotriene LTB4 (17-19).
ree radicals also inhibit neutralizing NE by its specific
ihibitor a,-antitrypsin via oxidation of methionine at posi-
on Met 353 (20).
We have shown that the baseline values of NE in the
itients studied were higher than those of a healthy volun-
er population. This is in keeping with the observations of
-evious studies from our group, and others that demon-
rated evidence of neutrophil activation in patients with
ironic liver diseases, particularly those with am alcohoiic
iology (21, 22).
The level of NE increased markedly after reperfusion and
as sustained for several hours thereafter. The relatively
tort duration between the samples taken during the anhe-
itic phase and samples from the early postreperfusion pe-
od further suggests that neutrophil activation, rather than,
r instance, delayed renal or hepatic clearance, is the likely
echanism of such changes.
Changes in NE activity after reperfusion were significantly
gher in patients with poor graft function, using the criteria
iscribed in Table 1. Patients in group II showed higher
ean NE levels compared with group I patients; however,
e changes did noc reach statistical significance. The high-
t values were seen in two of the three patients who died
ter surgery as a result of poor graft function. Such findings
rther suggest that neutrophils play a significant role in the
iology of reperfusion injury.
The degree of rise in NE levels following reperfusion seen
this study was markedly higher than that detected in
naitions such as acute myocardial infarction, multiple
luma. or inflammatory bowel diseases (13, 23, 24). This
ignt indicate more significant neutrophil-induced damage
lowing liver graft reperfusion when compared with the
ove-mentioned conditions. The fact that we collected our
mples from a site more central and closer to the likely site
of increased activity could have played a significant role in
such differences.
.Although WB could potentially cause neutrophil activa¬
tion. we do not believe that WE played a significant role in
the changes seen in this study, as the most marked increase
in NE levels occurred well after WE was discontinued and
remained so for several hours thereafter. In some patients,
significantly high levels of NE were seen 24 hr after discon¬
tinuation of WE. In addition, the continuous infusion of
aprotinin. which inhibits platelet aggregation and formation
of NE-al antitrypsin complex during WE. reduces neutro¬
phil activation further (25).
In this study, sTM levels increased significantly after
reperfusion. which is comparable to the results of a recent
study in patients who had OLT (26). Mean perioperative
changes of sTM correlated with that of NE. which may fur¬
ther support the hypothesis that release of sTM from endo¬
thelial cells into the circulation is a consequence of neutro¬
phil activation.
Neutrophilic proteases were shown to decrease TM activity
of the endothelial ceil membrane by a specific hydrogen per¬
oxide (HoOo) facilitating mechanism. This is thought to be
oxidation of Met 388 in the TM molecule (27). Loss of the
anticoagulant property of the endothelial surface in such a
mechanism potentially leads to microcircuiacory stagnation
and tissue ischemia, and this might explain the onset of the
no-reflow phenomenon, a recognized feature of preservation-
reperfusion injury.
In conclusion, this study demonstrates a significant degree
of neutrophil activation following graft reperfusion during
OLT, with evidence of endothelial cell damage as a result of
such activity. The degree of activation correlated with the
severity of PGD, which may suggest a role for neutrophils in
its etiology. Further work is required to understand the im¬
portant factors that determine neutrophil chemoattraction
and activation following reperfusion. This will help in devel¬
oping strategies to prevent such damage and improve graft
function.
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RELATIONSHIP OF FK506 WHOLE BLOOD CONCENTRATIONS
AND EFFICACY AND TOXICITY AFTER LIVER AND KIDNEY
TRANSPLANTATION
Ronald P. Kershner1 and William E. Fitzslmmons
FK506 (tacrolimus) is a safe and effective immuno¬
suppressant for the prevention of organ rejection af¬
ter organ transplantation. FK506 has a relatively nar¬
row therapeutic index and the correlation of dose to
blood concentration is poor as a result of moderate
variability in pharmacokinetic parameters between
patients. Therapeutic monitoring of whole blood
FK506 drug concentrations has been used in an effort
to determine whether a relationship exists between
1 Address correspondence to: Dr. Ronald P. Kershner. Fujisawa
USA, Inc., Three Parkway North. Deerfield, IL 60015.
Fujisawa USA, Inc., Deerfield, Illinois 60015
concentrations of FK506 in the blood and the develop¬
ment of toxicity or the risk for organ rejection. An
analysis of the relationship between FK506 blood lev¬
els and the occurrence of toxicity and rejection was
carried out using data from four recent clinical trials.
Trough FK506 levels within a 7-day window before the
onset of rejection or toxicity were analyzed using lo¬
gistic regression models. In kidney transplant patients
(n=92). a significant correlation between FK506 levels
and the incidence of both toxicity (P=0.01) and rejec¬
tion (P= 0.02) was seen. In liver transplant patients
from three clinical trials, FK506 levels correlated well
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INFLUENCE OF CYCLIC GUANOSINE MONOPHOSPHATE
CHANGES ON HEMODYNAMICS AFTER REPERFUSION IN LIVER
TRANSPLANTATION
K. I. Bzeizi,1 R. Jalan, N. Henderson, H. W. Thomas, A. Lee, and P. C. Hayes
Scottish Liver Transplant Unit and Department of Medicine, Royal Infirmary of Edinburgh. Edinburgh.
Scotland EH3 9YW
Orthotopic liver transplantation (OLT) is often asso¬
ciated with hemodynamic instability upon reperfu-
sion, recognized as postreperfusion syndrome.
Changes in vascular tone due to humoral factors re-
lea.- d upon reperfusion of the graft have been sug¬
gest d as a possible mechanism. In this study, we
looked at the perioperative changes in cyclic
guanosine monophosphate (cGMP), a mediator of vas¬
cular smooth muscle relaxation, and investigated its
relationship with hemodynamic parameters.
cGMP was measured in the plasma of 14 patients
undergoing OLT by radioimmunoassay serially at the
preanhepatic and anhepatic phases, and after reper¬
fusion at 30, 60, and 120 min. Hemodynamic data re¬
corded were systemic and pulmonary arterial pres-
sur s, cardiac output, and pulmonary and systemic
va: ular resistance.
cG-MP decreased markedly after reperfusion from a
baseline level of 5.33±0.7 ng/ml to 1.63+0.5 ng/ml
(PcO.Ol). Pulmonary arterial pressure increased from
17+1.21 mmHg to 23.5±1.9 mmHg (P<0.05), and pulmo¬
nary vascular resistance increased from 62.8+12.9
dynes/sec/cm3 to 135+42.7 dynes/sec/cm5 (P<0.01).
Changes in cardiac output and systemic vascular re¬
sistance were not significant. The changes in cGMP
correlated with pulmonary arterial pressure (r=0.74,
P=9.005) and pulmonary vascular resistance (r=0.7,
^-0.01).
1
Address correspondence to: K.I. Bzeizi, Department of Medicine,
R°yal Infirmary of Edinburgh, Lauriston Place, Edinburgh. EH3
9YW Scotland.
These data confirm the occurrence of hemodynamic
changes during OLT, and provide evidence to suggest
that the reduction in cGMP after reperfusion may me¬
diate the vascular changes.
The reperfusion phase during orthotopic liver transplanta¬
tion (OLT*) is a critical event with well-recognized and some¬
times profound hemodynamic and cardiac changes that may
be responsible for intraoperative death (1). The hemody¬
namic changes, defined as postreperfusion syndrome, are
predominantly an increase in pulmonary capillary wedge
pressure (PCWP) and central venous pressure (CVP), along
with a reduction in mean arterial pressure (MAP) and sys¬
temic vascular resistance. Such hemodynamic derangement
tends to improve in the majority of patients within 30-60
min, requiring only cardiovascular pharmacological support.
However, the changes may be severe enough in a small
proportion of patients to be life threatening (2).
Several potential mechanisms for these changes have been
considered, including sudden influx of cold, acidic and hy-
perkalemic blood, embolization, and release of vasoactive
substances from the grafted liver (3). The ischemia and
reperfusion that accompany organ transplantation are asso-
* Abbreviations: cGMP, cyclic guanosine monophosphate; CO, car¬
diac output; CVP, central venous pressure; MAP. mean arterial
pressure; NO, nitric oxide; OLT, orthotopic liver transplantation;
PAP, pulmonary arterial pressure; PCWP, pulmonary capillary
wedge pressure; PVR, pulmonary vascular resistance; SVR, systemic
vascular resistance.
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ciated with release of proinflammatory mediators, genera¬
tion of free radicals, and neutrophil sequestration and acti¬
vation (4). Such mediators could influence endothelial cell
function, and lead to disturbance of vasomotor control. Free
radicals have been shown to counteract the relaxation effects
of nitric oxide (NO) on vascular smooth muscle cells via
inhibition of guanylyl cyclase and reduction in the release of
cyclic guanosine 3',5'-monophosphate (cGMP) from endothe¬
lial cells (5).
This study was designed to test the hypothesis that the
hemodynamic changes associated with reperfusion may be
due to alteration in cGMP activity.
PATIENTS AND METHODS
Patient details. Fourteen patients (six men and eight women)
with a mean age of 52.4±5.4 years were studied. The indication for
transplantation was primary biliary cirrhosis (n= 6), alcoholic liver
disease (n= 5), and cryptogenic cirrhosis (n= 3). All patients under¬
went venovenous bypass during the anhepatic phase of the trans¬
plant procedure, with a mean duration of the anhepatic phase of
71.5±9.3 min.
Detailed hemodynamic measurements were recorded after induc¬
tion of anesthesia, during the anhepatic phase, and after reperfusion
at 30, 60, and 120 min. Pulmonary arterial pressure (PAP) and
PCWP were measured using a Swan-Ganz catheter, and MAP was
measured continuously using an intra-arterial line. Cardiac output
(CO) measurements were obtained in triplicate using the thermodi-
lution technique. Systemic vascular resistance (SVR) and pulmonary
vascular resistance (PVR) was calculated using the standard equa¬
tions: SVR i dynes/sec/cm') = (MAP - CVP) x 79.9/CO, and PVR
(dynes/sec/cm''') = (PAP - PCWP) x 79.9/CO.
We also recorded the amount of fluid administered to maintain
hemodynamic stability, and the blood products used to maintain
hemoglobin concentration >10 g/dl. platelet count >50xl0f'/L, and
prothrombin time <16 sec.
Measurement of cGMP. Blood samples were collected from a cath¬
eter placed at the right atrium at the same time points as the
hemodynamic recordings. Plasma was separated immediately (cen-
trifuged for 15 min at 3000Xg) and stored at -40°C until analysis.
cGMP was measured as described previously (6). Standards and
samples were assayed in duplicate. The standard was prepared by
double dilution of a stock of 32 nmol/L solution of cGMP to yield a
concentration gradient from 0.03125-32 nmol/L. One hundred mi¬
croliters of each concentration were assayed as described below for
the samples.
Plasma (500 p.1) was extracted into 1 ml of ethanol. The ethanolic
fraction was dried under air, and the pellet was resuspended in 500
p.1 of assay buffer. Fifteen microliters of acetylation mixture were
added to 100 p.1 of the assay buffer and combined with 150 p.1 of
I125-cGMP (diluted to give 400 cpm/150 /ul) and 100 p.1 of rabbit
anti-human cGMP polyclonal antibody (diluted to give 50-60% bind¬
ing). After thorough mixing, the samples were allowed to equilibrate
for 18 to 24 hr at 4°C. After equilibration, bound and unbound
I l2r'-cGMP were separated by the addition of 600 p.1 of dextran-cQa
charcoal and spinning (3000 rpm, 15 min. 4°C). The aqueous la
was removed and the bound trace was measured on a beta-count
The coefficient of variation for the assay was 3.5%, and the in(,
assay variation was 4.3%. Results are expressed as ng/ml.
Statistical analysis. All results were expressed as mean + §
The difference between mean before and after reperfusion was c
termined by one-way analysis of variance. Correlation between va
ables was determined using Spearman's rank correlation coefficiei
Values were considered statistically significant when the P-Va)
was less than 0.05.
RESULTS
Changes in the hemodynamic parameters are summarizi
in Table 1. The main changes were of PVR and PAP. The P\
increased slightly during the anhepatic phase from a ba£
line value of 62.8 = 12.9 dynes/sec/cm5 to 72.5=9.6 dynes/s(
cm5 (NS). More marked changes were seen after reperfusio
PVR increased to 135 = 42.7 dynes/sec/cmr> (P<0.01), andP/
increased from 17±1.2 mmHg to 22.8 = 2.6 mmHg (P<0.0
30 min after reperfusion. The latter increased to a maximu
of 23.5±1.9 mmHg 2 hr after reperfusion.
CO decreased slightly but not significantly during the a
hepatic phase to 8.8 =0.78 L/min from a mean pretranspla
value of 10.32:2.4 L/min. MAP decreased significantly at
min after reperfusion (P<0.05), but improved spontaneous
and subsequently returned to baseline values.
The mean pretransplant level of cGMP was 5.332:0.7 ng/:
(Fig. 1), which was significantly higher than the levels
healthy volunteers (1.352:0.43 ng/ml, n=10. P<0.01). cGft
increased marginally during the anhepatic phase
6.31 = 0.76 ng/ml (NS), but after reperfusion there was
rapid and significant decrease in cGMP to 1.632:0.50 ng/
(P<0.01).
The baseline cGMP correlated inversely with SVR a
MAP (P<0.05 and P=0.023, respectively) and directly wi
PVR recorded at the same time point (P<0.05). The corre
tion, however, was more obvious between the mean chang
in postreperfusion cGMP and those of PVR (r=0.7, P=0.(
n=12) and PAP (r=0.74, P=0.005, n=12) (Figs. 2 and 3). 1
correlation was detected between the intraoperative cGD
changes and those of CVP and CO at any time point.
Requirements were: mean blood transfusion, 7.3±4.2
(range, 2-18 U); cryoprecipitates, 3.6±1.5 U (0-16 U); pla
lets, 5.2±1.3 U (0-10 U); and fresh frozen plasma, 7.5=2.1
(2-12 U). No correlation was found between these paran
ters and the changes in cGMP.
All patients received dopamine at a fixed infusion rate o
/xg/kg/min. Seven patients required noradrenaline (8 mg/1
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FlGUKE 1. The perioperative profile of cGMP (PRE = preanhepatic,
.nhepatic, and 30, 60, and 120 min = postreperfusion time
points . Control: 1.35±0.43 ng/ml.
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FlG' 2. Correlation of the changes in cGMP (difference between
pretn.nsplant value and minimum postreperfusion one for each pa¬
tient) with those of PVR (r=0.7, P=0.01).
required adrenaline (1:100,000) at a rate of 3 ± 0.5 ml/hr. The
mean postreperfusion change in cGMP was 2.9i0.7 ng/ml in
these patients and 2.7±0.65 ng/ml in patients who did not
require any support (NS).
DISCUSSION
s study confirms the previous observations of major
hemodynamic disturbances during OLT (7). The most strik¬
ing changes were in PVR and PAP, both of which rose shortly
after reperfusion. The changes in PVR and PAP correlated
with the changes in cGMP levels.
cGMP, the vascular smooth muscle cell relaxant (5), was
elevated in this group of patients with end-stage chronic liver
disease prior to transplantation. Reduction in the concentra¬
tion of cGMP after reperfusion could be a result of decreased
activity of its main stimulants, or perhaps it could represent
mere normalization. Whatever the mechanism behind such
changes, the reduction in cGMP levels after reperfusion of
'he graft and the correlation with the changes in the pulmo-
nary hemodynamic parameters suggest a causal relation¬
ship.
Although levels of cGMP continued to fall after reperfu-
2 3 4 5 6
Change in cGMP (ng/ml)
Figure 3. Correlation of the changes in cGMP with the those of PAP
(r=0.74, P = 0.005).
sion, PVR showed signs of recovery. There is no direct expla¬
nation for these changes. One possibility could be the release
of other vasomotor mediators that may interfere with the
actions of cGMP. Prolongation of the hemodynamic readings
and measurements of cGMP for several hours afterward may
help delineate this relationship further.
Our finding of elevated pretransplant cGMP levels is com¬
parable to previous reports of elevated levels ofNO, the main
stimulant of cGMP generation in patients with cirrhosis (3,
.9). Niederberger et al. (10) have shown in a cirrhotic animal
model an increase in aortic cGMP that was reduced signifi¬
cantly after inhibition of NO production by the NO synthase
inhibitor N''-monomethyl-L-arginine. This reduction in NO
was followed by reversal of the hyperdynamic abnormalities
of the systemic circulation. Recently, Sogni et al. (77) showed
a significant correlation between endogenous NO and the
pulmonary vasodilatation seen in cirrhosis. Addition of the
cGMP analog 8-(4rchlorophenylthioi-guanosine-3',5'-cGMP
to the preservation fluid in an experimental rat model of lung
transplantation led to a significant reduction of PVR and an
increase in pulmonary artery blood flow after reperfusion
(12). These findings further support our conclusion about the
role of cGMP in the hemodynamic alterations observed dur¬
ing transplantation.
Although cGMP may be generated by pathways that do not
involve NO, such as stimulation of membrane-associated
guanylyl cyclase by atrial natriuretic peptide or by entero-
toxins, NO is the major stimulant for cGMP release from the
soluble guanylyl cyclase (13). cGMP is released by virtually
all cell types through activation of guanylyl cyclase. The
levels of cGMP are regulated by its rate of synthesis by
guanylyl cyclase and its rate of hydrolysis by cyclic nucleotide
phosphodiesterase (14), and its half-life ranges between 10
and 20 min (15).
The release and effects of cGMP and NO could be influ¬
enced by free radicals, which are generated after ischemia-
reperfusion. NO is the only known biological molecule that
can be produced in high enough concentrations to outcompete
superoxide dismutase for radicals. This interaction results in
formation of peroxymtrite anion (ONOO"), a radical with
vasomotor properties unlike those of its parent compound
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NO (16). Superoxide anion has been shown to induce vaso¬
constriction, and is known to have a direct inhibitory effect
on guarivlyl cyclase that leads to a decrease in cGMP produc¬
tion (5). It is plausible to consider that free radicals could
play a role in the changes of cGMP observed in this study.
In summary, this study demonstrates hemodynamic
changes affecting predominantly the pulmonary vasculature
after reperfusion of liver graft during OLT. These changes
correlated significantly with a reduction in the levels of
cGMP, the mediator of vascular smooth muscle relaxation,
which indicates a causal relationship. Further studies look¬
ing at the relationship of cGMP and NO with the other
mediators that rise after graft reperfusion will be of major
interest. These will provide the pathophysiological basis for
therapeutic options of maintaining cardiovascular stability
during the critical phase of reperfusion in organ transplan¬
tation.
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